|
G |
A2m |
alpha-2-macroglobulin |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of A2M protein |
CTD |
PMID:34896426 |
|
NCBI chr 6:121,612,920...121,656,197
Ensembl chr 6:121,612,335...121,656,186
|
|
G |
Aass |
aminoadipate-semialdehyde synthase |
increases expression |
EXP |
cypermethrin results in increased expression of AASS mRNA |
CTD |
PMID:21142847 |
|
NCBI chr 6:23,072,172...23,132,985
Ensembl chr 6:23,072,172...23,132,985
|
|
G |
Abat |
4-aminobutyrate aminotransferase |
decreases activity |
EXP |
cypermethrin results in decreased activity of ABAT protein |
CTD |
PMID:24220872 |
|
NCBI chr16:8,331,293...8,439,432
Ensembl chr16:8,331,293...8,439,432
|
|
G |
Abcb6 |
ATP-binding cassette, sub-family B member 6 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ABCB6 protein |
CTD |
PMID:34896426 |
|
NCBI chr 1:75,148,284...75,157,066
Ensembl chr 1:75,148,361...75,157,036
|
|
G |
Abcg1 |
ATP binding cassette subfamily G member 1 |
decreases expression |
ISO |
cypermethrin results in decreased expression of ABCG1 mRNA |
CTD |
PMID:25424538 |
|
NCBI chr17:31,276,668...31,336,958
Ensembl chr17:31,276,649...31,336,962
|
|
G |
Abcg5 |
ATP binding cassette subfamily G member 5 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ABCG5 protein |
CTD |
PMID:34896426 |
|
NCBI chr17:84,965,602...84,990,439
Ensembl chr17:84,965,662...84,990,439
|
|
G |
Acer2 |
alkaline ceramidase 2 |
decreases expression |
EXP |
cypermethrin results in decreased expression of ACER2 mRNA |
CTD |
PMID:29020013 |
|
NCBI chr 4:86,792,585...86,853,059
Ensembl chr 4:86,792,633...86,853,059
|
|
G |
Ache |
acetylcholinesterase |
increases activity decreases activity multiple interactions affects activity |
ISO |
cypermethrin results in increased activity of ACHE protein cypermethrin results in decreased activity of ACHE protein [cypermethrin co-treated with fenvalerate] results in decreased activity of ACHE protein; Chlorpyrifos promotes the reaction [cypermethrin results in decreased activity of ACHE protein]; cypermethrin promotes the reaction [Chlorpyrifos results in decreased activity of ACHE protein] cypermethrin affects the activity of ACHE protein |
CTD |
PMID:7595515 PMID:8385837 PMID:10355540 PMID:32006337 |
|
NCBI chr 5:137,286,516...137,292,728
Ensembl chr 5:137,285,781...137,292,728
|
|
G |
Ackr3 |
atypical chemokine receptor 3 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ACKR3 protein |
CTD |
PMID:34896426 |
|
NCBI chr 1:90,131,702...90,143,446
Ensembl chr 1:90,131,702...90,144,473
|
|
G |
Acot2 |
acyl-CoA thioesterase 2 |
decreases expression |
EXP |
cypermethrin results in decreased expression of ACOT2 mRNA |
CTD |
PMID:29020013 |
|
NCBI chr12:84,034,635...84,040,651
Ensembl chr12:84,034,635...84,040,647
|
|
G |
Acox1 |
acyl-Coenzyme A oxidase 1, palmitoyl |
multiple interactions |
EXP |
cypermethrin promotes the reaction [[lard co-treated with Cholesterol co-treated with Sucrose] results in increased expression of ACOX1 mRNA] |
CTD |
PMID:24440342 |
|
NCBI chr11:116,062,714...116,089,605
Ensembl chr11:116,062,714...116,089,871
|
|
G |
Acrv1 |
acrosomal vesicle protein 1 |
decreases expression |
ISO |
cypermethrin results in decreased expression of ACRV1 mRNA |
CTD |
PMID:35605701 |
|
NCBI chr 9:36,604,550...36,610,139
Ensembl chr 9:36,604,516...36,610,139
|
|
G |
Acsbg2 |
acyl-CoA synthetase bubblegum family member 2 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ACSBG2 protein |
CTD |
PMID:34896426 |
|
NCBI chr17:57,150,103...57,181,505
Ensembl chr17:57,150,103...57,181,447
|
|
G |
Actn1 |
actinin, alpha 1 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ACTN1 protein |
CTD |
PMID:34896426 |
|
NCBI chr12:80,214,316...80,307,165
Ensembl chr12:80,214,321...80,307,145
|
|
G |
Adal |
adenosine deaminase-like |
increases expression |
EXP |
cypermethrin results in increased expression of ADAL mRNA |
CTD |
PMID:29020013 |
|
NCBI chr 2:120,970,525...120,989,921
Ensembl chr 2:120,970,909...120,987,161
|
|
G |
Adamts7 |
ADAM metallopeptidase with thrombospondin type 1 motif 7 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of ADAMTS7 protein |
CTD |
PMID:34896426 |
|
NCBI chr 9:90,041,420...90,082,155
Ensembl chr 9:90,045,122...90,090,124
|
|
G |
Adcy2 |
adenylate cyclase 2 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ADCY2 protein |
CTD |
PMID:34896426 |
|
NCBI chr13:68,768,162...69,147,719
Ensembl chr13:68,768,162...69,147,660
|
|
G |
Add1 |
adducin 1 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ADD1 protein |
CTD |
PMID:34896426 |
|
NCBI chr 5:34,731,008...34,789,652
Ensembl chr 5:34,731,008...34,789,652
|
|
G |
Aebp1 |
AE binding protein 1 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of AEBP1 protein |
CTD |
PMID:34896426 |
|
NCBI chr11:5,806,085...5,822,248
Ensembl chr11:5,811,947...5,822,088
|
|
G |
Agt |
angiotensinogen |
affects expression multiple interactions |
ISO |
cypermethrin affects the expression of AGT Sesame Oil affects the reaction [cypermethrin affects the expression of AGT] |
CTD |
PMID:25816392 |
|
NCBI chr 8:125,283,326...125,296,445
Ensembl chr 8:125,283,273...125,296,445
|
|
G |
Ahr |
aryl-hydrocarbon receptor |
multiple interactions |
ISO |
[prothioconazole co-treated with terbutylazine co-treated with bitertanol co-treated with cypermethrin co-treated with Malathion] results in increased activity of AHR protein; cypermethrin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein] |
CTD |
PMID:25684042 |
|
NCBI chr12:35,547,978...35,584,988
Ensembl chr12:35,547,973...35,585,037
|
|
G |
Akt1 |
thymoma viral proto-oncogene 1 |
decreases expression increases expression decreases phosphorylation |
ISO EXP |
cypermethrin results in decreased expression of AKT1 mRNA cypermethrin results in increased expression of AKT1 mRNA cypermethrin results in decreased phosphorylation of AKT1 protein |
CTD |
PMID:22528246 PMID:27704156 PMID:34714723 PMID:37011868 |
|
NCBI chr12:112,620,260...112,641,266
Ensembl chr12:112,620,255...112,641,318
|
|
G |
Alb |
albumin |
decreases expression increases expression multiple interactions |
ISO |
cypermethrin results in decreased expression of ALB mRNA cypermethrin results in increased expression of ALB Sesame Oil inhibits the reaction [cypermethrin results in increased expression of ALB] |
CTD |
PMID:9650644 PMID:11428908 PMID:25816392 |
|
NCBI chr 5:90,608,729...90,624,461
Ensembl chr 5:90,608,756...90,624,461
|
|
G |
Aldh5a1 |
aldhehyde dehydrogenase family 5, subfamily A1 |
decreases expression |
ISO |
cypermethrin results in decreased expression of ALDH5A1 mRNA |
CTD |
PMID:22528246 |
|
NCBI chr13:25,091,562...25,121,740
Ensembl chr13:25,091,562...25,121,644
|
|
G |
Aldh8a1 |
aldehyde dehydrogenase 8 family, member A1 |
decreases expression |
ISO |
cypermethrin results in decreased expression of ALDH8A1 mRNA |
CTD |
PMID:25424538 |
|
NCBI chr10:21,253,199...21,272,477
Ensembl chr10:21,253,190...21,272,484
|
|
G |
Alox15 |
arachidonate 15-lipoxygenase |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ALOX15 protein |
CTD |
PMID:34896426 |
|
NCBI chr11:70,234,973...70,279,465
Ensembl chr11:70,234,978...70,242,857
|
|
G |
Alpl |
alkaline phosphatase, liver/bone/kidney |
multiple interactions increases activity |
EXP ISO |
[cypermethrin co-treated with Chlorpyrifos] results in increased expression of ALPL protein; Plant Extracts inhibits the reaction [[cypermethrin co-treated with Chlorpyrifos] results in increased expression of ALPL protein] cypermethrin results in increased activity of ALPL protein cypermethrin inhibits the reaction [Aldosterone results in increased expression of ALPL mRNA] |
CTD |
PMID:15365239 PMID:15991261 PMID:29149346 |
|
NCBI chr 4:137,469,042...137,523,695
Ensembl chr 4:137,469,044...137,523,695
|
|
G |
Als2 |
alsin Rho guanine nucleotide exchange factor |
increases expression |
EXP |
cypermethrin results in increased expression of ALS2 mRNA |
CTD |
PMID:21142847 |
|
NCBI chr 1:59,201,915...59,276,390
Ensembl chr 1:59,202,085...59,276,390
|
|
G |
Amh |
anti-Mullerian hormone |
increases expression decreases expression multiple interactions |
ISO EXP |
cypermethrin results in increased expression of AMH mRNA; cypermethrin results in increased expression of AMH protein cypermethrin results in decreased expression of AMH mRNA; cypermethrin results in decreased expression of AMH protein [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of AMH mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of AMH mRNA |
CTD |
PMID:34896426 PMID:35031408 PMID:35102696 PMID:35605701 PMID:36053783 |
|
NCBI chr10:80,641,074...80,643,513
Ensembl chr10:80,641,077...80,643,482
|
|
G |
Ank |
progressive ankylosis |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ANKH protein |
CTD |
PMID:34896426 |
|
NCBI chr15:27,466,763...27,594,995
Ensembl chr15:27,466,763...27,594,995
|
|
G |
Anxa6 |
annexin A6 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ANXA6 protein |
CTD |
PMID:34896426 |
|
NCBI chr11:54,869,779...54,924,297
Ensembl chr11:54,869,934...54,924,271
|
|
G |
Apaf1 |
apoptotic peptidase activating factor 1 |
increases expression multiple interactions decreases expression |
ISO EXP |
cypermethrin results in increased expression of APAF1 mRNA; cypermethrin results in increased expression of APAF1 protein [Chlorpyrifos co-treated with cypermethrin] results in decreased expression of APAF1 protein; Chlorpyrifos promotes the reaction [cypermethrin results in decreased expression of APAF1 mRNA]; cypermethrin promotes the reaction [Chlorpyrifos results in decreased expression of APAF1 mRNA] cypermethrin results in decreased expression of APAF1 mRNA; cypermethrin results in decreased expression of APAF1 protein |
CTD |
PMID:27704156 PMID:34559034 PMID:36063984 |
|
NCBI chr10:90,825,173...90,918,688
Ensembl chr10:90,825,173...90,918,632
|
|
G |
Apc |
APC, WNT signaling pathway regulator |
increases expression |
EXP ISO |
cypermethrin results in increased expression of APC mRNA |
CTD |
PMID:21142847 PMID:22528246 |
|
NCBI chr18:34,353,350...34,455,243
Ensembl chr18:34,353,977...34,455,605
|
|
G |
Apln |
apelin |
increases expression |
EXP |
cypermethrin results in increased expression of APLN mRNA |
CTD |
PMID:29020013 |
|
NCBI chr X:47,114,023...47,123,730
Ensembl chr X:47,114,023...47,123,730
|
|
G |
Aplnr |
apelin receptor |
increases expression |
EXP |
cypermethrin results in increased expression of APLNR mRNA |
CTD |
PMID:29020013 |
|
NCBI chr 2:84,966,704...84,970,267
Ensembl chr 2:84,966,569...84,970,267
|
|
G |
Apoa1 |
apolipoprotein A-I |
increases expression |
ISO |
cypermethrin results in increased expression of APOA1 mRNA |
CTD |
PMID:9650644 |
|
NCBI chr 9:46,139,928...46,141,767
Ensembl chr 9:46,139,878...46,141,764
|
|
G |
Apob |
apolipoprotein B |
increases expression |
ISO |
cypermethrin results in increased expression of APOB mRNA |
CTD |
PMID:9650644 |
|
NCBI chr12:8,027,629...8,066,839
Ensembl chr12:8,027,648...8,066,835
|
|
G |
Apoe |
apolipoprotein E |
decreases expression increases expression |
ISO EXP |
cypermethrin results in decreased expression of APOE mRNA cypermethrin results in increased expression of APOE mRNA |
CTD |
PMID:9650644 PMID:11428908 PMID:21142847 |
|
NCBI chr 7:19,430,169...19,434,326
Ensembl chr 7:19,430,034...19,433,113
|
|
G |
Aqp1 |
aquaporin 1 |
decreases expression |
EXP |
cypermethrin results in decreased expression of AQP1 mRNA |
CTD |
PMID:35031408 |
|
NCBI chr 6:55,313,284...55,325,540
Ensembl chr 6:55,313,417...55,325,540
|
|
G |
Aqr |
aquarius |
increases expression |
EXP |
cypermethrin results in increased expression of AQR mRNA |
CTD |
PMID:21142847 |
|
NCBI chr 2:113,931,642...114,005,788
Ensembl chr 2:113,931,651...114,017,505
|
|
G |
Ar |
androgen receptor |
multiple interactions decreases activity decreases expression |
ISO EXP |
[bitertanol co-treated with propiconazole co-treated with cypermethrin] inhibits the reaction [Dihydrotestosterone binds to and results in increased activity of AR protein]; [Dihydrotestosterone co-treated with cypermethrin] results in decreased expression of AR mRNA; [terbutylazine co-treated with bitertanol co-treated with propiconazole co-treated with cypermethrin co-treated with Malathion] inhibits the reaction [Dihydrotestosterone binds to and results in increased activity of AR protein]; [terbutylazine co-treated with bitertanol co-treated with propiconazole co-treated with cypermethrin co-treated with Malathion] results in decreased activity of AR protein; cypermethrin inhibits the reaction [Dihydrotestosterone results in increased activity of AR protein]; cypermethrin inhibits the reaction [Metribolone results in increased activity of AR protein] cypermethrin results in decreased activity of AR protein cypermethrin results in decreased expression of AR mRNA; cypermethrin results in decreased expression of AR protein cypermethrin inhibits the reaction [AR protein binds to SRC protein] [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of AR mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of AR mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of AR mRNA |
CTD |
PMID:16857237 PMID:17980950 PMID:18324785 PMID:20410157 PMID:22147539 PMID:23871939 PMID:24810582 PMID:30974244 PMID:33051911 PMID:33396045 PMID:34794910 PMID:34896426 More...
|
|
NCBI chr X:97,192,363...97,366,824
Ensembl chr X:97,192,375...97,366,821
|
|
G |
Arg1 |
arginase, liver |
multiple interactions |
EXP |
cypermethrin promotes the reaction [Lipopolysaccharides results in increased expression of ARG1 mRNA] |
CTD |
PMID:29471534 |
|
NCBI chr10:24,791,105...24,803,368
Ensembl chr10:24,791,119...24,803,382
|
|
G |
Armc5 |
armadillo repeat containing 5 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ARMC5 protein |
CTD |
PMID:34896426 |
|
NCBI chr 7:127,836,460...127,844,272
Ensembl chr 7:127,836,514...127,844,272
|
|
G |
Armcx5 |
armadillo repeat containing, X-linked 5 |
decreases expression |
EXP |
cypermethrin results in decreased expression of ARMCX5 mRNA |
CTD |
PMID:29020013 |
|
NCBI chr X:134,643,482...134,648,077
Ensembl chr X:134,643,482...134,648,071
|
|
G |
Arpc1b |
actin related protein 2/3 complex, subunit 1B |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of ARPC1B protein |
CTD |
PMID:34896426 |
|
NCBI chr 5:145,051,066...145,064,996
Ensembl chr 5:145,051,025...145,067,515
|
|
G |
Atf6 |
activating transcription factor 6 |
multiple interactions increases expression |
ISO |
Quercetin inhibits the reaction [cypermethrin results in increased expression of ATF6 mRNA] |
CTD |
PMID:35876585 |
|
NCBI chr 1:170,532,026...170,696,414
Ensembl chr 1:170,532,243...170,695,340
|
|
G |
Atg12 |
autophagy related 12 |
increases expression |
ISO |
cypermethrin results in increased expression of ATG12 mRNA |
CTD |
PMID:27704156 |
|
NCBI chr18:46,865,484...46,874,683
Ensembl chr18:46,863,211...46,874,647
|
|
G |
Atg3 |
autophagy related 3 |
increases expression |
ISO |
cypermethrin results in increased expression of ATG3 mRNA |
CTD |
PMID:27704156 |
|
NCBI chr16:44,979,192...45,008,901
Ensembl chr16:44,979,148...45,008,901
|
|
G |
Atg5 |
autophagy related 5 |
increases expression |
ISO |
cypermethrin results in increased expression of ATG5 mRNA |
CTD |
PMID:27704156 |
|
NCBI chr10:44,144,325...44,240,295
Ensembl chr10:44,144,354...44,240,287
|
|
G |
Atg7 |
autophagy related 7 |
increases expression |
ISO |
cypermethrin results in increased expression of ATG7 mRNA |
CTD |
PMID:27704156 |
|
NCBI chr 6:114,620,075...114,837,565
Ensembl chr 6:114,620,058...114,837,575
|
|
G |
Atm |
ataxia telangiectasia mutated |
increases expression |
EXP |
cypermethrin results in increased expression of ATM mRNA |
CTD |
PMID:21142847 |
|
NCBI chr 9:53,348,422...53,448,125
Ensembl chr 9:53,350,449...53,448,040
|
|
G |
Atn1 |
atrophin 1 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ATN1 protein |
CTD |
PMID:34896426 |
|
NCBI chr 6:124,719,507...124,733,450
Ensembl chr 6:124,719,507...124,733,487 Ensembl chr 6:124,719,507...124,733,487
|
|
G |
Atp2a1 |
ATPase, Ca++ transporting, cardiac muscle, fast twitch 1 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ATP2A1 protein |
CTD |
PMID:34896426 |
|
NCBI chr 7:126,045,032...126,062,245
Ensembl chr 7:126,045,030...126,062,280
|
|
G |
Atp5mk |
ATP synthase membrane subunit k |
decreases expression |
EXP |
cypermethrin results in decreased expression of ATP5MK mRNA |
CTD |
PMID:29020013 |
|
NCBI chr19:47,071,910...47,079,086
Ensembl chr19:47,071,903...47,079,086
|
|
G |
Atp5pd |
ATP synthase peripheral stalk subunit d |
decreases expression multiple interactions |
ISO |
cypermethrin results in decreased expression of ATP5PD protein Minocycline inhibits the reaction [cypermethrin results in decreased expression of ATP5PD protein] |
CTD |
PMID:21561882 |
|
NCBI chr11:115,306,517...115,310,775
Ensembl chr11:115,306,515...115,310,788
|
|
G |
Atp6v1f |
ATPase, H+ transporting, lysosomal V1 subunit F |
increases expression |
ISO |
cypermethrin results in increased expression of ATP6V1F mRNA |
CTD |
PMID:22528246 |
|
NCBI chr 6:29,467,782...29,470,508
Ensembl chr 6:29,467,717...29,470,511
|
|
G |
Atp6v1g2 |
ATPase, H+ transporting, lysosomal V1 subunit G2 |
increases expression |
ISO |
cypermethrin results in increased expression of ATP6V1G2 mRNA |
CTD |
PMID:27704156 |
|
NCBI chr17:35,453,910...35,457,743
Ensembl chr17:35,452,636...35,457,743
|
|
G |
Atr |
ataxia telangiectasia and Rad3 related |
decreases expression |
ISO |
cypermethrin results in decreased expression of ATR protein |
CTD |
PMID:36063984 |
|
NCBI chr 9:95,739,655...95,834,813
Ensembl chr 9:95,739,650...95,833,834
|
|
G |
Atrx |
ATRX, chromatin remodeler |
increases expression |
EXP |
cypermethrin results in increased expression of ATRX mRNA |
CTD |
PMID:21142847 |
|
NCBI chr X:104,841,221...104,972,978
Ensembl chr X:104,841,221...104,973,009
|
|
G |
Avil |
advillin |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of AVIL protein |
CTD |
PMID:34896426 |
|
NCBI chr10:126,835,933...126,856,857
Ensembl chr10:126,836,578...126,856,863
|
|
G |
B3galt4 |
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4 |
increases expression |
EXP |
cypermethrin results in increased expression of B3GALT4 mRNA |
CTD |
PMID:29020013 |
|
NCBI chr17:34,168,886...34,170,462
Ensembl chr17:34,168,883...34,170,462
|
|
G |
Bambi |
BMP and activin membrane-bound inhibitor |
increases expression |
EXP |
cypermethrin results in increased expression of BAMBI mRNA |
CTD |
PMID:29020013 |
|
NCBI chr18:3,507,011...3,516,404
Ensembl chr18:3,507,923...3,516,404
|
|
G |
Bax |
BCL2-associated X protein |
increases expression multiple interactions affects localization |
ISO |
cypermethrin results in increased expression of BAX mRNA; cypermethrin results in increased expression of BAX protein [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of BAX mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of BAX mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of BAX mRNA; Cyclosporine inhibits the reaction [cypermethrin affects the localization of BAX protein]; HBEGF protein inhibits the reaction [cypermethrin results in increased expression of BAX protein]; Mn(III) 5,10,15,20-tetrakis(N-methylpyridinium-2-yl)porphyrin inhibits the reaction [cypermethrin affects the localization of BAX protein]; Quercetin inhibits the reaction [cypermethrin results in increased expression of BAX mRNA]; Quercetin inhibits the reaction [cypermethrin results in increased expression of BAX protein] Acetylcysteine inhibits the reaction [cypermethrin results in increased expression of BAX mRNA] |
CTD |
PMID:22048644 PMID:22528246 PMID:25370934 PMID:29945211 PMID:32028016 PMID:33396045 PMID:34896426 PMID:35876585 PMID:36053783 More...
|
|
NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322
|
|
G |
Bcan |
brevican |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of BCAN protein |
CTD |
PMID:34896426 |
|
NCBI chr 3:87,894,839...87,908,458
Ensembl chr 3:87,894,838...87,907,537
|
|
G |
Bcl2 |
B cell leukemia/lymphoma 2 |
multiple interactions decreases expression increases expression |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of BCL2 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of BCL2 mRNA; HBEGF protein inhibits the reaction [cypermethrin results in decreased expression of BCL2 protein]; Quercetin inhibits the reaction [cypermethrin results in decreased expression of BCL2 mRNA]; Quercetin inhibits the reaction [cypermethrin results in decreased expression of BCL2 protein] cypermethrin results in decreased expression of BCL2 mRNA; cypermethrin results in decreased expression of BCL2 protein cypermethrin results in increased expression of BCL2 mRNA |
CTD |
PMID:22048644 PMID:22528246 PMID:27704156 PMID:32028016 PMID:33396045 PMID:34896426 PMID:35876585 PMID:36053783 More...
|
|
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
|
|
G |
Bcl2l1 |
BCL2-like 1 |
multiple interactions decreases expression increases expression |
ISO EXP |
HBEGF protein inhibits the reaction [cypermethrin results in decreased expression of BCL2L1 protein] cypermethrin results in increased expression of BCL2L1 mRNA cypermethrin results in decreased expression of BCL2L1 mRNA |
CTD |
PMID:22048644 PMID:27704156 PMID:34714723 |
|
NCBI chr 2:152,600,652...152,673,632
Ensembl chr 2:152,622,588...152,673,648
|
|
G |
Bcl6 |
B cell leukemia/lymphoma 6 |
multiple interactions |
EXP |
[[[cypermethrin results in decreased expression of MIR155 mRNA] which results in increased expression of BCL6 mRNA] which results in decreased expression of MAP2K4 protein] which results in decreased phosphorylation of and results in decreased activity of MAPK8 protein; [[[cypermethrin results in decreased expression of MIR155 mRNA] which results in increased expression of BCL6 mRNA] which results in decreased expression of MAP2K4 protein] which results in decreased phosphorylation of and results in decreased activity of MAPK9 protein; [[cypermethrin results in decreased expression of MIR155 mRNA] which results in increased expression of BCL6 mRNA] which results in decreased expression of MAP2K4 protein; [cypermethrin results in decreased expression of MIR155 mRNA] which results in increased expression of BCL6 mRNA |
CTD |
PMID:29471534 |
|
NCBI chr16:23,780,058...23,807,602
Ensembl chr16:23,783,802...23,807,602
|
|
G |
Bclaf1 |
BCL2-associated transcription factor 1 |
increases expression |
ISO |
cypermethrin results in increased expression of BCLAF1 protein |
CTD |
PMID:36063984 |
|
NCBI chr10:20,187,897...20,218,390
Ensembl chr10:20,188,215...20,220,359
|
|
G |
Bdnf |
brain derived neurotrophic factor |
multiple interactions increases expression |
EXP ISO |
cypermethrin inhibits the reaction [Veratridine results in increased expression of BDNF mRNA] cypermethrin results in increased expression of BDNF mRNA |
CTD |
PMID:11082455 PMID:16166269 |
|
NCBI chr 2:109,505,045...109,557,388
Ensembl chr 2:109,505,045...109,557,352
|
|
G |
Birc2 |
baculoviral IAP repeat-containing 2 |
increases expression |
ISO |
cypermethrin results in increased expression of BIRC2 mRNA |
CTD |
PMID:27704156 |
|
NCBI chr 9:7,818,227...7,837,123
Ensembl chr 9:7,818,228...7,837,065
|
|
G |
Bmf |
BCL2 modifying factor |
increases expression |
ISO EXP |
cypermethrin results in increased expression of BMF mRNA cypermethrin results in increased expression of BMF mRNA; cypermethrin results in increased expression of BMF protein |
CTD |
PMID:27704156 PMID:35031408 |
|
NCBI chr 2:118,359,238...118,385,240
Ensembl chr 2:118,359,238...118,380,168
|
|
G |
Bmp2 |
bone morphogenetic protein 2 |
decreases expression |
EXP |
cypermethrin results in decreased expression of BMP2 mRNA; cypermethrin results in decreased expression of BMP2 protein |
CTD |
PMID:36116546 |
|
NCBI chr 2:133,394,079...133,404,816
Ensembl chr 2:133,394,079...133,404,805
|
|
G |
Bnip3 |
BCL2/adenovirus E1B interacting protein 3 |
increases expression |
ISO |
cypermethrin results in increased expression of BNIP3 mRNA |
CTD |
PMID:32028016 |
|
NCBI chr 7:138,492,565...138,511,235
Ensembl chr 7:138,492,565...138,511,248
|
|
G |
Braf |
Braf transforming gene |
increases expression |
ISO |
cypermethrin results in increased expression of BRAF mRNA |
CTD |
PMID:22528246 |
|
NCBI chr 6:39,580,171...39,702,592
Ensembl chr 6:39,580,171...39,702,397
|
|
G |
Brca1 |
breast cancer 1, early onset |
decreases expression multiple interactions |
ISO |
cypermethrin results in decreased expression of BRCA1 protein [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of BRCA1 protein |
CTD |
PMID:34896426 PMID:36063984 |
|
NCBI chr11:101,379,587...101,442,808
Ensembl chr11:101,379,590...101,442,781
|
|
G |
Brdt |
bromodomain, testis-specific |
multiple interactions |
ISO |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of BRDT mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of BRDT mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of BRDT mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of BRDT protein |
CTD |
PMID:33051911 PMID:33396045 PMID:34896426 |
|
NCBI chr 5:107,478,982...107,534,927
Ensembl chr 5:107,479,025...107,534,924
|
|
G |
Brinp3 |
bone morphogenetic protein/retinoic acid inducible neural specific 3 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of BRINP3 protein |
CTD |
PMID:34896426 |
|
NCBI chr 1:146,371,367...146,778,210
Ensembl chr 1:146,370,498...146,778,210
|
|
G |
Btg2 |
BTG anti-proliferation factor 2 |
decreases expression |
EXP |
cypermethrin results in decreased expression of BTG2 mRNA |
CTD |
PMID:35031408 |
|
NCBI chr 1:134,002,603...134,006,893
Ensembl chr 1:134,002,908...134,006,858
|
|
G |
C1galt1c1 |
C1GALT1-specific chaperone 1 |
increases expression |
EXP |
cypermethrin results in increased expression of C1GALT1C1 mRNA |
CTD |
PMID:29020013 |
|
NCBI chr X:37,719,660...37,724,020
Ensembl chr X:37,719,662...37,723,964
|
|
G |
C1qb |
complement component 1, q subcomponent, beta polypeptide |
increases expression |
EXP |
cypermethrin results in increased expression of C1QB mRNA |
CTD |
PMID:35031408 |
|
NCBI chr 4:136,607,437...136,613,511
Ensembl chr 4:136,607,440...136,613,498
|
|
G |
Cacna1a |
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
decreases expression |
ISO |
cypermethrin results in decreased expression of CACNA1A protein |
CTD |
PMID:36063984 |
|
NCBI chr 8:85,065,257...85,366,880
Ensembl chr 8:85,065,268...85,366,875
|
|
G |
Cacna1c |
calcium channel, voltage-dependent, L type, alpha 1C subunit |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CACNA1C protein |
CTD |
PMID:34896426 |
|
NCBI chr 6:118,564,201...119,174,345
Ensembl chr 6:118,564,201...119,173,851
|
|
G |
Cacna1s |
calcium channel, voltage-dependent, L type, alpha 1S subunit |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CACNA1S protein |
CTD |
PMID:34896426 |
|
NCBI chr 1:135,980,549...136,047,268
Ensembl chr 1:135,980,488...136,047,560
|
|
G |
Cacna2d1 |
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CACNA2D1 protein |
CTD |
PMID:34896426 |
|
NCBI chr 5:16,139,390...16,579,509
Ensembl chr 5:16,139,786...16,579,502
|
|
G |
Camk2a |
calcium/calmodulin-dependent protein kinase II alpha |
increases expression |
ISO |
cypermethrin results in increased expression of CAMK2A mRNA |
CTD |
PMID:32028016 |
|
NCBI chr18:61,058,704...61,121,224
Ensembl chr18:61,058,690...61,121,224
|
|
G |
Camk2b |
calcium/calmodulin-dependent protein kinase II, beta |
increases expression |
ISO |
cypermethrin results in increased expression of CAMK2B mRNA |
CTD |
PMID:32028016 |
|
NCBI chr11:5,919,642...6,016,401
Ensembl chr11:5,919,644...6,016,362
|
|
G |
Camkk1 |
calcium/calmodulin-dependent protein kinase kinase 1, alpha |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of CAMKK1 protein |
CTD |
PMID:34896426 |
|
NCBI chr11:72,906,869...72,932,899
Ensembl chr11:72,909,834...72,932,899
|
|
G |
Camsap1 |
calmodulin regulated spectrin-associated protein 1 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of CAMSAP1 protein |
CTD |
PMID:34896426 |
|
NCBI chr 2:25,816,850...25,873,574
Ensembl chr 2:25,816,850...25,873,294
|
|
G |
Carmil3 |
capping protein regulator and myosin 1 linker 3 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CARMIL3 protein |
CTD |
PMID:34896426 |
|
NCBI chr14:55,728,108...55,745,729
Ensembl chr14:55,728,108...55,745,729
|
|
G |
Casp1 |
caspase 1 |
increases expression |
ISO |
cypermethrin results in increased expression of CASP1 mRNA |
CTD |
PMID:22528246 |
|
NCBI chr 9:5,298,517...5,307,281
Ensembl chr 9:5,298,508...5,307,290
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases expression increases activity |
ISO EXP |
Acetylcysteine inhibits the reaction [cypermethrin results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [cypermethrin results in increased expression of CASP3 mRNA]; cypermethrin inhibits the reaction [Docosahexaenoic Acids results in increased cleavage of and results in increased activity of CASP3 protein] [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of CASP3 mRNA; cypermethrin results in increased cleavage of and results in increased activity of CASP3 protein; Quercetin inhibits the reaction [cypermethrin results in increased expression of CASP3 mRNA]; Quercetin inhibits the reaction [cypermethrin results in increased expression of CASP3 protein] [cypermethrin co-treated with Chlorpyrifos co-treated with profenofos] results in increased cleavage of CASP3 protein cypermethrin results in increased expression of CASP3 mRNA; cypermethrin results in increased expression of CASP3 protein |
CTD |
PMID:11341974 PMID:21987380 PMID:22048644 PMID:25370934 PMID:27704156 PMID:29945211 PMID:32028016 PMID:34714723 PMID:34896426 PMID:35876585 More...
|
|
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
|
|
G |
Casp6 |
caspase 6 |
increases expression |
ISO |
cypermethrin results in increased expression of CASP6 mRNA |
CTD |
PMID:22528246 |
|
NCBI chr 3:129,695,064...129,707,761
Ensembl chr 3:129,695,074...129,707,752
|
|
G |
Casp7 |
caspase 7 |
multiple interactions increases expression |
ISO |
cypermethrin results in increased cleavage of and results in increased activity of CASP7 protein cypermethrin results in increased expression of CASP7 mRNA |
CTD |
PMID:22048644 PMID:27704156 |
|
NCBI chr19:56,382,640...56,430,780
Ensembl chr19:56,385,561...56,430,776
|
|
G |
Casp9 |
caspase 9 |
multiple interactions increases expression |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of CASP9 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CASP9 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of CASP9 mRNA; cypermethrin results in increased cleavage of and results in increased activity of CASP9 protein cypermethrin results in increased expression of CASP9 mRNA Acetylcysteine inhibits the reaction [cypermethrin results in increased expression of CASP9 mRNA] |
CTD |
PMID:22048644 PMID:22528246 PMID:27704156 PMID:29945211 PMID:33396045 PMID:34896426 PMID:36053783 More...
|
|
NCBI chr 4:141,520,923...141,543,289
Ensembl chr 4:141,520,923...141,543,287
|
|
G |
Cat |
catalase |
multiple interactions increases activity decreases activity increases expression affects activity affects binding decreases expression |
EXP ISO |
[cypermethrin co-treated with Chlorpyrifos] results in decreased activity of CAT protein; [propetamphos co-treated with cypermethrin] results in decreased activity of CAT protein; Plant Extracts inhibits the reaction [[cypermethrin co-treated with Chlorpyrifos] results in decreased activity of CAT protein] [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the activity of CAT protein; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased activity of CAT protein; [cypermethrin co-treated with fenvalerate] results in increased activity of CAT protein; [cypermethrin co-treated with propetamphos] results in decreased activity of CAT protein; Quercetin inhibits the reaction [cypermethrin results in decreased activity of CAT protein]; Sesame Oil affects the reaction [cypermethrin affects the activity of CAT protein] cypermethrin results in increased activity of CAT protein cypermethrin results in increased expression of CAT mRNA cypermethrin binds to CAT protein cypermethrin results in decreased expression of CAT mRNA cypermethrin results in decreased expression of CAT protein |
CTD |
PMID:10355540 PMID:12965126 PMID:15365239 PMID:15991261 PMID:18214882 PMID:21142847 PMID:21397294 PMID:23900960 PMID:25816392 PMID:25926273 PMID:28584332 PMID:32214279 PMID:32278787 PMID:33396045 PMID:34714723 PMID:35512476 PMID:35678313 PMID:35876585 More...
|
|
NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
|
|
G |
Cbx8 |
chromobox 8 |
decreases expression |
ISO |
cypermethrin results in decreased expression of CBX8 protein |
CTD |
PMID:36063984 |
|
NCBI chr11:118,929,262...118,931,739
Ensembl chr11:118,927,131...118,931,795
|
|
G |
Cc2d1a |
coiled-coil and C2 domain containing 1A |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CC2D1A protein |
CTD |
PMID:34896426 |
|
NCBI chr 8:84,859,457...84,874,546
Ensembl chr 8:84,859,457...84,874,565
|
|
G |
Ccar1 |
cell division cycle and apoptosis regulator 1 |
increases expression |
ISO |
cypermethrin results in increased expression of CCAR1 protein |
CTD |
PMID:36063984 |
|
NCBI chr10:62,579,707...62,628,147
Ensembl chr10:62,579,707...62,628,065
|
|
G |
Ccl7 |
C-C motif chemokine ligand 7 |
multiple interactions |
EXP |
cypermethrin promotes the reaction [Lipopolysaccharides results in increased expression of CCL7 mRNA] |
CTD |
PMID:29471534 |
|
NCBI chr11:81,936,538...81,938,351
Ensembl chr11:81,936,538...81,938,351
|
|
G |
Ccn1 |
cellular communication network factor 1 |
multiple interactions decreases expression |
ISO EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CCN1 protein cypermethrin results in decreased expression of CCN1 mRNA |
CTD |
PMID:34896426 PMID:35031408 |
|
NCBI chr 3:145,352,726...145,355,740
Ensembl chr 3:145,352,731...145,355,736
|
|
G |
Ccna1 |
cyclin A1 |
decreases expression increases expression |
EXP ISO |
cypermethrin results in decreased expression of CCNA1 mRNA cypermethrin results in increased expression of CCNA1 mRNA |
CTD |
PMID:24810582 PMID:35605701 |
|
NCBI chr 3:54,952,890...54,965,055
Ensembl chr 3:54,952,890...54,962,922
|
|
G |
Ccna2 |
cyclin A2 |
decreases expression |
ISO |
cypermethrin results in decreased expression of CCNA2 mRNA |
CTD |
PMID:22528246 |
|
NCBI chr 3:36,619,014...36,627,187
Ensembl chr 3:36,619,014...36,626,299
|
|
G |
Ccnb1 |
cyclin B1 |
affects expression |
ISO |
cypermethrin affects the expression of CCNB1 mRNA |
CTD |
PMID:35605701 |
|
NCBI chr13:100,915,247...100,922,994
Ensembl chr13:100,915,158...100,923,078
|
|
G |
Ccnd1 |
cyclin D1 |
increases expression multiple interactions |
ISO |
cypermethrin results in increased expression of CCND1 mRNA fulvestrant inhibits the reaction [cypermethrin results in increased expression of CCND1 mRNA] |
CTD |
PMID:26877835 |
|
NCBI chr 7:144,483,668...144,493,568
Ensembl chr 7:144,483,668...144,493,662
|
|
G |
Ccnd2 |
cyclin D2 |
increases expression decreases expression |
ISO EXP |
cypermethrin results in increased expression of CCND2 mRNA cypermethrin results in decreased expression of CCND2 mRNA |
CTD |
PMID:22528246 PMID:24810582 |
|
NCBI chr 6:127,102,125...127,131,913
Ensembl chr 6:127,102,125...127,129,156
|
|
G |
Ccnd3 |
cyclin D3 |
decreases expression |
EXP |
cypermethrin results in decreased expression of CCND3 mRNA |
CTD |
PMID:36116546 |
|
NCBI chr17:47,815,976...47,910,614
Ensembl chr17:47,815,976...47,910,616
|
|
G |
Ccs |
copper chaperone for superoxide dismutase |
increases expression |
EXP |
cypermethrin results in increased expression of CCS mRNA |
CTD |
PMID:21142847 |
|
NCBI chr19:4,875,394...4,889,326
Ensembl chr19:4,875,394...4,889,360
|
|
G |
Cd36 |
CD36 molecule |
decreases expression |
EXP |
cypermethrin results in decreased expression of CD36 mRNA |
CTD |
PMID:35031408 |
|
NCBI chr 5:17,986,680...18,093,828
Ensembl chr 5:17,986,688...18,093,799
|
|
G |
Cd52 |
CD52 antigen |
decreases expression |
EXP |
cypermethrin results in decreased expression of CD52 mRNA |
CTD |
PMID:35031408 |
|
NCBI chr 4:133,820,849...133,822,384
Ensembl chr 4:133,809,759...133,822,393
|
|
G |
Cd9 |
CD9 antigen |
multiple interactions |
ISO |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of CD9 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of CD9 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of CD9 mRNA |
CTD |
PMID:33051911 PMID:33396045 PMID:34896426 |
|
NCBI chr 6:125,437,229...125,471,723
Ensembl chr 6:125,437,229...125,471,754
|
|
G |
Cd93 |
CD93 antigen |
increases expression |
EXP |
cypermethrin results in increased expression of CD93 mRNA |
CTD |
PMID:29020013 |
|
NCBI chr 2:148,278,571...148,285,455
Ensembl chr 2:148,278,560...148,285,483
|
|
G |
Cdh12 |
cadherin 12 |
increases expression |
ISO |
cypermethrin results in increased expression of CDH12 mRNA |
CTD |
PMID:22528246 |
|
NCBI chr15:20,448,967...21,598,668
Ensembl chr15:20,449,351...21,589,619
|
|
G |
Cdh22 |
cadherin 22 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CDH22 protein |
CTD |
PMID:34896426 |
|
NCBI chr 2:164,953,421...165,076,892
Ensembl chr 2:164,953,427...165,076,773
|
|
G |
Cdk11b |
cyclin dependent kinase 11B |
decreases expression |
ISO |
cypermethrin results in decreased expression of CDK11 protein |
CTD |
PMID:36063984 |
|
NCBI chr 4:155,709,303...155,734,392
Ensembl chr 4:155,709,311...155,734,395
|
|
G |
Cdk13 |
cyclin dependent kinase 13 |
decreases expression |
ISO |
cypermethrin results in decreased expression of CDK13 protein |
CTD |
PMID:36063984 |
|
NCBI chr13:17,885,309...17,979,960
Ensembl chr13:17,884,900...17,979,682
|
|
G |
Cdk4 |
cyclin dependent kinase 4 |
decreases expression |
EXP |
cypermethrin results in decreased expression of CDK4 protein |
CTD |
PMID:36116546 |
|
NCBI chr10:126,899,404...126,903,157
Ensembl chr10:126,899,403...126,903,789
|
|
G |
Cdk5rap2 |
CDK5 regulatory subunit associated protein 2 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CDK5RAP2 protein |
CTD |
PMID:34896426 |
|
NCBI chr 4:70,135,092...70,328,672
Ensembl chr 4:70,135,093...70,328,680
|
|
G |
Cdk6 |
cyclin dependent kinase 6 |
decreases expression |
EXP |
cypermethrin results in decreased expression of CDK6 protein |
CTD |
PMID:36116546 |
|
NCBI chr 5:3,391,004...3,581,008
Ensembl chr 5:3,391,485...3,581,008
|
|
G |
Cdk9 |
cyclin dependent kinase 9 |
decreases expression |
ISO |
cypermethrin results in decreased expression of CDK9 mRNA |
CTD |
PMID:22528246 |
|
NCBI chr 2:32,595,794...32,608,098
Ensembl chr 2:32,595,796...32,603,088
|
|
G |
Cdkn1a |
cyclin dependent kinase inhibitor 1A |
decreases expression increases expression |
EXP ISO |
cypermethrin results in decreased expression of CDKN1A mRNA; cypermethrin results in decreased expression of CDKN1A protein cypermethrin results in increased expression of CDKN1A mRNA |
CTD |
PMID:36063984 PMID:36116546 PMID:37011868 |
|
NCBI chr17:29,309,953...29,319,696
Ensembl chr17:29,309,950...29,319,701
|
|
G |
Cdkn1b |
cyclin dependent kinase inhibitor 1B |
decreases expression |
EXP |
cypermethrin results in decreased expression of CDKN1B mRNA |
CTD |
PMID:35031408 |
|
NCBI chr 6:134,897,364...134,902,488
Ensembl chr 6:134,897,364...134,902,476
|
|
G |
Cdkn1c |
cyclin dependent kinase inhibitor 1C |
increases expression |
EXP |
cypermethrin results in increased expression of CDKN1C mRNA; cypermethrin results in increased expression of CDKN1C protein |
CTD |
PMID:37011868 |
|
NCBI chr 7:143,012,076...143,014,735
Ensembl chr 7:143,012,076...143,014,787
|
|
G |
Cdkn2a |
cyclin dependent kinase inhibitor 2A |
increases expression |
ISO |
cypermethrin results in increased expression of CDKN2A mRNA |
CTD |
PMID:36063984 |
|
NCBI chr 4:89,192,710...89,212,856
Ensembl chr 4:89,192,708...89,212,890
|
|
G |
Cdkn2b |
cyclin dependent kinase inhibitor 2B |
increases expression |
ISO |
cypermethrin results in increased expression of CDKN2B mRNA |
CTD |
PMID:22528246 |
|
NCBI chr 4:89,224,526...89,229,269
Ensembl chr 4:89,224,536...89,229,276
|
|
G |
Cdkn2d |
cyclin dependent kinase inhibitor 2D |
decreases expression |
ISO |
cypermethrin results in decreased expression of CDKN2D mRNA |
CTD |
PMID:22528246 |
|
NCBI chr 9:21,199,759...21,202,553
Ensembl chr 9:21,199,706...21,202,703
|
|
G |
Cebpe |
CCAAT/enhancer binding protein epsilon |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [cypermethrin inhibits the reaction [Tretinoin results in increased expression of CEBPE mRNA]]; cypermethrin inhibits the reaction [Tretinoin results in increased expression of CEBPE mRNA] |
CTD |
PMID:29945211 |
|
NCBI chr14:54,947,823...54,949,604
Ensembl chr14:54,947,817...54,949,631
|
|
G |
Cenpa |
centromere protein A |
increases expression |
EXP |
cypermethrin results in increased expression of CENPA mRNA |
CTD |
PMID:29020013 |
|
NCBI chr 5:30,824,214...30,832,181
Ensembl chr 5:30,824,121...30,832,174
|
|
G |
Ces1d |
carboxylesterase 1D |
increases hydrolysis |
ISO |
CES1 protein results in increased hydrolysis of cypermethrin |
CTD |
PMID:16359636 |
|
NCBI chr 8:93,892,700...93,924,432
Ensembl chr 8:93,892,696...93,924,466
|
|
G |
Ces2a |
carboxylesterase 2A |
affects metabolic processing |
EXP |
CES2A protein affects the metabolism of cypermethrin |
CTD |
PMID:15123619 |
|
NCBI chr 8:105,460,635...105,468,266
Ensembl chr 8:105,460,635...105,468,266
|
|
G |
Ces2e |
carboxylesterase 2E |
affects metabolic processing |
EXP |
CES2E protein affects the metabolism of cypermethrin |
CTD |
PMID:15123619 |
|
NCBI chr 8:105,652,892...105,661,304
Ensembl chr 8:105,652,892...105,661,304
|
|
G |
Ces2h |
carboxylesterase 2H |
increases hydrolysis |
ISO |
CES2 protein results in increased hydrolysis of cypermethrin |
CTD |
PMID:16359636 |
|
NCBI chr 8:105,727,462...105,747,042
Ensembl chr 8:105,727,485...105,747,810
|
|
G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CFTR protein |
CTD |
PMID:34896426 |
|
NCBI chr 6:18,170,686...18,322,769
Ensembl chr 6:18,170,686...18,322,767
|
|
G |
Cga |
glycoprotein hormones, alpha subunit |
increases expression multiple interactions |
EXP |
cypermethrin results in increased expression of CGA mRNA 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [cypermethrin results in increased expression of CGA mRNA]; 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide inhibits the reaction [cypermethrin results in increased expression of CGA mRNA]; bisindolylmaleimide I inhibits the reaction [cypermethrin results in increased expression of CGA mRNA]; Egtazic Acid inhibits the reaction [cypermethrin results in increased expression of CGA mRNA]; Nimodipine inhibits the reaction [cypermethrin results in increased expression of CGA mRNA] |
CTD |
PMID:28731686 PMID:29149324 PMID:35931855 |
|
NCBI chr 4:34,893,779...34,907,374
Ensembl chr 4:34,893,779...34,907,370
|
|
G |
Chac1 |
ChaC, cation transport regulator 1 |
increases expression |
ISO |
cypermethrin results in increased expression of CHAC1 mRNA |
CTD |
PMID:25424538 |
|
NCBI chr 2:119,181,723...119,184,807
Ensembl chr 2:119,181,710...119,184,862
|
|
G |
Chat |
choline acetyltransferase |
decreases expression |
ISO |
cypermethrin results in decreased expression of CHAT mRNA; cypermethrin results in decreased expression of CHAT protein |
CTD |
PMID:26115703 |
|
NCBI chr14:32,130,160...32,187,866
Ensembl chr14:32,130,160...32,187,946
|
|
G |
Chchd2 |
coiled-coil-helix-coiled-coil-helix domain containing 2 |
increases expression |
EXP |
cypermethrin results in increased expression of CHCHD2 mRNA |
CTD |
PMID:29020013 |
|
NCBI chr 5:129,910,002...129,916,311
Ensembl chr 5:129,909,997...129,916,311
|
|
G |
Chrm2 |
cholinergic receptor, muscarinic 2, cardiac |
multiple interactions decreases expression |
ISO |
cypermethrin promotes the reaction [cypermethrin results in decreased expression of CHRM2 mRNA]; cypermethrin promotes the reaction [cypermethrin results in decreased expression of CHRM2 protein] cypermethrin results in decreased expression of CHRM2 mRNA; cypermethrin results in decreased expression of CHRM2 protein |
CTD |
PMID:25288152 |
|
NCBI chr 6:36,364,928...36,505,573
Ensembl chr 6:36,365,019...36,505,349
|
|
G |
Ciita |
class II transactivator |
multiple interactions |
ISO |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of CIITA mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CIITA mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of CIITA mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of CIITA mRNA |
CTD |
PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783 |
|
NCBI chr16:10,297,877...10,348,928
Ensembl chr16:10,297,923...10,346,282
|
|
G |
Cldn5 |
claudin 5 |
increases expression |
EXP |
cypermethrin results in increased expression of CLDN5 mRNA |
CTD |
PMID:29020013 |
|
NCBI chr16:18,595,597...18,597,012
Ensembl chr16:18,595,597...18,597,012
|
|
G |
Clu |
clusterin |
multiple interactions |
ISO |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of CLU mRNA |
CTD |
PMID:33051911 |
|
NCBI chr14:66,206,093...66,218,992
Ensembl chr14:66,205,932...66,218,996
|
|
G |
Cntn3 |
contactin 3 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CNTN3 protein |
CTD |
PMID:34896426 |
|
NCBI chr 6:102,140,265...102,541,575
Ensembl chr 6:102,139,616...102,550,062
|
|
G |
Col27a1 |
collagen, type XXVII, alpha 1 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of COL27A1 protein |
CTD |
PMID:34896426 |
|
NCBI chr 4:63,132,246...63,253,228
Ensembl chr 4:63,132,241...63,253,228
|
|
G |
Colec12 |
collectin sub-family member 12 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of COLEC12 protein |
CTD |
PMID:34896426 |
|
NCBI chr18:9,707,648...9,877,995
Ensembl chr18:9,707,595...9,882,644
|
|
G |
Commd4 |
COMM domain containing 4 |
increases expression |
ISO |
cypermethrin results in increased expression of COMMD4 mRNA |
CTD |
PMID:27704156 |
|
NCBI chr 9:57,062,319...57,065,633
Ensembl chr 9:57,062,319...57,065,615
|
|
G |
Copg2 |
coatomer protein complex, subunit gamma 2 |
decreases expression |
ISO |
cypermethrin results in decreased expression of COPG2 mRNA |
CTD |
PMID:22528246 |
|
NCBI chr 6:30,747,552...30,873,712
Ensembl chr 6:30,747,553...30,873,729
|
|
G |
Cops2 |
COP9 signalosome subunit 2 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of COPS2 protein |
CTD |
PMID:34896426 |
|
NCBI chr 2:125,672,222...125,701,002
Ensembl chr 2:125,672,224...125,701,059
|
|
G |
Cox14 |
cytochrome c oxidase assembly protein 14 |
increases expression |
EXP |
cypermethrin results in increased expression of COX14 mRNA |
CTD |
PMID:29020013 |
|
NCBI chr15:99,623,499...99,626,017
Ensembl chr15:99,623,528...99,627,413
|
|
G |
Cox7c |
cytochrome c oxidase subunit 7C |
decreases expression |
EXP |
cypermethrin results in decreased expression of COX7C mRNA |
CTD |
PMID:29020013 |
|
NCBI chr13:86,192,917...86,194,914
Ensembl chr13:86,192,935...86,195,023
|
|
G |
Cox8b |
cytochrome c oxidase subunit 8B |
decreases expression |
EXP |
cypermethrin results in decreased expression of COX8B mRNA |
CTD |
PMID:29020013 |
|
NCBI chr 7:140,478,855...140,480,359
Ensembl chr 7:140,478,858...140,480,359
|
|
G |
Cpt1a |
carnitine palmitoyltransferase 1a, liver |
multiple interactions |
EXP |
cypermethrin promotes the reaction [[lard co-treated with Cholesterol co-treated with Sucrose] results in increased expression of CPT1A mRNA] |
CTD |
PMID:24440342 |
|
NCBI chr19:3,372,328...3,435,735
Ensembl chr19:3,372,334...3,435,733
|
|
G |
Creb1 |
cAMP responsive element binding protein 1 |
multiple interactions |
EXP ISO |
[cypermethrin results in decreased susceptibility to Dihydrotestosterone] which results in decreased phosphorylation of CREB1 protein [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of CREB1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of CREB1 mRNA |
CTD |
PMID:30974244 PMID:33051911 PMID:33396045 PMID:34896426 |
|
NCBI chr 1:64,571,963...64,643,707
Ensembl chr 1:64,571,804...64,643,707
|
|
G |
Crebbp |
CREB binding protein |
multiple interactions |
ISO |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of CREBBP mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CREBBP mRNA |
CTD |
PMID:33051911 PMID:33396045 PMID:34896426 |
|
NCBI chr16:3,899,198...4,031,864
Ensembl chr16:3,899,192...4,031,861
|
|
G |
Crem |
cAMP responsive element modulator |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of CREM mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CREM mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of CREM mRNA |
CTD |
PMID:33396045 PMID:34896426 PMID:36053783 |
|
NCBI chr18:3,263,181...3,337,688
Ensembl chr18:3,266,048...3,337,748
|
|
G |
Crlf1 |
cytokine receptor-like factor 1 |
decreases expression |
ISO |
cypermethrin results in decreased expression of CRLF1 mRNA |
CTD |
PMID:22528246 |
|
NCBI chr 8:70,945,798...70,956,728
Ensembl chr 8:70,945,808...70,956,731
|
|
G |
Cry2 |
cryptochrome circadian regulator 2 |
increases expression |
EXP |
cypermethrin results in increased expression of CRY2 mRNA |
CTD |
PMID:21142847 |
|
NCBI chr 2:92,233,991...92,264,426
Ensembl chr 2:92,233,991...92,264,388
|
|
G |
Csf2 |
colony stimulating factor 2 (granulocyte-macrophage) |
multiple interactions |
ISO |
CSF2 protein inhibits the reaction [cypermethrin results in decreased activity of SOD1 protein] |
CTD |
PMID:37871686 |
|
NCBI chr11:54,138,096...54,140,725
Ensembl chr11:54,138,097...54,140,493
|
|
G |
Csf3r |
colony stimulating factor 3 receptor |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [cypermethrin inhibits the reaction [Tretinoin results in increased expression of CSF3R mRNA]]; cypermethrin inhibits the reaction [Tretinoin results in increased expression of CSF3R mRNA] |
CTD |
PMID:29945211 |
|
NCBI chr 4:125,917,241...125,938,233
Ensembl chr 4:125,918,343...125,938,233
|
|
G |
Ctsb |
cathepsin B |
increases expression |
ISO |
cypermethrin results in increased expression of CTSB mRNA |
CTD |
PMID:27704156 |
|
NCBI chr14:63,359,911...63,383,372
Ensembl chr14:63,359,911...63,383,372
|
|
G |
Cxcl16 |
C-X-C motif chemokine ligand 16 |
increases expression multiple interactions |
ISO |
cypermethrin results in increased expression of CXCL16 mRNA; cypermethrin results in increased expression of CXCL16 protein CXCL16 protein promotes the reaction [cypermethrin results in increased expression of IL18 mRNA]; CXCL16 protein promotes the reaction [cypermethrin results in increased expression of IL1B mRNA]; HES1 inhibits the reaction [cypermethrin results in increased expression of CXCL16 protein]; pyrazolanthrone inhibits the reaction [cypermethrin results in increased expression of CXCL16 protein] |
CTD |
PMID:35512476 |
|
NCBI chr11:70,345,215...70,350,810
Ensembl chr11:70,344,809...70,350,810
|
|
G |
Cybb |
cytochrome b-245, beta polypeptide |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of CYBB mRNA |
CTD |
PMID:33396045 |
|
NCBI chr X:9,301,493...9,354,005
Ensembl chr X:9,301,491...9,354,010
|
|
G |
Cycs |
cytochrome c, somatic |
affects localization multiple interactions increases activity increases expression |
ISO |
cypermethrin affects the localization of CYCS protein [propetamphos co-treated with cypermethrin] results in increased activity of CYCS protein; Quercetin inhibits the reaction [cypermethrin results in increased expression of CYCS protein] cypermethrin results in increased activity of CYCS protein |
CTD |
PMID:22528246 PMID:25926273 PMID:35876585 PMID:36063984 |
|
NCBI chr 6:50,539,543...50,543,549
Ensembl chr 6:50,539,543...50,543,518
|
|
G |
Cygb |
cytoglobin |
increases expression |
EXP |
cypermethrin results in increased expression of CYGB mRNA |
CTD |
PMID:21142847 |
|
NCBI chr11:116,536,421...116,544,887
Ensembl chr11:116,536,421...116,545,139
|
|
G |
Cyld |
CYLD lysine 63 deubiquitinase |
increases expression |
ISO |
cypermethrin results in increased expression of CYLD mRNA |
CTD |
PMID:27704156 |
|
NCBI chr 8:89,423,506...89,478,574
Ensembl chr 8:89,423,675...89,478,573
|
|
G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
decreases expression multiple interactions increases expression |
EXP ISO |
cypermethrin results in decreased expression of CYP11A1 mRNA; cypermethrin results in decreased expression of CYP11A1 protein 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [cypermethrin results in increased expression of CYP11A1 mRNA]; Egtazic Acid inhibits the reaction [cypermethrin results in increased expression of CYP11A1 mRNA]; Nimodipine inhibits the reaction [cypermethrin results in increased expression of CYP11A1 mRNA] [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in increased expression of CYP11A1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of CYP11A1 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of CYP11A1 mRNA; MIR140 mRNA affects the reaction [cypermethrin results in decreased expression of CYP11A1 protein]; SF1 protein inhibits the reaction [cypermethrin results in decreased expression of CYP11A1 protein] |
CTD |
PMID:20131380 PMID:21560301 PMID:24810582 PMID:28731686 PMID:33051911 PMID:33396045 PMID:34794910 PMID:34896426 PMID:35102696 PMID:35605701 PMID:35931855 PMID:36053783 More...
|
|
NCBI chr 9:57,905,307...57,934,314
Ensembl chr 9:57,913,694...57,934,306
|
|
G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
decreases expression multiple interactions affects expression |
EXP ISO |
cypermethrin results in decreased expression of CYP17A1 mRNA; cypermethrin results in decreased expression of CYP17A1 protein [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of CYP17A1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of CYP17A1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CYP17A1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CYP17A1 protein; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of CYP17A1 mRNA cypermethrin affects the expression of CYP17A1 mRNA |
CTD |
PMID:21397294 PMID:21560301 PMID:24810582 PMID:33051911 PMID:33396045 PMID:34896426 PMID:35031408 PMID:35102696 PMID:35605701 PMID:36053783 More...
|
|
NCBI chr19:46,655,604...46,661,439
Ensembl chr19:46,655,604...46,661,611
|
|
G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
increases activity multiple interactions increases expression affects expression decreases expression |
ISO EXP |
cypermethrin results in increased activity of CYP19A1 protein [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of CYP19A1 mRNA; [bitertanol co-treated with propiconazole co-treated with cypermethrin co-treated with Malathion co-treated with terbutylazine] results in increased expression of CYP19A1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of CYP19A1 mRNA cypermethrin results in increased expression of CYP19A1 mRNA cypermethrin affects the expression of CYP19A1 mRNA cypermethrin results in decreased expression of CYP19A1 mRNA |
CTD |
PMID:16996190 PMID:23954766 PMID:24810582 PMID:33051911 PMID:33396045 PMID:35031408 PMID:35605701 More...
|
|
NCBI chr 9:54,073,221...54,175,448
Ensembl chr 9:54,073,221...54,175,394
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
decreases activity increases expression affects expression |
EXP ISO |
cypermethrin results in decreased activity of CYP1A1 protein cypermethrin results in increased expression of CYP1A1 mRNA cypermethrin affects the expression of CYP1A1 mRNA |
CTD |
PMID:18420780 PMID:23447098 PMID:26115703 PMID:32214279 |
|
NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
decreases activity increases expression |
EXP ISO |
cypermethrin results in decreased activity of CYP1A2 protein cypermethrin results in increased expression of CYP1A2 mRNA |
CTD |
PMID:18420780 PMID:23447098 PMID:26115703 |
|
NCBI chr 9:57,584,220...57,590,938
Ensembl chr 9:57,584,220...57,590,986
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
decreases activity affects expression increases expression |
EXP |
cypermethrin results in decreased activity of CYP1B1 protein cypermethrin affects the expression of CYP1B1 mRNA cypermethrin results in increased expression of CYP1B1 |
CTD |
PMID:18420780 PMID:32214279 |
|
NCBI chr17:80,014,369...80,022,490
Ensembl chr17:80,008,966...80,022,490
|
|
G |
Cyp26b1 |
cytochrome P450, family 26, subfamily b, polypeptide 1 |
multiple interactions decreases expression |
EXP |
Sodium Selenite inhibits the reaction [cypermethrin results in decreased expression of CYP26B1 mRNA] |
CTD |
PMID:31659573 |
|
NCBI chr 6:84,548,396...84,570,890
Ensembl chr 6:84,548,396...84,570,890
|
|
G |
Cyp2a4 |
cytochrome P450, family 2, subfamily a, polypeptide 4 |
increases expression |
ISO |
cypermethrin results in increased expression of CYP2A4 mRNA |
CTD |
PMID:22310298 |
|
NCBI chr 7:26,006,617...26,014,513
Ensembl chr 7:26,006,594...26,014,513
|
|
G |
Cyp2a5 |
cytochrome P450, family 2, subfamily a, polypeptide 5 |
increases expression |
ISO |
cypermethrin results in increased expression of CYP2A6 mRNA |
CTD |
PMID:22310298 |
|
NCBI chr 7:26,534,764...26,542,689
Ensembl chr 7:26,534,730...26,542,973
|
|
G |
Cyp2b10 |
cytochrome P450, family 2, subfamily b, polypeptide 10 |
decreases activity increases activity increases expression multiple interactions |
EXP ISO |
cypermethrin results in decreased activity of CYP2B10 protein cypermethrin results in increased activity of CYP2B6 protein cypermethrin results in increased expression of CYP2B6 mRNA; cypermethrin results in increased expression of CYP2B6 protein cypermethrin results in increased expression of CYP2B10 mRNA Sodium Selenite inhibits the reaction [cypermethrin results in increased expression of CYP2B10 mRNA] |
CTD |
PMID:15548381 PMID:18420780 PMID:22310298 PMID:31659573 |
|
NCBI chr 7:25,597,083...25,626,049
Ensembl chr 7:25,597,045...25,626,049
|
|
G |
Cyp2b13 |
cytochrome P450, family 2, subfamily b, polypeptide 13 |
increases expression |
ISO |
cypermethrin results in increased expression of CYP2B2 mRNA |
CTD |
PMID:23447098 PMID:26115703 |
|
NCBI chr 7:25,760,813...25,795,622
Ensembl chr 7:25,760,922...25,795,622
|
|
G |
Cyp2c29 |
cytochrome P450, family 2, subfamily c, polypeptide 29 |
decreases activity increases expression |
EXP ISO |
cypermethrin results in decreased activity of CYP2C29 protein cypermethrin results in increased expression of CYP2C8 mRNA |
CTD |
PMID:18420780 PMID:22310298 |
|
NCBI chr19:39,275,541...39,319,157
Ensembl chr19:39,257,849...39,319,157
|
|
G |
Cyp2c38 |
cytochrome P450, family 2, subfamily c, polypeptide 38 |
increases expression |
ISO |
cypermethrin results in increased expression of CYP2C19 mRNA |
CTD |
PMID:22310298 |
|
NCBI chr19:39,379,109...39,451,519
Ensembl chr19:39,378,000...39,451,519
|
|
G |
Cyp2c65 |
cytochrome P450, family 2, subfamily c, polypeptide 65 |
decreases activity increases expression |
ISO |
cypermethrin results in decreased activity of CYP2C9 protein cypermethrin results in increased expression of CYP2C9 mRNA |
CTD |
PMID:18420780 PMID:22310298 |
|
NCBI chr19:39,049,450...39,082,392
Ensembl chr19:39,049,459...39,082,388
|
|
G |
Cyp2d22 |
cytochrome P450, family 2, subfamily d, polypeptide 22 |
decreases activity |
ISO |
cypermethrin results in decreased activity of CYP2D6 protein |
CTD |
PMID:18420780 |
|
NCBI chr15:82,254,728...82,264,461
Ensembl chr15:82,254,728...82,264,461
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
decreases activity multiple interactions increases expression increases activity |
EXP ISO |
cypermethrin results in decreased activity of CYP2E1 protein cypermethrin inhibits the reaction [CYP2E1 protein results in increased hydroxylation of Chlorzoxazone] cypermethrin results in increased expression of CYP2E1 mRNA; cypermethrin results in increased expression of CYP2E1 protein [cypermethrin co-treated with propetamphos] results in increased activity of CYP2E1 protein cypermethrin results in increased activity of CYP2E1 protein |
CTD |
PMID:18420780 PMID:20815782 PMID:22634058 PMID:23447098 PMID:25926273 PMID:26115703 More...
|
|
NCBI chr 7:140,343,732...140,354,903
Ensembl chr 7:140,343,652...140,354,900
|
|
G |
Cyp2j11 |
cytochrome P450, family 2, subfamily j, polypeptide 11 |
increases expression multiple interactions |
EXP |
cypermethrin results in increased expression of CYP2J11 mRNA Sodium Selenite inhibits the reaction [cypermethrin results in increased expression of CYP2J11 mRNA] |
CTD |
PMID:31659573 |
|
NCBI chr 4:96,182,745...96,236,930
Ensembl chr 4:96,182,745...96,236,899
|
|
G |
Cyp3a11 |
cytochrome P450, family 3, subfamily a, polypeptide 11 |
decreases activity |
EXP |
cypermethrin results in decreased activity of CYP3A11 protein |
CTD |
PMID:18420780 |
|
NCBI chr 5:145,791,417...145,816,664
Ensembl chr 5:145,791,236...145,816,774
|
|
G |
Cyp3a13 |
cytochrome P450, family 3, subfamily a, polypeptide 13 |
multiple interactions increases expression |
EXP |
Sodium Selenite inhibits the reaction [cypermethrin results in increased expression of CYP3A13 mRNA] |
CTD |
PMID:31659573 |
|
NCBI chr 5:137,891,195...137,923,872
Ensembl chr 5:137,891,194...137,919,881
|
|
G |
Cyp3a44 |
cytochrome P450, family 3, subfamily a, polypeptide 44 |
multiple interactions decreases expression |
EXP |
Sodium Selenite inhibits the reaction [cypermethrin results in decreased expression of CYP3A44 mRNA] |
CTD |
PMID:31659573 |
|
NCBI chr 5:145,710,793...145,742,701
Ensembl chr 5:145,710,793...145,742,684
|
|
G |
Dap3 |
death associated protein 3 |
increases expression |
ISO |
cypermethrin results in increased expression of DAP3 mRNA |
CTD |
PMID:22528246 |
|
NCBI chr 3:88,828,110...88,858,504
Ensembl chr 3:88,828,110...88,858,488
|
|
G |
Dazap1 |
DAZ associated protein 1 |
multiple interactions |
ISO |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of DAZAP1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of DAZAP1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of DAZAP1 mRNA |
CTD |
PMID:33051911 PMID:33396045 PMID:34896426 |
|
NCBI chr10:80,097,168...80,124,242
Ensembl chr10:80,097,320...80,124,242
|
|
G |
Dbi |
diazepam binding inhibitor |
decreases expression |
EXP |
cypermethrin results in decreased expression of DBI mRNA |
CTD |
PMID:29020013 |
|
NCBI chr 1:120,041,010...120,048,826
Ensembl chr 1:120,041,010...120,048,808
|
|
G |
Ddias |
DNA damage-induced apoptosis suppressor |
decreases expression |
ISO |
cypermethrin results in decreased expression of DDIAS protein |
CTD |
PMID:36063984 |
|
NCBI chr 7:92,506,734...92,523,455
Ensembl chr 7:92,506,733...92,523,455
|
|
G |
Ddr1 |
discoidin domain receptor family, member 1 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of DDR1 protein |
CTD |
PMID:34896426 |
|
NCBI chr17:35,992,459...36,015,633
Ensembl chr17:35,992,459...36,015,513
|
|
G |
Ddx25 |
DEAD box helicase 25 |
multiple interactions |
ISO |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of DDX25 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of DDX25 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of DDX25 mRNA |
CTD |
PMID:33051911 PMID:33396045 PMID:34896426 |
|
NCBI chr 9:35,453,144...35,469,766
Ensembl chr 9:35,447,943...35,469,824
|
|
G |
Ddx3y |
DEAD box helicase 3, Y-linked |
multiple interactions |
ISO |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of DDX3Y mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of DDX3Y mRNA |
CTD |
PMID:33051911 PMID:33396045 PMID:34896426 |
|
NCBI chr Y:1,260,715...1,286,630
Ensembl chr Y:1,260,771...1,286,629
|
|
G |
Ddx4 |
DEAD box helicase 4 |
decreases expression |
EXP |
cypermethrin results in decreased expression of DDX4 protein |
CTD |
PMID:35031408 |
|
NCBI chr13:112,734,867...112,790,342
Ensembl chr13:112,734,867...112,789,009
|
|
G |
Ddx46 |
DEAD box helicase 46 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of DDX46 protein |
CTD |
PMID:34896426 |
|
NCBI chr13:55,782,790...55,829,080
Ensembl chr13:55,782,841...55,829,069
|
|
G |
Dennd4a |
DENN domain containing 4A |
increases expression |
ISO |
cypermethrin results in increased expression of DENND4A mRNA |
CTD |
PMID:27704156 |
|
NCBI chr 9:64,713,408...64,826,949
Ensembl chr 9:64,718,622...64,826,949
|
|
G |
Depp1 |
DEPP1 autophagy regulator |
decreases expression |
EXP |
cypermethrin results in decreased expression of DEPP1 mRNA |
CTD |
PMID:29020013 |
|
NCBI chr 6:116,627,645...116,629,808
Ensembl chr 6:116,627,570...116,629,755
|
|
G |
Dgat1 |
diacylglycerol O-acyltransferase 1 |
multiple interactions |
EXP |
[lard co-treated with Cholesterol co-treated with Sucrose co-treated with cypermethrin] results in increased expression of DGAT1 mRNA |
CTD |
PMID:24440342 |
|
NCBI chr15:76,386,215...76,396,167
Ensembl chr15:76,386,215...76,396,153
|
|
G |
Dhh |
desert hedgehog |
increases expression |
ISO |
cypermethrin results in increased expression of DHH mRNA; cypermethrin results in increased expression of DHH protein |
CTD |
PMID:35102696 |
|
NCBI chr15:98,779,496...98,796,443
Ensembl chr15:98,789,033...98,796,421
|
|
G |
Dhrs9 |
dehydrogenase/reductase 9 |
decreases expression multiple interactions |
EXP |
cypermethrin results in decreased expression of DHRS9 mRNA Sodium Selenite inhibits the reaction [cypermethrin results in decreased expression of DHRS9 mRNA] |
CTD |
PMID:31659573 |
|
NCBI chr 2:69,210,806...69,233,430
Ensembl chr 2:69,210,789...69,234,877
|
|
G |
Dhx30 |
DExH-box helicase 30 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of DHX30 protein |
CTD |
PMID:34896426 |
|
NCBI chr 9:109,913,387...109,946,728
Ensembl chr 9:109,913,388...109,946,898
|
|
G |
Dhx9 |
DExH-box helicase 9 |
increases expression |
ISO |
cypermethrin results in increased expression of DHX9 protein |
CTD |
PMID:36063984 |
|
NCBI chr 1:153,331,506...153,363,464
Ensembl chr 1:153,331,504...153,363,406
|
|
G |
Dlg2 |
discs large MAGUK scaffold protein 2 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of DLG2 protein |
CTD |
PMID:34896426 |
|
NCBI chr 7:90,125,399...92,098,454
Ensembl chr 7:90,125,880...92,098,455
|
|
G |
Dlst |
dihydrolipoamide S-succinyltransferase |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of DLST protein |
CTD |
PMID:34896426 |
|
NCBI chr12:85,157,597...85,180,865
Ensembl chr12:85,157,607...85,181,619
|
|
G |
Dmrta1 |
doublesex and mab-3 related transcription factor like family A1 |
increases expression |
EXP |
cypermethrin results in increased expression of DMRTA1 mRNA |
CTD |
PMID:29020013 |
|
NCBI chr 4:89,576,435...89,583,003
Ensembl chr 4:89,567,673...89,583,009
|
|
G |
Dnmt1 |
DNA methyltransferase 1 |
multiple interactions increases expression |
ISO |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of DNMT1 mRNA cypermethrin results in increased expression of DNMT1 mRNA |
CTD |
PMID:33051911 PMID:35605701 |
|
NCBI chr 9:20,818,501...20,871,084
Ensembl chr 9:20,818,505...20,871,184
|
|
G |
Dnmt3a |
DNA methyltransferase 3A |
multiple interactions increases expression decreases expression |
ISO |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of DNMT3A mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of DNMT3A mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of DNMT3A mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of DNMT3A mRNA; [pyrazolanthrone co-treated with cypermethrin] results in decreased expression of DNMT3A protein; asiatic acid inhibits the reaction [cypermethrin results in decreased expression of DNMT3A protein]; cypermethrin results in decreased expression of and results in decreased activity of DNMT3A protein; diallyl tetrasulfide inhibits the reaction [cypermethrin results in decreased expression of DNMT3A protein]; DNMT3A protein inhibits the reaction [cypermethrin results in increased expression of MIR140 mRNA]; DNMT3A protein inhibits the reaction [cypermethrin results in increased expression of WWP2 mRNA] cypermethrin results in increased expression of DNMT3A mRNA cypermethrin results in decreased expression of DNMT3A mRNA; cypermethrin results in decreased expression of DNMT3A protein |
CTD |
PMID:33051911 PMID:33396045 PMID:34794910 PMID:34896426 PMID:35605701 PMID:36053783 More...
|
|
NCBI chr12:3,851,559...3,964,442
Ensembl chr12:3,856,007...3,964,443
|
|
G |
Dnmt3b |
DNA methyltransferase 3B |
multiple interactions increases expression decreases expression |
ISO |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of DNMT3B mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of DNMT3B mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of DNMT3B mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of DNMT3B mRNA; [pyrazolanthrone co-treated with cypermethrin] results in decreased expression of DNMT3B protein; asiatic acid inhibits the reaction [cypermethrin results in decreased expression of DNMT3B protein]; cypermethrin results in decreased expression of and results in decreased activity of DNMT3B protein; diallyl tetrasulfide inhibits the reaction [cypermethrin results in decreased expression of DNMT3B protein] cypermethrin results in increased expression of DNMT3B mRNA cypermethrin results in decreased expression of DNMT3B mRNA; cypermethrin results in decreased expression of DNMT3B protein |
CTD |
PMID:33051911 PMID:33396045 PMID:34794910 PMID:34896426 PMID:35605701 PMID:36053783 More...
|
|
NCBI chr 2:153,491,332...153,529,650
Ensembl chr 2:153,491,370...153,529,650
|
|
G |
Dnmt3l |
DNA methyltransferase 3-like |
increases expression |
ISO |
cypermethrin results in increased expression of DNMT3L mRNA |
CTD |
PMID:35605701 |
|
NCBI chr10:77,878,121...77,899,456
Ensembl chr10:77,877,781...77,899,456
|
|
G |
Drd2 |
dopamine receptor D2 |
multiple interactions decreases expression |
ISO |
cypermethrin inhibits the reaction [[Quinpirole binds to and results in increased activity of DRD2 protein] which results in increased uptake of Dopamine]; cypermethrin promotes the reaction [cypermethrin results in decreased expression of DRD2 mRNA]; cypermethrin promotes the reaction [cypermethrin results in decreased expression of DRD2 protein] cypermethrin results in decreased expression of DRD2 mRNA; cypermethrin results in decreased expression of DRD2 protein |
CTD |
PMID:10936494 PMID:25288152 |
|
NCBI chr 9:49,251,703...49,319,468
Ensembl chr 9:49,251,927...49,319,477
|
|
G |
Duox1 |
dual oxidase 1 |
increases expression |
EXP |
cypermethrin results in increased expression of DUOX1 mRNA |
CTD |
PMID:21142847 |
|
NCBI chr 2:122,143,525...122,178,454
Ensembl chr 2:122,146,153...122,178,453
|
|
G |
Duox2 |
dual oxidase 2 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of DUOX2 protein |
CTD |
PMID:34896426 |
|
NCBI chr 2:122,109,727...122,129,221
Ensembl chr 2:122,109,728...122,128,930
|
|
G |
E2f4 |
E2F transcription factor 4 |
increases expression |
ISO |
cypermethrin results in increased expression of E2F4 protein |
CTD |
PMID:36063984 |
|
NCBI chr 8:106,024,295...106,032,002
Ensembl chr 8:106,024,295...106,032,002
|
|
G |
E4f1 |
E4F transcription factor 1 |
decreases expression |
ISO |
cypermethrin results in decreased expression of E4F1 protein |
CTD |
PMID:36063984 |
|
NCBI chr17:24,662,752...24,674,366
Ensembl chr17:24,662,752...24,689,287
|
|
G |
Ecel1 |
endothelin converting enzyme-like 1 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ECEL1 protein |
CTD |
PMID:34896426 |
|
NCBI chr 1:87,070,596...87,084,867
Ensembl chr 1:87,075,377...87,084,243
|
|
G |
Egfr |
epidermal growth factor receptor |
affects binding decreases expression decreases phosphorylation multiple interactions |
ISO EXP |
cypermethrin binds to EGFR protein cypermethrin results in decreased expression of EGFR mRNA; cypermethrin results in decreased expression of EGFR protein cypermethrin results in decreased phosphorylation of EGFR protein [cypermethrin results in decreased susceptibility to Dihydrotestosterone] which results in decreased phosphorylation of EGFR protein |
CTD |
PMID:22048644 PMID:30974244 |
|
NCBI chr11:16,700,153...16,868,158
Ensembl chr11:16,702,203...16,868,158
|
|
G |
Egr1 |
early growth response 1 |
multiple interactions increases expression |
EXP |
1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [cypermethrin results in increased expression of EGR1 protein]; bisindolylmaleimide I inhibits the reaction [cypermethrin results in increased expression of EGR1 protein]; cypermethrin inhibits the reaction [Dihydrotestosterone results in increased expression of EGR1 mRNA]; cypermethrin inhibits the reaction [Dihydrotestosterone results in increased expression of EGR1 protein]; Egtazic Acid inhibits the reaction [cypermethrin results in increased expression of EGR1 protein] cypermethrin results in increased expression of EGR1 mRNA; cypermethrin results in increased expression of EGR1 protein |
CTD |
PMID:29149324 PMID:30974244 |
|
NCBI chr18:34,994,260...34,998,009
Ensembl chr18:34,992,876...34,998,037
|
|
G |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
multiple interactions increases expression |
ISO |
Quercetin inhibits the reaction [cypermethrin results in increased expression of EIF2AK3 mRNA] |
CTD |
PMID:35876585 |
|
NCBI chr 6:70,821,468...70,882,225
Ensembl chr 6:70,821,499...70,882,229
|
|
G |
Eif4e |
eukaryotic translation initiation factor 4E |
increases expression |
EXP |
cypermethrin results in increased expression of EIF4E mRNA |
CTD |
PMID:29020013 |
|
NCBI chr 3:138,231,952...138,265,457
Ensembl chr 3:138,231,940...138,265,457
|
|
G |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
increases phosphorylation |
EXP |
cypermethrin results in increased phosphorylation of EIF4EBP1 mRNA; cypermethrin results in increased phosphorylation of EIF4EBP1 protein |
CTD |
PMID:37011868 |
|
NCBI chr 8:27,750,355...27,765,684
Ensembl chr 8:27,750,357...27,766,702
|
|
G |
Elac2 |
elaC ribonuclease Z 2 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ELAC2 protein |
CTD |
PMID:34896426 |
|
NCBI chr11:64,869,856...64,892,906
Ensembl chr11:64,869,864...64,892,895
|
|
G |
Ell3 |
elongation factor RNA polymerase II-like 3 |
increases expression |
ISO |
cypermethrin results in increased expression of ELL3 protein |
CTD |
PMID:36063984 |
|
NCBI chr 2:121,269,508...121,273,082
Ensembl chr 2:121,269,491...121,274,759
|
|
G |
Ep300 |
E1A binding protein p300 |
multiple interactions |
ISO |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of EP300 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of EP300 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of EP300 mRNA |
CTD |
PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783 |
|
NCBI chr15:81,470,329...81,536,273
Ensembl chr15:81,469,552...81,536,278
|
|
G |
Epha3 |
Eph receptor A3 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of EPHA3 protein |
CTD |
PMID:34896426 |
|
NCBI chr16:63,363,895...63,684,538
Ensembl chr16:63,363,897...63,684,538
|
|
G |
Epha6 |
Eph receptor A6 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of EPHA6 protein |
CTD |
PMID:34896426 |
|
NCBI chr16:59,473,424...60,431,196
Ensembl chr16:59,473,846...60,425,894
|
|
G |
Ephx1 |
epoxide hydrolase 1, microsomal |
increases expression |
ISO |
cypermethrin results in increased expression of EPHX1 mRNA |
CTD |
PMID:22528246 |
|
NCBI chr 1:180,817,121...180,845,134
Ensembl chr 1:180,803,775...180,848,469
|
|
G |
Erbb3 |
erb-b2 receptor tyrosine kinase 3 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of ERBB3 protein |
CTD |
PMID:34896426 |
|
NCBI chr10:128,403,392...128,425,504
Ensembl chr10:128,403,392...128,425,521
|
|
G |
Erc2 |
ELKS/RAB6-interacting/CAST family member 2 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ERC2 protein |
CTD |
PMID:34896426 |
|
NCBI chr14:27,344,232...28,200,494
Ensembl chr14:27,344,385...28,200,494
|
|
G |
Ercc2 |
excision repair cross-complementing rodent repair deficiency, complementation group 2 |
decreases expression |
ISO |
cypermethrin results in decreased expression of ERCC2 mRNA |
CTD |
PMID:22528246 |
|
NCBI chr 7:19,115,942...19,129,619
Ensembl chr 7:19,115,935...19,129,619
|
|
G |
Ercc3 |
excision repair cross-complementing rodent repair deficiency, complementation group 3 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ERCC3 protein |
CTD |
PMID:34896426 |
|
NCBI chr18:32,373,357...32,403,206
Ensembl chr18:32,373,353...32,403,204
|
|
G |
Ercc6 |
excision repair cross-complementing rodent repair deficiency, complementation group 6 |
increases expression |
EXP |
cypermethrin results in increased expression of ERCC6 mRNA |
CTD |
PMID:21142847 |
|
NCBI chr14:32,235,248...32,302,947
Ensembl chr14:32,235,478...32,302,947
|
|
G |
Ern1 |
endoplasmic reticulum to nucleus signalling 1 |
increases expression multiple interactions |
ISO |
cypermethrin results in increased expression of ERN1 mRNA Quercetin inhibits the reaction [cypermethrin results in increased expression of ERN1 mRNA] |
CTD |
PMID:35876585 |
|
NCBI chr11:106,285,474...106,378,701
Ensembl chr11:106,285,476...106,378,678
|
|
G |
Esm1 |
endothelial cell-specific molecule 1 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ESM1 protein |
CTD |
PMID:34896426 |
|
NCBI chr13:113,346,193...113,354,638
Ensembl chr13:113,346,193...113,354,632
|
|
G |
Esr1 |
estrogen receptor 1 (alpha) |
multiple interactions increases activity affects binding decreases expression increases expression |
ISO EXP |
cypermethrin binds to and results in increased activity of ESR1 protein; cypermethrin metabolite binds to and results in increased activity of ESR1 protein cypermethrin results in increased activity of ESR1 protein cypermethrin binds to ESR1 protein cypermethrin results in decreased expression of ESR1 mRNA cypermethrin results in increased expression of ESR1 mRNA cypermethrin results in decreased expression of ESR1 mRNA; cypermethrin results in decreased expression of ESR1 protein cypermethrin results in increased expression of ESR1 mRNA; cypermethrin results in increased expression of ESR1 protein [cypermethrin co-treated with emamectin benzoate] results in decreased expression of ESR1 mRNA; [cypermethrin co-treated with emamectin benzoate] results in decreased expression of ESR1 protein; cypermethrin inhibits the reaction [Estradiol results in increased activity of ESR1 protein] |
CTD |
PMID:12396874 PMID:15064155 PMID:16395479 PMID:20397420 PMID:20574910 PMID:24388911 PMID:24810582 PMID:28531659 PMID:29253587 PMID:33049310 PMID:36116546 PMID:37984602 More...
|
|
NCBI chr10:4,561,989...4,955,633
Ensembl chr10:4,561,593...4,955,614
|
|
G |
Esr2 |
estrogen receptor 2 (beta) |
increases expression multiple interactions |
EXP ISO |
cypermethrin results in increased expression of ESR2 mRNA cypermethrin binds to and results in increased activity of ESR2 protein |
CTD |
PMID:20574910 PMID:33049310 |
|
NCBI chr12:76,167,193...76,224,033
Ensembl chr12:76,167,193...76,224,033
|
|
G |
Exoc3 |
exocyst complex component 3 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of EXOC3 protein |
CTD |
PMID:34896426 |
|
NCBI chr13:74,317,921...74,358,151
Ensembl chr13:74,317,607...74,356,851
|
|
G |
Ezh2 |
enhancer of zeste 2 polycomb repressive complex 2 subunit |
multiple interactions |
ISO |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in increased expression of EZH2 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of EZH2 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of EZH2 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of EZH2 mRNA |
CTD |
PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783 |
|
NCBI chr 6:47,507,208...47,613,843
Ensembl chr 6:47,507,073...47,572,275
|
|
G |
F3 |
coagulation factor III |
decreases expression |
EXP |
cypermethrin results in decreased expression of F3 mRNA |
CTD |
PMID:29020013 |
|
NCBI chr 3:121,517,186...121,528,701
Ensembl chr 3:121,517,186...121,528,697
|
|
G |
Fabp4 |
fatty acid binding protein 4, adipocyte |
increases expression |
EXP |
cypermethrin results in increased expression of FABP4 mRNA |
CTD |
PMID:35031408 |
|
NCBI chr 3:10,269,406...10,273,653
Ensembl chr 3:10,269,148...10,273,636
|
|
G |
Fancc |
Fanconi anemia, complementation group C |
increases expression |
EXP |
cypermethrin results in increased expression of FANCC mRNA |
CTD |
PMID:21142847 |
|
NCBI chr13:63,452,519...63,645,126
Ensembl chr13:63,432,857...63,645,092
|
|
G |
Fancg |
Fanconi anemia, complementation group G |
increases expression |
EXP |
cypermethrin results in increased expression of FANCG mRNA |
CTD |
PMID:21142847 |
|
NCBI chr 4:43,002,337...43,010,565
Ensembl chr 4:43,002,343...43,010,506
|
|
G |
Farp1 |
FERM, ARH/RhoGEF and pleckstrin domain protein 1 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of FARP1 protein |
CTD |
PMID:34896426 |
|
NCBI chr14:121,272,563...121,521,156
Ensembl chr14:121,272,612...121,521,156
|
|
G |
Fas |
Fas cell surface death receptor |
increases expression |
ISO |
cypermethrin results in increased expression of FAS mRNA |
CTD |
PMID:27704156 |
|
NCBI chr19:34,267,926...34,305,175
Ensembl chr19:34,268,066...34,305,172
|
|
G |
Fau |
FAU ubiquitin like and ribosomal protein S30 fusion |
decreases expression |
EXP |
cypermethrin results in decreased expression of FAU mRNA |
CTD |
PMID:29020013 |
|
NCBI chr19:6,107,977...6,109,554
Ensembl chr19:6,107,874...6,109,554
|
|
G |
Fbln5 |
fibulin 5 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of FBLN5 protein |
CTD |
PMID:34896426 |
|
NCBI chr12:101,712,820...101,785,541
Ensembl chr12:101,712,824...101,785,314
|
|
G |
Fem1b |
fem 1 homolog b |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of FEM1B protein |
CTD |
PMID:34896426 |
|
NCBI chr 9:62,699,106...62,718,930
Ensembl chr 9:62,699,103...62,719,216
|
|
G |
Fgf5 |
fibroblast growth factor 5 |
decreases expression |
EXP |
cypermethrin results in decreased expression of FGF5 mRNA |
CTD |
PMID:32214279 |
|
NCBI chr 5:98,402,108...98,424,892
Ensembl chr 5:98,402,043...98,424,889
|
|
G |
Fhl5 |
four and a half LIM domains 5 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of FHL5 protein |
CTD |
PMID:34896426 |
|
NCBI chr 4:25,199,907...25,242,852
Ensembl chr 4:25,199,908...25,242,876
|
|
G |
Flt1 |
FMS-like tyrosine kinase 1 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of FLT1 protein |
CTD |
PMID:34896426 |
|
NCBI chr 5:147,498,414...147,663,419
Ensembl chr 5:147,498,414...147,662,821
|
|
G |
Flt4 |
FMS-like tyrosine kinase 4 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of FLT4 protein |
CTD |
PMID:34896426 |
|
NCBI chr11:49,500,506...49,543,566
Ensembl chr11:49,500,090...49,543,566
|
|
G |
Fmo2 |
flavin containing monooxygenase 2 |
increases expression |
EXP |
cypermethrin results in increased expression of FMO2 mRNA |
CTD |
PMID:21142847 |
|
NCBI chr 1:162,701,886...162,726,327
Ensembl chr 1:162,701,886...162,726,295
|
|
G |
Fos |
FBJ osteosarcoma oncogene |
multiple interactions increases expression |
EXP ISO |
1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [cypermethrin results in increased expression of FOS protein]; bisindolylmaleimide I inhibits the reaction [cypermethrin results in increased expression of FOS protein]; cypermethrin inhibits the reaction [Veratridine results in increased expression of FOS mRNA]; Egtazic Acid inhibits the reaction [cypermethrin results in increased expression of FOS protein] cypermethrin results in increased expression of FOS mRNA; cypermethrin results in increased expression of FOS protein |
CTD |
PMID:8856738 PMID:11082455 PMID:29149324 |
|
NCBI chr12:85,520,664...85,524,048
Ensembl chr12:85,520,664...85,524,047
|
|
G |
Foxa2 |
forkhead box A2 |
increases expression |
EXP |
cypermethrin results in increased expression of FOXA2 mRNA |
CTD |
PMID:32214279 |
|
NCBI chr 2:147,884,797...147,888,889
Ensembl chr 2:147,884,797...147,888,889
|
|
G |
Foxf2 |
forkhead box F2 |
decreases expression |
ISO |
cypermethrin results in decreased expression of FOXF2 mRNA |
CTD |
PMID:22528246 |
|
NCBI chr13:31,809,686...31,815,390
Ensembl chr13:31,809,799...31,815,386
|
|
G |
Foxo1 |
forkhead box O1 |
increases expression |
EXP |
cypermethrin results in increased expression of FOXO1 mRNA; cypermethrin results in increased expression of FOXO1 protein |
CTD |
PMID:37011868 |
|
NCBI chr 3:52,175,758...52,257,530
Ensembl chr 3:52,175,757...52,260,642
|
|
G |
Fshb |
follicle stimulating hormone beta |
increases expression decreases expression multiple interactions increases secretion affects expression |
ISO EXP |
cypermethrin results in increased expression of FSHB protein cypermethrin results in decreased expression of FSHB protein [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of FSHB protein; [cypermethrin co-treated with emamectin benzoate] results in increased expression of FSHB protein; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of FSHB protein; Vitamin E inhibits the reaction [cypermethrin results in decreased expression of FSHB protein] cypermethrin results in increased expression of FSHB mRNA; cypermethrin results in increased expression of FSHB protein 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [cypermethrin results in increased expression of FSHB mRNA]; 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [cypermethrin results in increased secretion of FSHB protein]; 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide inhibits the reaction [cypermethrin results in increased expression of FSHB mRNA]; bisindolylmaleimide I inhibits the reaction [cypermethrin results in increased expression of FSHB mRNA]; cypermethrin results in increased expression of and results in increased secretion of FSHB protein; Egtazic Acid inhibits the reaction [cypermethrin results in increased expression of FSHB mRNA]; Egtazic Acid inhibits the reaction [cypermethrin results in increased secretion of FSHB protein]; Nimodipine inhibits the reaction [cypermethrin results in increased expression of FSHB mRNA]; Nimodipine inhibits the reaction [cypermethrin results in increased secretion of FSHB protein] cypermethrin affects the expression of FSHB mRNA |
CTD |
PMID:23447098 PMID:24759048 PMID:28731686 PMID:29149324 PMID:34896426 PMID:35031408 PMID:35931855 PMID:36053783 PMID:37984602 More...
|
|
NCBI chr 2:106,886,331...106,889,996
Ensembl chr 2:106,886,485...106,890,001
|
|
G |
Fshr |
follicle stimulating hormone receptor |
multiple interactions |
ISO |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of FSHR mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of FSHR mRNA; [cypermethrin co-treated with Diethylhexyl Phthalate] results in decreased expression of FSHR mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of FSHR mRNA |
CTD |
PMID:24641848 PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783 |
|
NCBI chr17:89,292,380...89,508,103
Ensembl chr17:89,292,380...89,508,103
|
|
G |
G6pdx |
glucose-6-phosphate dehydrogenase X-linked |
multiple interactions decreases activity |
ISO |
[cypermethrin co-treated with propetamphos] results in decreased activity of G6PD protein cypermethrin results in decreased activity of G6PD protein |
CTD |
PMID:25926273 |
|
NCBI chr X:73,453,089...73,472,486
Ensembl chr X:73,453,089...73,472,800
|
|
G |
Gabra1 |
gamma-aminobutyric acid type A receptor subunit alpha 1 |
multiple interactions decreases expression |
ISO |
cypermethrin promotes the reaction [cypermethrin results in decreased expression of GABRA1 mRNA]; cypermethrin promotes the reaction [cypermethrin results in decreased expression of GABRA1 protein] cypermethrin results in decreased expression of GABRA1 mRNA; cypermethrin results in decreased expression of GABRA1 protein |
CTD |
PMID:25288152 |
|
NCBI chr11:42,021,766...42,073,893
Ensembl chr11:42,021,766...42,073,757
|
|
G |
Gabrg2 |
gamma-aminobutyric acid type A receptor, subunit gamma 2 |
decreases expression |
EXP |
cypermethrin results in decreased expression of GABRG2 mRNA |
CTD |
PMID:24220872 |
|
NCBI chr11:41,801,017...41,891,684
Ensembl chr11:41,801,030...41,891,684
|
|
G |
Gad1 |
glutamate decarboxylase 1 |
decreases expression |
ISO |
cypermethrin results in decreased expression of GAD1 mRNA; cypermethrin results in decreased expression of GAD1 protein |
CTD |
PMID:26115703 |
|
NCBI chr 2:70,392,109...70,432,358
Ensembl chr 2:70,383,416...70,432,358
|
|
G |
Gadd45a |
growth arrest and DNA-damage-inducible 45 alpha |
increases expression |
ISO |
cypermethrin results in increased expression of GADD45A mRNA |
CTD |
PMID:22528246 PMID:27704156 |
|
NCBI chr 6:67,012,080...67,014,391
Ensembl chr 6:67,012,080...67,014,441
|
|
G |
Gap43 |
growth associated protein 43 |
increases expression |
ISO |
cypermethrin results in increased expression of GAP43 mRNA |
CTD |
PMID:32028016 |
|
NCBI chr16:42,068,915...42,161,014
Ensembl chr16:42,068,805...42,161,014
|
|
G |
Gars1 |
glycyl-tRNA synthetase 1 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GARS1 protein |
CTD |
PMID:34896426 |
|
NCBI chr 6:55,014,986...55,056,489
Ensembl chr 6:55,014,992...55,056,485
|
|
G |
Gata2 |
GATA binding protein 2 |
decreases expression |
ISO |
cypermethrin results in decreased expression of GATA2 mRNA |
CTD |
PMID:22528246 |
|
NCBI chr 6:88,170,873...88,184,014
Ensembl chr 6:88,170,873...88,184,014
|
|
G |
Gata4 |
GATA binding protein 4 |
multiple interactions |
ISO |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of GATA4 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of GATA4 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of GATA4 mRNA |
CTD |
PMID:33051911 PMID:34896426 PMID:36053783 |
|
NCBI chr14:63,436,363...63,509,161
Ensembl chr14:63,436,371...63,509,141
|
|
G |
Gc |
vitamin D binding protein |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GC protein |
CTD |
PMID:34896426 |
|
NCBI chr 5:89,565,370...89,605,757
Ensembl chr 5:89,565,381...89,605,757
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GCLC protein |
CTD |
PMID:34896426 |
|
NCBI chr 9:77,661,817...77,701,771
Ensembl chr 9:77,661,817...77,701,767
|
|
G |
Gdf9 |
growth differentiation factor 9 |
increases expression |
ISO |
cypermethrin results in increased expression of GDF9 mRNA |
CTD |
PMID:35605701 |
|
NCBI chr11:53,321,773...53,328,731
Ensembl chr11:53,321,850...53,328,731
|
|
G |
Gdnf |
glial cell line derived neurotrophic factor |
multiple interactions |
ISO |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of GDNF mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of GDNF mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of GDNF mRNA |
CTD |
PMID:33051911 PMID:33396045 PMID:34896426 |
|
NCBI chr15:7,839,529...7,867,061
Ensembl chr15:7,840,327...7,867,056
|
|
G |
Gfra1 |
glial cell line derived neurotrophic factor family receptor alpha 1 |
multiple interactions |
ISO |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of GFRA1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GFRA1 mRNA |
CTD |
PMID:33051911 PMID:33396045 PMID:34896426 |
|
NCBI chr19:58,224,013...58,444,387
Ensembl chr19:58,224,036...58,444,341
|
|
G |
Gh |
growth hormone |
decreases expression |
ISO |
cypermethrin results in decreased expression of GH1 protein |
CTD |
PMID:26115703 |
|
NCBI chr11:106,191,087...106,194,529
Ensembl chr11:106,191,097...106,192,691
|
|
G |
Gimap8 |
GTPase, IMAP family member 8 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GIMAP8 protein |
CTD |
PMID:34896426 |
|
NCBI chr 6:48,624,120...48,637,809
Ensembl chr 6:48,624,168...48,637,809
|
|
G |
Gja6 |
gap junction protein, alpha 6 |
increases expression |
EXP |
cypermethrin results in increased expression of GJA6 mRNA |
CTD |
PMID:29020013 |
|
NCBI chr X:159,685,112...159,690,048
Ensembl chr X:159,685,112...159,690,048
|
|
G |
Gjc2 |
gap junction protein, gamma 2 |
increases expression multiple interactions |
ISO |
cypermethrin results in increased expression of GJC2 protein modified form Minocycline inhibits the reaction [cypermethrin results in increased expression of GJC2 protein modified form] |
CTD |
PMID:21561882 |
|
NCBI chr11:59,066,390...59,074,039
Ensembl chr11:59,066,394...59,074,039
|
|
G |
Glud1 |
glutamate dehydrogenase 1 |
increases expression |
ISO |
cypermethrin results in increased expression of GLUD1 mRNA |
CTD |
PMID:32573024 |
|
NCBI chr14:34,032,684...34,066,990
Ensembl chr14:34,032,684...34,067,222
|
|
G |
Glul |
glutamate-ammonia ligase |
decreases activity |
EXP |
cypermethrin results in decreased activity of GLUL protein |
CTD |
PMID:24649940 |
|
NCBI chr 1:153,775,692...153,785,469
Ensembl chr 1:153,775,690...153,785,469
|
|
G |
Gnl1 |
guanine nucleotide binding protein-like 1 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GNL1 protein |
CTD |
PMID:34896426 |
|
NCBI chr17:36,290,847...36,300,354
Ensembl chr17:36,290,743...36,300,354
|
|
G |
Gnrh1 |
gonadotropin releasing hormone 1 |
affects secretion increases expression affects expression multiple interactions |
EXP ISO |
cypermethrin affects the secretion of GNRH1 protein cypermethrin results in increased expression of GNRH1 mRNA cypermethrin affects the expression of GNRH1 mRNA [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of GNRH1 protein; [cypermethrin co-treated with emamectin benzoate] results in decreased expression of GNRH1 protein |
CTD |
PMID:28731686 PMID:34896426 PMID:35931855 PMID:37984602 |
|
NCBI chr14:67,982,717...67,986,889
Ensembl chr14:67,982,630...67,986,888
|
|
G |
Got1 |
glutamic-oxaloacetic transaminase 1, soluble |
multiple interactions decreases activity increases activity increases secretion |
EXP ISO |
[cypermethrin co-treated with Chlorpyrifos] results in increased expression of GOT1 protein; Plant Extracts inhibits the reaction [[cypermethrin co-treated with Chlorpyrifos] results in increased expression of GOT1 protein] cypermethrin results in decreased activity of GOT1 protein cypermethrin results in increased activity of GOT1 protein Phenobarbital inhibits the reaction [cypermethrin results in increased secretion of GOT1 protein]; Proadifen promotes the reaction [cypermethrin results in increased secretion of GOT1 protein] |
CTD |
PMID:2466999 PMID:11428908 PMID:15365239 PMID:15991261 |
|
NCBI chr19:43,488,191...43,514,743
Ensembl chr19:43,488,191...43,513,044
|
|
G |
Got2 |
glutamatic-oxaloacetic transaminase 2, mitochondrial |
increases expression multiple interactions |
ISO |
cypermethrin results in increased expression of GOT2 Sesame Oil inhibits the reaction [cypermethrin results in increased expression of GOT2] |
CTD |
PMID:25816392 |
|
NCBI chr 8:96,590,761...96,615,029
Ensembl chr 8:96,590,762...96,615,175
|
|
G |
Gphn |
gephyrin |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GPHN protein |
CTD |
PMID:34896426 |
|
NCBI chr12:78,264,099...78,731,546
Ensembl chr12:78,273,153...78,731,546
|
|
G |
Gpt |
glutamic pyruvic transaminase, soluble |
multiple interactions increases secretion increases activity increases expression |
EXP ISO |
[cypermethrin co-treated with Chlorpyrifos] results in increased expression of GPT protein; Plant Extracts inhibits the reaction [[cypermethrin co-treated with Chlorpyrifos] results in increased expression of GPT protein] cypermethrin results in increased secretion of GPT protein cypermethrin results in increased activity of GPT protein [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the activity of GPT protein; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased activity of GPT protein; Phenobarbital inhibits the reaction [cypermethrin results in increased secretion of GPT protein]; Proadifen promotes the reaction [cypermethrin results in increased secretion of GPT protein]; Sesame Oil inhibits the reaction [cypermethrin results in increased expression of GPT] cypermethrin results in increased expression of GPT mRNA |
CTD |
PMID:11428908 PMID:15365239 PMID:15991261 PMID:25816392 PMID:32573024 PMID:33396045 PMID:35678313 More...
|
|
NCBI chr15:76,580,926...76,583,875
Ensembl chr15:76,579,916...76,583,886
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
multiple interactions increases expression affects expression decreases expression |
EXP ISO |
[cypermethrin co-treated with Chlorpyrifos] results in decreased activity of GPX1 protein; Plant Extracts inhibits the reaction [[cypermethrin co-treated with Chlorpyrifos] results in decreased activity of GPX1 protein] cypermethrin results in increased expression of GPX1 mRNA cypermethrin affects the expression of GPX1 mRNA cypermethrin results in decreased expression of GPX1 mRNA; cypermethrin results in decreased expression of GPX1 protein [cypermethrin co-treated with emamectin benzoate] results in decreased activity of GPX1 protein |
CTD |
PMID:15991261 PMID:21397294 PMID:32214279 PMID:35512476 PMID:37984602 |
|
NCBI chr 9:108,216,279...108,217,541
Ensembl chr 9:108,216,102...108,217,542
|
|
G |
Gpx2 |
glutathione peroxidase 2 |
increases expression |
EXP |
cypermethrin results in increased expression of GPX2 mRNA |
CTD |
PMID:21397294 |
|
NCBI chr12:76,839,109...76,842,328
Ensembl chr12:76,839,107...76,842,273
|
|
G |
Gpx4 |
glutathione peroxidase 4 |
increases expression decreases expression |
EXP ISO |
cypermethrin results in increased expression of GPX4 mRNA cypermethrin results in decreased expression of GPX4 mRNA |
CTD |
PMID:21142847 PMID:32214279 PMID:35512476 |
|
NCBI chr10:79,883,000...79,892,273
Ensembl chr10:79,883,000...79,892,273
|
|
G |
Grb2 |
growth factor receptor bound protein 2 |
decreases expression |
ISO |
cypermethrin results in decreased expression of GRB2 mRNA |
CTD |
PMID:27704156 |
|
NCBI chr11:115,534,871...115,599,423
Ensembl chr11:115,534,871...115,599,423
|
|
G |
Gria1 |
glutamate receptor, ionotropic, AMPA1 (alpha 1) |
affects expression |
EXP |
cypermethrin affects the expression of GRIA1 protein |
CTD |
PMID:26143737 |
|
NCBI chr11:56,902,342...57,221,070
Ensembl chr11:56,902,213...57,221,070
|
|
G |
Gria3 |
glutamate receptor, ionotropic, AMPA3 (alpha 3) |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GRIA3 protein |
CTD |
PMID:34896426 |
|
NCBI chr X:40,489,351...40,767,478
Ensembl chr X:40,489,731...40,767,478
|
|
G |
Grid2ip |
glutamate receptor, ionotropic, delta 2 (Grid2) interacting protein 1 |
decreases expression |
ISO |
cypermethrin results in decreased expression of GRID2IP protein |
CTD |
PMID:36063984 |
|
NCBI chr 5:143,343,085...143,377,534
Ensembl chr 5:143,343,093...143,377,907
|
|
G |
Grik5 |
glutamate receptor, ionotropic, kainate 5 (gamma 2) |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GRIK5 protein |
CTD |
PMID:34896426 |
|
NCBI chr 7:24,709,274...24,775,421
Ensembl chr 7:24,709,274...24,771,771
|
|
G |
Grin1 |
glutamate receptor, ionotropic, NMDA1 (zeta 1) |
decreases expression |
ISO |
cypermethrin results in decreased expression of GRIN1 protein |
CTD |
PMID:36063984 |
|
NCBI chr 2:25,181,189...25,209,199
Ensembl chr 2:25,181,193...25,209,199
|
|
G |
Grin2a |
glutamate receptor, ionotropic, NMDA2A (epsilon 1) |
decreases expression |
ISO |
cypermethrin results in decreased expression of GRIN2A protein |
CTD |
PMID:28975519 PMID:36063984 |
|
NCBI chr16:9,385,765...9,813,744
Ensembl chr16:9,385,762...9,813,424
|
|
G |
Grin2b |
glutamate receptor, ionotropic, NMDA2B (epsilon 2) |
decreases expression |
ISO |
cypermethrin results in decreased expression of GRIN2B protein |
CTD |
PMID:28975519 |
|
NCBI chr 6:135,690,219...136,150,658
Ensembl chr 6:135,690,231...136,150,509
|
|
G |
Grm1 |
glutamate receptor, metabotropic 1 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GRM1 protein |
CTD |
PMID:34896426 |
|
NCBI chr10:10,561,803...10,958,126
Ensembl chr10:10,561,803...10,958,100
|
|
G |
Grm5 |
glutamate receptor, metabotropic 5 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GRM5 protein |
CTD |
PMID:34896426 |
|
NCBI chr 7:87,233,212...87,784,271
Ensembl chr 7:87,233,376...87,784,115
|
|
G |
Grn |
granulin |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GRN protein |
CTD |
PMID:34896426 |
|
NCBI chr11:102,321,333...102,327,635
Ensembl chr11:102,321,141...102,327,874
|
|
G |
Grp |
gastrin releasing peptide |
increases expression |
EXP |
cypermethrin results in increased expression of GRP mRNA |
CTD |
PMID:29020013 |
|
NCBI chr18:66,005,826...66,019,670
Ensembl chr18:66,005,891...66,019,667
|
|
G |
Gsr |
glutathione reductase |
multiple interactions increases expression |
EXP |
[cypermethrin co-treated with Chlorpyrifos] results in decreased activity of GSR protein; Plant Extracts inhibits the reaction [[cypermethrin co-treated with Chlorpyrifos] results in decreased activity of GSR protein] cypermethrin results in increased expression of GSR mRNA |
CTD |
PMID:15991261 PMID:21142847 |
|
NCBI chr 8:34,143,266...34,188,190
Ensembl chr 8:34,142,551...34,188,191
|
|
G |
Gsta1 |
glutathione S-transferase, alpha 1 (Ya) |
increases expression |
EXP |
cypermethrin results in increased expression of GSTA1; cypermethrin results in increased expression of GSTA1 mRNA |
CTD |
PMID:32214279 |
|
NCBI chr 9:78,137,951...78,149,965
Ensembl chr 9:78,137,938...78,149,966
|
|
G |
Gsta4 |
glutathione S-transferase, alpha 4 |
increases expression |
ISO |
cypermethrin results in increased expression of GSTA4 mRNA |
CTD |
PMID:20815782 |
|
NCBI chr 9:78,099,248...78,116,631
Ensembl chr 9:78,090,056...78,116,631
|
|
G |
Gstk1 |
glutathione S-transferase kappa 1 |
increases expression |
EXP |
cypermethrin results in increased expression of GSTK1 mRNA |
CTD |
PMID:21142847 |
|
NCBI chr 6:42,222,869...42,227,375
Ensembl chr 6:42,222,869...42,227,381
|
|
G |
Gstp1 |
glutathione S-transferase, pi 1 |
decreases expression |
ISO |
cypermethrin results in decreased expression of GSTP1 mRNA |
CTD |
PMID:22528246 |
|
NCBI chr19:4,085,411...4,087,912
Ensembl chr19:4,085,407...4,087,985
|
|
G |
Gtf2h1 |
general transcription factor II H, polypeptide 1 |
increases expression |
EXP |
cypermethrin results in increased expression of GTF2H1 mRNA |
CTD |
PMID:21142847 |
|
NCBI chr 7:46,445,518...46,473,224
Ensembl chr 7:46,445,527...46,473,224
|
|
G |
Gtf2i |
general transcription factor II I |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GTF2I protein |
CTD |
PMID:34896426 |
|
NCBI chr 5:134,266,686...134,346,571
Ensembl chr 5:134,266,688...134,343,614
|
|
G |
Gucy2e |
guanylate cyclase 2e |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GUCY2E protein |
CTD |
PMID:34896426 |
|
NCBI chr11:69,108,943...69,128,083
Ensembl chr11:69,108,943...69,127,862
|
|
G |
H1f2 |
H1.2 linker histone, cluster member |
decreases expression |
EXP |
cypermethrin results in decreased expression of H1F2 mRNA |
CTD |
PMID:29020013 |
|
NCBI chr13:23,922,790...23,923,514
Ensembl chr13:23,922,791...23,924,350
|
|
G |
H2ax |
H2A.X variant histone |
increases phosphorylation |
ISO |
cypermethrin results in increased phosphorylation of H2AX protein |
CTD |
PMID:35512476 |
|
NCBI chr 9:44,246,012...44,247,374
Ensembl chr 9:44,245,991...44,247,374
|
|
G |
H2bc8 |
H2B clustered histone 8 |
decreases expression |
EXP |
cypermethrin results in decreased expression of H2BC7 mRNA |
CTD |
PMID:29020013 |
|
NCBI chr13:23,755,574...23,756,037
Ensembl chr13:23,755,570...23,756,187
|
|
G |
H4c2 |
H4 clustered histone 2 |
decreases expression |
EXP |
cypermethrin results in decreased expression of H4C14 mRNA |
CTD |
PMID:29020013 |
|
NCBI chr13:23,940,920...23,941,369
Ensembl chr13:23,940,996...23,941,392
|
|
G |
H4c3 |
H4 clustered histone 3 |
decreases expression |
EXP |
cypermethrin results in decreased expression of H4C6 mRNA |
CTD |
PMID:29020013 |
|
NCBI chr13:23,882,067...23,882,441
Ensembl chr13:23,881,618...23,882,437
|
|
G |
Hadha |
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of HADHA protein |
CTD |
PMID:34896426 |
|
NCBI chr 5:30,324,421...30,359,978
Ensembl chr 5:30,323,302...30,360,160
|
|
G |
Hamp2 |
hepcidin antimicrobial peptide 2 |
increases expression |
EXP |
cypermethrin results in increased expression of HAMP2 mRNA |
CTD |
PMID:29020013 |
|
NCBI chr 7:30,621,797...30,623,606
Ensembl chr 7:30,621,797...30,624,106
|
|
G |
Hba-a2 |
hemoglobin alpha, adult chain 2 |
decreases expression |
EXP |
cypermethrin results in decreased expression of HBA-A2 mRNA |
CTD |
PMID:29020013 |
|
NCBI chr11:32,246,492...32,247,310
Ensembl chr11:32,246,489...32,247,298
|
|
G |
Hbegf |
heparin-binding EGF-like growth factor |
multiple interactions decreases expression decreases response to substance |
ISO |
cypermethrin results in decreased expression of and results in decreased secretion of HBEGF protein; HBEGF protein inhibits the reaction [cypermethrin results in decreased expression of BCL2 protein]; HBEGF protein inhibits the reaction [cypermethrin results in decreased expression of BCL2L1 protein]; HBEGF protein inhibits the reaction [cypermethrin results in increased expression of BAX protein] cypermethrin results in decreased expression of HBEGF mRNA HBEGF protein results in decreased susceptibility to cypermethrin |
CTD |
PMID:22048644 |
|
NCBI chr18:36,637,980...36,648,858
Ensembl chr18:36,637,980...36,648,858
|
|
G |
Hcn2 |
hyperpolarization-activated, cyclic nucleotide-gated K+ 2 |
decreases expression |
ISO |
cypermethrin results in decreased expression of HCN2 protein |
CTD |
PMID:36063984 |
|
NCBI chr10:79,552,468...79,571,942
Ensembl chr10:79,552,468...79,571,942
|
|
G |
Hdac1 |
histone deacetylase 1 |
multiple interactions |
ISO |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of HDAC1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of HDAC1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of HDAC1 mRNA |
CTD |
PMID:33051911 PMID:33396045 PMID:34896426 |
|
NCBI chr 4:129,409,897...129,436,516
Ensembl chr 4:129,409,897...129,436,506
|
|
G |
Hdac10 |
histone deacetylase 10 |
multiple interactions |
ISO |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of HDAC10 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of HDAC10 mRNA |
CTD |
PMID:33051911 PMID:33396045 PMID:34896426 |
|
NCBI chr15:89,007,506...89,012,903
Ensembl chr15:89,007,510...89,012,903
|
|
G |
Hdac4 |
histone deacetylase 4 |
multiple interactions |
ISO |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of HDAC4 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of HDAC4 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of HDAC4 mRNA |
CTD |
PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783 |
|
NCBI chr 1:91,856,501...92,123,424
Ensembl chr 1:91,856,501...92,123,421
|
|
G |
Hdc |
histidine decarboxylase |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of HDC mRNA |
CTD |
PMID:34896426 |
|
NCBI chr 2:126,435,579...126,465,942
Ensembl chr 2:126,435,587...126,461,219
|
|
G |
Hes1 |
hes family bHLH transcription factor 1 |
decreases expression multiple interactions |
ISO |
cypermethrin results in decreased expression of HES1 mRNA; cypermethrin results in decreased expression of HES1 protein HES1 inhibits the reaction [cypermethrin results in increased expression of CXCL16 protein]; MIR21 promotes the reaction [cypermethrin results in decreased expression of HES1 protein] |
CTD |
PMID:35512476 |
|
NCBI chr16:29,883,259...29,886,614
Ensembl chr16:29,883,202...29,886,614
|
|
G |
Hic1 |
hypermethylated in cancer 1 |
increases expression |
EXP |
cypermethrin results in increased expression of HIC1 mRNA |
CTD |
PMID:35031408 |
|
NCBI chr11:75,052,203...75,059,970
Ensembl chr11:75,055,391...75,060,345
|
|
G |
Hif1a |
hypoxia inducible factor 1, alpha subunit |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of HIF1A mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of HIF1A mRNA |
CTD |
PMID:33396045 PMID:34896426 |
|
NCBI chr12:73,948,186...73,994,304
Ensembl chr12:73,948,149...73,994,304
|
|
G |
Hif3a |
hypoxia inducible factor 3, alpha subunit |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of HIF3A protein |
CTD |
PMID:34896426 |
|
NCBI chr 7:16,764,918...16,796,352
Ensembl chr 7:16,765,432...16,796,352
|
|
G |
Hmgcr |
3-hydroxy-3-methylglutaryl-Coenzyme A reductase |
multiple interactions |
ISO |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of HMGCR mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of HMGCR mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of HMGCR mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of HMGCR mRNA |
CTD |
PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783 |
|
NCBI chr13:96,785,470...96,807,444
Ensembl chr13:96,785,475...96,807,444
|
|
G |
Hmgcs1 |
3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1 |
decreases expression multiple interactions |
EXP ISO |
cypermethrin results in decreased expression of HMGCS1 mRNA [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of HMGCS1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of HMGCS1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of HMGCS1 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of HMGCS1 mRNA |
CTD |
PMID:21397294 PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783 |
|
NCBI chr13:120,151,887...120,169,796
Ensembl chr13:120,151,915...120,169,796
|
|
G |
Hmox1 |
heme oxygenase 1 |
affects expression multiple interactions increases expression decreases expression |
ISO EXP |
cypermethrin affects the expression of HMOX1 [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of HMOX1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of HMOX1 mRNA; Acetylcysteine inhibits the reaction [cypermethrin results in increased expression of HMOX1 mRNA]; Quercetin inhibits the reaction [cypermethrin results in decreased expression of HMOX1 mRNA]; Sesame Oil affects the reaction [cypermethrin affects the expression of HMOX1] cypermethrin results in decreased expression of HMOX1 mRNA; cypermethrin results in decreased expression of HMOX1 protein |
CTD |
PMID:23900960 PMID:25816392 PMID:31907151 PMID:33396045 PMID:34896426 PMID:35876585 More...
|
|
NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
|
|
G |
Hoxa10 |
homeobox A10 |
decreases expression |
EXP |
cypermethrin results in decreased expression of HOXA10 mRNA; cypermethrin results in decreased expression of HOXA10 protein |
CTD |
PMID:29253587 PMID:36116546 |
|
NCBI chr 6:52,208,177...52,217,658
Ensembl chr 6:52,208,177...52,217,834
|
|
G |
Hp1bp3 |
heterochromatin protein 1, binding protein 3 |
multiple interactions |
ISO |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of HP1BP3 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of HP1BP3 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of HP1BP3 mRNA |
CTD |
PMID:33051911 PMID:33396045 PMID:34896426 |
|
NCBI chr 4:137,943,781...137,971,994
Ensembl chr 4:137,943,607...137,971,994
|
|
G |
Hpdl |
4-hydroxyphenylpyruvate dioxygenase-like |
increases expression |
EXP |
cypermethrin results in increased expression of HPDL mRNA |
CTD |
PMID:29020013 |
|
NCBI chr 4:116,677,104...116,678,705
Ensembl chr 4:116,677,101...116,678,904
|
|
G |
Hrk |
harakiri, BCL2 interacting protein (contains only BH3 domain) |
decreases expression |
EXP |
cypermethrin results in decreased expression of HRK mRNA |
CTD |
PMID:29020013 |
|
NCBI chr 5:118,307,829...118,327,543
Ensembl chr 5:118,302,713...118,327,543
|
|
G |
Hsd11b2 |
hydroxysteroid 11-beta dehydrogenase 2 |
increases expression |
EXP |
cypermethrin results in increased expression of HSD11B2 mRNA |
CTD |
PMID:35031408 |
|
NCBI chr 8:106,245,378...106,250,620
Ensembl chr 8:106,245,387...106,250,620
|
|
G |
Hsd17b1 |
hydroxysteroid (17-beta) dehydrogenase 1 |
decreases expression |
EXP |
cypermethrin results in decreased expression of HSD17B1 mRNA |
CTD |
PMID:35031408 |
|
NCBI chr11:100,968,792...100,972,014
Ensembl chr11:100,969,237...100,971,353
|
|
G |
Hsd17b3 |
hydroxysteroid (17-beta) dehydrogenase 3 |
decreases expression multiple interactions |
EXP ISO |
cypermethrin results in decreased expression of HSD17B3 mRNA; cypermethrin results in decreased expression of HSD17B3 protein [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of HSD17B3 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of HSD17B3 mRNA |
CTD |
PMID:24810582 PMID:33051911 PMID:33396045 PMID:34896426 |
|
NCBI chr13:64,206,088...64,237,076
Ensembl chr13:64,206,080...64,237,044
|
|
G |
Hsd3b1 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
decreases expression multiple interactions affects expression |
EXP ISO |
cypermethrin results in decreased expression of HSD3B1 mRNA; cypermethrin results in decreased expression of HSD3B1 protein [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of HSD3B1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of HSD3B1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of HSD3B1 mRNA cypermethrin affects the expression of HSD3B1 mRNA |
CTD |
PMID:24810582 PMID:33051911 PMID:33396045 PMID:34896426 PMID:35605701 |
|
NCBI chr 3:98,749,672...98,767,110
Ensembl chr 3:98,759,510...98,767,110
|
|
G |
Hsf1 |
heat shock factor 1 |
increases expression |
ISO |
cypermethrin results in increased expression of HSF1 protein |
CTD |
PMID:36063984 |
|
NCBI chr15:76,361,562...76,385,355
Ensembl chr15:76,361,622...76,386,113
|
|
G |
Hsf2 |
heat shock factor 2 |
multiple interactions |
ISO |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of HSF2 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of HSF2 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of HSF2 mRNA |
CTD |
PMID:33051911 PMID:33396045 PMID:34896426 |
|
NCBI chr10:57,359,862...57,389,239
Ensembl chr10:57,362,481...57,389,231
|
|
G |
Hspa1a |
heat shock protein 1A |
increases expression |
ISO |
cypermethrin results in increased expression of HSPA1A mRNA |
CTD |
PMID:35605701 |
|
NCBI chr17:35,188,335...35,191,132
Ensembl chr17:35,188,166...35,191,132
|
|
G |
Hspa5 |
heat shock protein 5 |
decreases expression increases expression |
ISO |
cypermethrin results in decreased expression of HSPA5 mRNA cypermethrin results in increased expression of HSPA5 mRNA |
CTD |
PMID:25424538 PMID:35876585 |
|
NCBI chr 2:34,662,102...34,666,541
Ensembl chr 2:34,661,982...34,667,559
|
|
G |
Hspbap1 |
Hspb associated protein 1 |
increases expression |
ISO |
cypermethrin results in increased expression of HSPBAP1 mRNA |
CTD |
PMID:27704156 |
|
NCBI chr16:35,590,009...35,648,832
Ensembl chr16:35,590,745...35,648,847
|
|
G |
Hspd1 |
heat shock protein 1 (chaperonin) |
increases expression multiple interactions |
ISO |
cypermethrin results in increased expression of HSPD1 protein Minocycline inhibits the reaction [cypermethrin results in increased expression of HSPD1 protein] |
CTD |
PMID:21561882 |
|
NCBI chr 1:55,116,992...55,127,402
Ensembl chr 1:55,116,994...55,127,402
|
|
G |
Hspg2 |
perlecan (heparan sulfate proteoglycan 2) |
decreases expression |
EXP |
cypermethrin results in decreased expression of HSPG2 mRNA |
CTD |
PMID:35031408 |
|
NCBI chr 4:137,196,062...137,297,941
Ensembl chr 4:137,196,080...137,297,941
|
|
G |
Htr2a |
5-hydroxytryptamine (serotonin) receptor 2A |
multiple interactions increases expression |
ISO |
cypermethrin promotes the reaction [cypermethrin results in increased expression of HTR2A mRNA]; cypermethrin promotes the reaction [cypermethrin results in increased expression of HTR2A protein] cypermethrin results in increased expression of HTR2A mRNA; cypermethrin results in increased expression of HTR2A protein |
CTD |
PMID:25288152 |
|
NCBI chr14:74,878,314...74,944,299
Ensembl chr14:74,878,280...74,946,934
|
|
G |
Htra4 |
HtrA serine peptidase 4 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of HTRA4 protein |
CTD |
PMID:34896426 |
|
NCBI chr 8:25,514,944...25,529,160
Ensembl chr 8:25,514,945...25,528,978
|
|
G |
Htt |
huntingtin |
increases expression |
ISO |
cypermethrin results in increased expression of HTT mRNA |
CTD |
PMID:27704156 |
|
NCBI chr 5:34,919,084...35,069,878
Ensembl chr 5:34,919,084...35,069,878
|
|
G |
Idh3a |
isocitrate dehydrogenase 3 (NAD+) alpha |
decreases expression |
ISO |
cypermethrin results in decreased expression of IDH3A protein |
CTD |
PMID:21561882 |
|
NCBI chr 9:54,493,795...54,511,946
Ensembl chr 9:54,493,618...54,511,945
|
|
G |
Ifitm3 |
interferon induced transmembrane protein 3 |
increases expression |
EXP |
cypermethrin results in increased expression of IFITM3 mRNA |
CTD |
PMID:29020013 |
|
NCBI chr 7:140,589,503...140,590,657
Ensembl chr 7:140,589,499...140,590,683
|
|
G |
Ifng |
interferon gamma |
decreases expression |
ISO |
cypermethrin results in decreased expression of IFNG mRNA |
CTD |
PMID:22528246 |
|
NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797
|
|
G |
Ift70b |
intraflagellar transport 70B |
increases expression |
EXP |
cypermethrin results in increased expression of IFT70B mRNA |
CTD |
PMID:29020013 |
|
NCBI chr 2:75,766,193...75,768,806
Ensembl chr 2:75,766,193...75,768,929
|
|
G |
Igf1 |
insulin-like growth factor 1 |
decreases expression |
ISO |
cypermethrin results in decreased expression of IGF1 mRNA |
CTD |
PMID:22528246 |
|
NCBI chr10:87,694,127...87,772,909
Ensembl chr10:87,694,127...87,772,904
|
|
G |
Igf1r |
insulin-like growth factor I receptor |
increases expression |
ISO |
cypermethrin results in increased expression of IGF1R mRNA |
CTD |
PMID:27704156 |
|
NCBI chr 7:67,601,486...67,883,416
Ensembl chr 7:67,602,575...67,883,416
|
|
G |
Igfbp1 |
insulin-like growth factor binding protein 1 |
decreases expression |
EXP |
cypermethrin results in decreased expression of IGFBP1 mRNA; cypermethrin results in decreased expression of IGFBP1 protein |
CTD |
PMID:36116546 |
|
NCBI chr11:7,147,787...7,152,546
Ensembl chr11:7,147,782...7,152,546
|
|
G |
Igsf9 |
immunoglobulin superfamily, member 9 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of IGSF9 protein |
CTD |
PMID:34896426 |
|
NCBI chr 1:172,307,616...172,326,444
Ensembl chr 1:172,309,355...172,326,445
|
|
G |
Il10 |
interleukin 10 |
increases expression decreases expression |
ISO EXP |
cypermethrin results in increased expression of IL10 mRNA cypermethrin results in decreased expression of IL10 mRNA |
CTD |
PMID:22528246 PMID:34714723 |
|
NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
|
|
G |
Il11 |
interleukin 11 |
increases expression |
ISO |
cypermethrin results in increased expression of IL11 mRNA |
CTD |
PMID:22528246 |
|
NCBI chr 7:4,775,372...4,785,877
Ensembl chr 7:4,775,372...4,785,858
|
|
G |
Il18 |
interleukin 18 |
increases expression multiple interactions |
ISO |
cypermethrin results in increased expression of IL18 mRNA CXCL16 protein promotes the reaction [cypermethrin results in increased expression of IL18 mRNA] |
CTD |
PMID:35512476 |
|
NCBI chr 9:50,466,000...50,493,141
Ensembl chr 9:50,466,127...50,493,140
|
|
G |
Il1b |
interleukin 1 beta |
increases expression multiple interactions |
ISO EXP |
cypermethrin results in increased expression of IL1B mRNA; cypermethrin results in increased expression of IL1B protein Acetylcysteine inhibits the reaction [cypermethrin results in increased expression of IL1B protein]; CXCL16 protein promotes the reaction [cypermethrin results in increased expression of IL1B mRNA]; Quercetin inhibits the reaction [cypermethrin results in increased expression of IL1B mRNA] cypermethrin inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA] |
CTD |
PMID:22528246 PMID:23900960 PMID:29471534 PMID:35512476 PMID:35876585 PMID:36063984 More...
|
|
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
|
|
G |
Il6 |
interleukin 6 |
affects expression multiple interactions increases expression |
ISO |
cypermethrin affects the expression of IL6 Quercetin inhibits the reaction [cypermethrin results in increased expression of IL6 mRNA]; Sesame Oil affects the reaction [cypermethrin affects the expression of IL6] |
CTD |
PMID:25816392 PMID:35876585 PMID:36063984 |
|
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
|
|
G |
Il9 |
interleukin 9 |
increases expression |
ISO |
cypermethrin results in increased expression of IL9 mRNA |
CTD |
PMID:22528246 |
|
NCBI chr13:56,627,090...56,630,070
Ensembl chr13:56,627,090...56,630,059
|
|
G |
Il9r |
interleukin 9 receptor |
increases expression |
ISO |
cypermethrin results in increased expression of IL9R mRNA |
CTD |
PMID:22528246 |
|
NCBI chr11:32,137,544...32,155,283
Ensembl chr11:32,137,541...32,150,279
|
|
G |
Ilk |
integrin linked kinase |
decreases expression |
ISO |
cypermethrin results in decreased expression of ILK mRNA |
CTD |
PMID:22528246 |
|
NCBI chr 7:105,385,797...105,392,132
Ensembl chr 7:105,385,799...105,392,132
|
|
G |
Ina |
internexin neuronal intermediate filament protein, alpha |
increases expression multiple interactions |
ISO |
cypermethrin results in increased expression of INA protein Minocycline inhibits the reaction [cypermethrin results in increased expression of INA protein] |
CTD |
PMID:21561882 |
|
NCBI chr19:47,003,120...47,013,766
Ensembl chr19:47,003,137...47,013,766
|
|
G |
Inhba |
inhibin beta-A |
multiple interactions |
ISO |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of INHBA mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of INHBA mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of INHBA protein |
CTD |
PMID:33051911 PMID:33396045 PMID:34896426 |
|
NCBI chr13:16,178,841...16,206,194
Ensembl chr13:16,186,436...16,206,206
|
|
G |
Inhbb |
inhibin beta-B |
multiple interactions decreases expression |
ISO EXP |
[cypermethrin co-treated with Diethylhexyl Phthalate] results in decreased expression of INHBB mRNA cypermethrin results in decreased expression of INHBB mRNA; cypermethrin results in decreased expression of INHBB protein |
CTD |
PMID:24641848 PMID:30974244 |
|
NCBI chr 1:119,343,193...119,349,978
Ensembl chr 1:119,343,195...119,349,978
|
|
G |
Ino80 |
INO80 complex subunit |
decreases expression |
ISO |
cypermethrin results in decreased expression of INO80 protein |
CTD |
PMID:36063984 |
|
NCBI chr 2:119,203,523...119,308,168
Ensembl chr 2:119,203,523...119,308,168
|
|
G |
Insl3 |
insulin-like 3 |
decreases expression |
EXP ISO |
cypermethrin results in decreased expression of INSL3 mRNA cypermethrin results in decreased expression of INSL3 mRNA; cypermethrin results in decreased expression of INSL3 protein |
CTD |
PMID:24810582 PMID:34794910 |
|
NCBI chr 8:72,141,896...72,143,221
Ensembl chr 8:72,141,858...72,143,219
|
|
G |
Insr |
insulin receptor |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of INSR protein |
CTD |
PMID:34896426 |
|
NCBI chr 8:3,200,922...3,329,649
Ensembl chr 8:3,172,061...3,329,617
|
|
G |
Insrr |
insulin receptor-related receptor |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of INSRR protein |
CTD |
PMID:34896426 |
|
NCBI chr 3:87,704,215...87,723,408
Ensembl chr 3:87,704,258...87,723,408
|
|
G |
Ints14 |
integrator complex subunit 14 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of INTS14 protein |
CTD |
PMID:34896426 |
|
NCBI chr 9:64,868,143...64,894,260
Ensembl chr 9:64,868,187...64,894,260
|
|
G |
Iqsec3 |
IQ motif and Sec7 domain 3 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of IQSEC3 protein |
CTD |
PMID:34896426 |
|
NCBI chr 6:121,349,886...121,450,697
Ensembl chr 6:121,349,892...121,450,637
|
|
G |
Iqub |
IQ motif and ubiquitin domain containing |
increases expression |
EXP |
cypermethrin results in increased expression of IQUB mRNA |
CTD |
PMID:29020013 |
|
NCBI chr 6:24,444,864...24,515,066
Ensembl chr 6:24,444,864...24,515,066
|
|
G |
Irs2 |
insulin receptor substrate 2 |
decreases expression |
ISO |
cypermethrin results in decreased expression of IRS2 mRNA |
CTD |
PMID:22528246 |
|
NCBI chr 8:11,034,681...11,058,929
Ensembl chr 8:11,034,681...11,058,458
|
|
G |
Itgae |
integrin alpha E, epithelial-associated |
decreases expression |
ISO |
cypermethrin results in decreased expression of ITGAE mRNA |
CTD |
PMID:22528246 |
|
NCBI chr11:72,981,396...73,038,272
Ensembl chr11:72,981,409...73,038,272
|
|
G |
Itgam |
integrin alpha M |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [cypermethrin inhibits the reaction [Tretinoin results in increased expression of ITGAM mRNA]]; cypermethrin inhibits the reaction [Tretinoin results in increased expression of ITGAM mRNA] |
CTD |
PMID:29945211 |
|
NCBI chr 7:127,661,812...127,717,663
Ensembl chr 7:127,661,812...127,717,663
|
|
G |
Itgb3 |
integrin beta 3 |
increases expression |
ISO |
cypermethrin results in increased expression of ITGB3 mRNA |
CTD |
PMID:22528246 |
|
NCBI chr11:104,498,826...104,561,302
Ensembl chr11:104,498,826...104,561,302
|
|
G |
Itgb6 |
integrin beta 6 |
increases expression |
ISO |
cypermethrin results in increased expression of ITGB6 mRNA |
CTD |
PMID:22528246 |
|
NCBI chr 2:60,428,636...60,553,005
Ensembl chr 2:60,428,636...60,552,987
|
|
G |
Itpkc |
inositol 1,4,5-trisphosphate 3-kinase C |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ITPKC protein |
CTD |
PMID:34896426 |
|
NCBI chr 7:26,906,595...26,928,042
Ensembl chr 7:26,906,597...26,928,086
|
|
G |
Itpr1 |
inositol 1,4,5-trisphosphate receptor 1 |
decreases expression increases expression |
ISO |
cypermethrin results in decreased expression of ITPR1 mRNA cypermethrin results in increased expression of ITPR1 protein |
CTD |
PMID:22528246 PMID:36063984 |
|
NCBI chr 6:108,190,044...108,528,077
Ensembl chr 6:108,190,057...108,528,070
|
|
G |
Itsn1 |
intersectin 1 (SH3 domain protein 1A) |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ITSN1 protein |
CTD |
PMID:34896426 |
|
NCBI chr16:91,526,198...91,717,479
Ensembl chr16:91,526,169...91,717,485
|
|
G |
Jag1 |
jagged 1 |
multiple interactions decreases expression |
ISO |
MIR21 promotes the reaction [cypermethrin results in decreased expression of JAG1 protein] cypermethrin results in decreased expression of JAG1 mRNA; cypermethrin results in decreased expression of JAG1 protein |
CTD |
PMID:35512476 |
|
NCBI chr 2:136,923,371...136,958,440
Ensembl chr 2:136,923,376...136,958,564
|
|
G |
Jak2 |
Janus kinase 2 |
increases expression multiple interactions |
ISO |
cypermethrin results in increased expression of JAK2 mRNA Quercetin inhibits the reaction [cypermethrin results in increased expression of JAK2 mRNA] |
CTD |
PMID:35876585 |
|
NCBI chr19:29,229,006...29,290,495
Ensembl chr19:29,229,228...29,290,480
|
|
G |
Jph3 |
junctophilin 3 |
increases expression |
ISO |
cypermethrin results in increased expression of JPH3 mRNA |
CTD |
PMID:27704156 |
|
NCBI chr 8:122,457,298...122,517,822
Ensembl chr 8:122,456,362...122,521,015
|
|
G |
Jun |
jun proto-oncogene |
increases expression multiple interactions decreases phosphorylation increases phosphorylation |
ISO EXP |
cypermethrin results in increased expression of JUN protein 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [cypermethrin results in increased expression of JUN protein]; bisindolylmaleimide I inhibits the reaction [cypermethrin results in increased expression of JUN protein]; Egtazic Acid inhibits the reaction [cypermethrin results in increased expression of JUN protein] cypermethrin results in increased expression of JUN mRNA; cypermethrin results in increased expression of JUN protein [cypermethrin co-treated with pyrazolanthrone] results in decreased phosphorylation of JUN protein; diallyl tetrasulfide inhibits the reaction [cypermethrin results in decreased phosphorylation of JUN protein]; pyrazolanthrone inhibits the reaction [cypermethrin results in increased phosphorylation of JUN protein] |
CTD |
PMID:8856738 PMID:29149324 PMID:34794910 PMID:35512476 |
|
NCBI chr 4:94,937,273...94,940,459
Ensembl chr 4:94,937,271...94,940,459
|
|
G |
Jup |
junction plakoglobin |
decreases expression |
ISO |
cypermethrin results in decreased expression of JUP mRNA |
CTD |
PMID:22528246 |
|
NCBI chr11:100,259,682...100,288,639
Ensembl chr11:100,259,784...100,288,589
|
|
G |
Kat7 |
K(lysine) acetyltransferase 7 |
increases expression |
ISO |
cypermethrin results in increased expression of KAT7 protein |
CTD |
PMID:36063984 |
|
NCBI chr11:95,162,683...95,201,030
Ensembl chr11:95,165,085...95,201,072
|
|
G |
Kbtbd8 |
kelch repeat and BTB (POZ) domain containing 8 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of KBTBD8 protein |
CTD |
PMID:34896426 |
|
NCBI chr 6:95,094,861...95,106,774
Ensembl chr 6:95,094,221...95,106,771
|
|
G |
Kcna5 |
potassium voltage-gated channel, shaker-related subfamily, member 5 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of KCNA5 protein |
CTD |
PMID:34896426 |
|
NCBI chr 6:126,509,514...126,512,518
Ensembl chr 6:126,509,514...126,512,375
|
|
G |
Kcnb2 |
potassium voltage gated channel, Shab-related subfamily, member 2 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of KCNB2 protein |
CTD |
PMID:34896426 |
|
NCBI chr 1:15,357,149...15,793,975
Ensembl chr 1:15,357,478...15,793,974
|
|
G |
Kcnh3 |
potassium voltage-gated channel, subfamily H (eag-related), member 3 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of KCNH3 protein |
CTD |
PMID:34896426 |
|
NCBI chr15:99,122,396...99,140,699
Ensembl chr15:99,122,742...99,140,698
|
|
G |
Kcnj9 |
potassium inwardly-rectifying channel, subfamily J, member 9 |
decreases expression |
ISO |
cypermethrin results in decreased expression of KCNJ9 mRNA |
CTD |
PMID:22528246 |
|
NCBI chr 1:172,148,075...172,156,889
Ensembl chr 1:172,148,068...172,156,885
|
|
G |
Kcnq2 |
potassium voltage-gated channel, subfamily Q, member 2 |
decreases expression |
ISO |
cypermethrin results in decreased expression of KCNQ2 protein |
CTD |
PMID:36063984 |
|
NCBI chr 2:180,717,372...180,777,368
Ensembl chr 2:180,717,372...180,777,093
|
|
G |
Kcnt1 |
potassium channel, subfamily T, member 1 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of KCNT1 protein |
CTD |
PMID:34896426 |
|
NCBI chr 2:25,753,807...25,808,285
Ensembl chr 2:25,753,746...25,808,285
|
|
G |
Kcnv2 |
potassium channel, subfamily V, member 2 |
decreases expression |
ISO |
cypermethrin results in decreased expression of KCNV2 protein |
CTD |
PMID:36063984 |
|
NCBI chr19:27,299,461...27,314,579
Ensembl chr19:27,299,988...27,314,579
|
|
G |
Kdm3a |
lysine (K)-specific demethylase 3A |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of KDM3A protein |
CTD |
PMID:34896426 |
|
NCBI chr 6:71,565,954...71,609,963
Ensembl chr 6:71,565,956...71,609,974
|
|
G |
Kdr |
kinase insert domain protein receptor |
increases expression |
EXP |
cypermethrin results in increased expression of KDR mRNA |
CTD |
PMID:29020013 |
|
NCBI chr 5:76,093,487...76,139,880
Ensembl chr 5:76,093,487...76,139,118
|
|
G |
Kif9 |
kinesin family member 9 |
increases expression |
EXP |
cypermethrin results in increased expression of KIF9 mRNA |
CTD |
PMID:21142847 |
|
NCBI chr 9:110,306,062...110,354,242
Ensembl chr 9:110,306,026...110,354,247
|
|
G |
Kiss1 |
KiSS-1 metastasis-suppressor |
affects expression multiple interactions increases expression |
EXP ISO |
cypermethrin affects the expression of KISS1 mRNA [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of KISS1 protein; [cypermethrin co-treated with emamectin benzoate] results in increased expression of KISS1 mRNA; [cypermethrin co-treated with emamectin benzoate] results in increased expression of KISS1 protein; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of KISS1 protein cypermethrin results in increased expression of KISS1 mRNA |
CTD |
PMID:34896426 PMID:35931855 PMID:36053783 PMID:37984602 |
|
NCBI chr 1:133,249,625...133,257,460
Ensembl chr 1:133,237,565...133,257,460 Ensembl chr 1:133,237,565...133,257,460
|
|
G |
Kiss1r |
KISS1 receptor |
multiple interactions |
ISO |
[cypermethrin co-treated with emamectin benzoate] results in increased expression of KISS1R mRNA; [cypermethrin co-treated with emamectin benzoate] results in increased expression of KISS1R protein |
CTD |
PMID:37984602 |
|
NCBI chr10:79,752,786...79,759,922
Ensembl chr10:79,752,805...79,758,107
|
|
G |
Kitl |
kit ligand |
multiple interactions |
ISO |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of KITLG mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of KITLG mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of KITLG mRNA |
CTD |
PMID:33051911 PMID:33396045 PMID:34896426 |
|
NCBI chr10:99,851,477...99,936,278
Ensembl chr10:99,851,492...99,936,278
|
|
G |
Klf2 |
Kruppel-like transcription factor 2 (lung) |
decreases expression |
ISO |
cypermethrin results in decreased expression of KLF2 mRNA |
CTD |
PMID:25424538 |
|
NCBI chr 8:73,072,906...73,075,498
Ensembl chr 8:73,072,877...73,075,500
|
|
G |
Klf4 |
Kruppel-like transcription factor 4 (gut) |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of KLF4 mRNA |
CTD |
PMID:33396045 |
|
NCBI chr 4:55,527,137...55,536,984
Ensembl chr 4:55,527,143...55,532,466
|
|
G |
Kmt2e |
lysine (K)-specific methyltransferase 2E |
increases expression |
ISO |
cypermethrin results in increased expression of KMT2E protein |
CTD |
PMID:36063984 |
|
NCBI chr 5:23,638,034...23,709,233
Ensembl chr 5:23,639,439...23,709,233
|
|
G |
Kti12 |
KTI12 homolog, chromatin associated |
increases expression |
EXP |
cypermethrin results in increased expression of KTI12 mRNA |
CTD |
PMID:29020013 |
|
NCBI chr 4:108,705,054...108,706,609
Ensembl chr 4:108,704,982...108,706,610
|
|
G |
Kyat1 |
kynurenine aminotransferase 1 |
decreases activity |
EXP |
cypermethrin results in decreased activity of KYAT1 protein |
CTD |
PMID:7175100 |
|
NCBI chr 2:30,075,136...30,096,307
Ensembl chr 2:30,075,136...30,095,859
|
|
G |
Kynu |
kynureninase |
decreases activity |
EXP |
cypermethrin results in decreased activity of KYNU protein |
CTD |
PMID:7175100 |
|
NCBI chr 2:43,445,270...43,572,734
Ensembl chr 2:43,445,341...43,572,734
|
|
G |
L3mbtl2 |
L3MBTL2 polycomb repressive complex 1 subunit |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of L3MBTL2 protein |
CTD |
PMID:34896426 |
|
NCBI chr15:81,548,090...81,572,516
Ensembl chr15:81,548,090...81,572,516
|
|
G |
Lct |
lactase |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of LCT protein |
CTD |
PMID:34896426 |
|
NCBI chr 1:128,212,493...128,256,055
Ensembl chr 1:128,212,493...128,256,055
|
|
G |
Lef1 |
lymphoid enhancer binding factor 1 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of LEF1 protein |
CTD |
PMID:34896426 |
|
NCBI chr 3:130,903,972...131,018,006
Ensembl chr 3:130,904,120...131,018,005
|
|
G |
Lepr |
leptin receptor |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of LEPR protein |
CTD |
PMID:34896426 |
|
NCBI chr 4:101,574,393...101,676,375
Ensembl chr 4:101,574,601...101,672,549
|
|
G |
Lgals7 |
lectin, galactose binding, soluble 7 |
decreases expression |
ISO |
cypermethrin results in decreased expression of LGALS7 mRNA |
CTD |
PMID:22528246 |
|
NCBI chr 7:28,563,258...28,565,711
Ensembl chr 7:28,563,278...28,565,709
|
|
G |
Lhb |
luteinizing hormone beta |
increases expression decreases expression multiple interactions increases secretion affects secretion |
ISO EXP |
cypermethrin results in increased expression of LHB protein cypermethrin results in decreased expression of LHB protein [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of LHB protein; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of LHB protein; Vitamin E inhibits the reaction [cypermethrin results in decreased expression of LHB protein] cypermethrin results in increased expression of LHB mRNA; cypermethrin results in increased expression of LHB protein 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [cypermethrin results in increased expression of LHB mRNA]; 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [cypermethrin results in increased secretion of LHB protein]; 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide inhibits the reaction [cypermethrin results in increased expression of LHB mRNA]; bisindolylmaleimide I inhibits the reaction [cypermethrin results in increased expression of LHB mRNA]; cypermethrin inhibits the reaction [cetrorelix results in decreased secretion of LHB protein]; cypermethrin results in increased expression of and results in increased secretion of LHB protein; Egtazic Acid inhibits the reaction [cypermethrin results in increased expression of LHB mRNA]; Egtazic Acid inhibits the reaction [cypermethrin results in increased secretion of LHB protein]; Nimodipine inhibits the reaction [cypermethrin results in increased expression of LHB mRNA]; Nimodipine inhibits the reaction [cypermethrin results in increased secretion of LHB protein] cypermethrin affects the secretion of LHB protein |
CTD |
PMID:23447098 PMID:24759048 PMID:28731686 PMID:29149324 PMID:34896426 PMID:35031408 PMID:35102696 PMID:35931855 PMID:36053783 More...
|
|
NCBI chr 7:45,070,370...45,071,278
Ensembl chr 7:45,070,244...45,071,321
|
|
G |
Lhcgr |
luteinizing hormone/choriogonadotropin receptor |
multiple interactions decreases expression |
ISO |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of LHCGR mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of LHCGR mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of LHCGR mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of LHR mRNA cypermethrin results in decreased expression of LHCGR mRNA; cypermethrin results in decreased expression of LHCGR protein |
CTD |
PMID:33051911 PMID:33396045 PMID:34794910 PMID:34896426 PMID:35102696 PMID:36053783 More...
|
|
NCBI chr17:89,023,812...89,099,487
Ensembl chr17:89,023,909...89,099,418
|
|
G |
Lif |
leukemia inhibitory factor |
decreases expression multiple interactions |
EXP |
cypermethrin results in decreased expression of LIF mRNA; cypermethrin results in decreased expression of LIF protein Sirolimus promotes the reaction [cypermethrin results in decreased expression of LIF protein] |
CTD |
PMID:37011868 |
|
NCBI chr11:4,207,587...4,222,514
Ensembl chr11:4,207,557...4,222,514
|
|
G |
Lpar3 |
lysophosphatidic acid receptor 3 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of LPAR3 protein |
CTD |
PMID:34896426 |
|
NCBI chr 3:145,926,716...145,991,969
Ensembl chr 3:145,926,718...145,991,941
|
|
G |
Lpp |
LIM domain containing preferred translocation partner in lipoma |
increases expression multiple interactions |
EXP ISO |
cypermethrin results in increased expression of LPP mRNA [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of LPP protein |
CTD |
PMID:29020013 PMID:34896426 |
|
NCBI chr16:24,212,100...24,811,328
Ensembl chr16:24,212,257...24,811,328
|
|
G |
Lrrc8c |
leucine rich repeat containing 8 family, member C |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of LRRC8C protein |
CTD |
PMID:34896426 |
|
NCBI chr 5:105,666,850...105,760,884
Ensembl chr 5:105,667,254...105,760,884
|
|
G |
Ltb4r2 |
leukotriene B4 receptor 2 |
decreases expression |
EXP |
cypermethrin results in decreased expression of LTB4R2 mRNA |
CTD |
PMID:29020013 |
|
NCBI chr14:55,995,379...56,001,523
Ensembl chr14:55,998,885...56,002,595
|
|
G |
Ltbp2 |
latent transforming growth factor beta binding protein 2 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of LTBP2 protein |
CTD |
PMID:34896426 |
|
NCBI chr12:84,829,986...84,923,581
Ensembl chr12:84,829,986...84,923,306
|
|
G |
Lysmd2 |
LysM, putative peptidoglycan-binding, domain containing 2 |
increases expression |
EXP |
cypermethrin results in increased expression of LYSMD2 mRNA |
CTD |
PMID:29020013 |
|
NCBI chr 9:75,532,403...75,545,055
Ensembl chr 9:75,533,023...75,545,053
|
|
G |
Magea9-ps |
MAGE family member A9, pseudogene |
decreases expression |
EXP |
cypermethrin results in decreased expression of MAGEA9-PS mRNA |
CTD |
PMID:29020013 |
|
NCBI chr X:71,913,124...71,913,780
Ensembl chr X:71,912,973...71,913,871
|
|
G |
Magi2 |
membrane associated guanylate kinase, WW and PDZ domain containing 2 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MAGI2 protein |
CTD |
PMID:34896426 |
|
NCBI chr 5:19,431,787...20,909,790
Ensembl chr 5:19,432,034...20,909,790
|
|
G |
Mamdc4 |
MAM domain containing 4 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of MAMDC4 protein |
CTD |
PMID:34896426 |
|
NCBI chr 2:25,453,124...25,461,328
Ensembl chr 2:25,453,127...25,464,857
|
|
G |
Man1b1 |
mannosidase, alpha, class 1B, member 1 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MAN1B1 protein |
CTD |
PMID:34896426 |
|
NCBI chr 2:25,222,742...25,242,225
Ensembl chr 2:25,222,350...25,242,224
|
|
G |
Man2c1 |
mannosidase, alpha, class 2C, member 1 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MAN2C1 protein |
CTD |
PMID:34896426 |
|
NCBI chr 9:57,037,953...57,049,497
Ensembl chr 9:57,037,974...57,050,006
|
|
G |
Maoa |
monoamine oxidase A |
decreases activity decreases expression multiple interactions |
ISO |
cypermethrin results in decreased activity of MAOA protein cypermethrin results in decreased expression of MAOA mRNA Chlorpyrifos promotes the reaction [cypermethrin results in decreased activity of MAOA protein]; Chlorpyrifos promotes the reaction [cypermethrin results in decreased expression of MAOA mRNA]; cypermethrin promotes the reaction [Chlorpyrifos results in decreased activity of MAOA protein]; cypermethrin promotes the reaction [Chlorpyrifos results in decreased expression of MAOA mRNA] |
CTD |
PMID:8385837 PMID:32006337 |
|
NCBI chr X:16,485,937...16,554,051
Ensembl chr X:16,485,937...16,554,057
|
|
G |
Map10 |
microtubule-associated protein 10 |
increases expression |
ISO |
cypermethrin results in increased expression of MAP10 protein |
CTD |
PMID:36063984 |
|
NCBI chr 8:126,396,557...126,400,104
Ensembl chr 8:126,396,557...126,400,098
|
|
G |
Map1lc3a |
microtubule-associated protein 1 light chain 3 alpha |
increases expression |
ISO |
cypermethrin results in increased expression of MAP1LC3A mRNA |
CTD |
PMID:27704156 PMID:35876585 |
|
NCBI chr 2:155,118,284...155,119,993
Ensembl chr 2:155,118,217...155,119,993
|
|
G |
Map1lc3b |
microtubule-associated protein 1 light chain 3 beta |
increases expression |
ISO |
cypermethrin results in increased expression of MAP1LC3B mRNA |
CTD |
PMID:35876585 |
|
NCBI chr 8:122,317,177...122,325,499
Ensembl chr 8:122,317,100...122,325,499
|
|
G |
Map2 |
microtubule-associated protein 2 |
decreases expression |
ISO |
cypermethrin results in decreased expression of MAP2 mRNA |
CTD |
PMID:22528246 |
|
NCBI chr 1:66,214,337...66,481,742
Ensembl chr 1:66,214,432...66,481,742
|
|
G |
Map2k4 |
mitogen-activated protein kinase kinase 4 |
multiple interactions |
EXP |
[[[cypermethrin results in decreased expression of MIR155 mRNA] which results in increased expression of BCL6 mRNA] which results in decreased expression of MAP2K4 protein] which results in decreased phosphorylation of and results in decreased activity of MAPK8 protein; [[[cypermethrin results in decreased expression of MIR155 mRNA] which results in increased expression of BCL6 mRNA] which results in decreased expression of MAP2K4 protein] which results in decreased phosphorylation of and results in decreased activity of MAPK9 protein; [[cypermethrin results in decreased expression of MIR155 mRNA] which results in increased expression of BCL6 mRNA] which results in decreased expression of MAP2K4 protein |
CTD |
PMID:29471534 |
|
NCBI chr11:65,579,070...65,679,185
Ensembl chr11:65,579,069...65,679,123
|
|
G |
Map3k1 |
mitogen-activated protein kinase kinase kinase 1 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MAP3K1 protein |
CTD |
PMID:34896426 |
|
NCBI chr13:111,882,962...111,954,803
Ensembl chr13:111,882,962...111,945,527
|
|
G |
Map3k4 |
mitogen-activated protein kinase kinase kinase 4 |
increases expression |
ISO |
cypermethrin results in increased expression of MAP3K4 mRNA |
CTD |
PMID:22528246 |
|
NCBI chr17:12,446,508...12,537,683
Ensembl chr17:12,446,508...12,537,683
|
|
G |
Map4k2 |
mitogen-activated protein kinase kinase kinase kinase 2 |
increases expression |
ISO |
cypermethrin results in increased expression of MAP4K2 protein |
CTD |
PMID:36063984 |
|
NCBI chr19:6,391,023...6,405,649
Ensembl chr19:6,391,165...6,405,645
|
|
G |
Map4k5 |
mitogen-activated protein kinase kinase kinase kinase 5 |
increases expression |
ISO |
cypermethrin results in increased expression of MAP4K5 protein |
CTD |
PMID:36063984 |
|
NCBI chr12:69,850,531...69,939,937
Ensembl chr12:69,850,524...69,939,974
|
|
G |
Map9 |
microtubule-associated protein 9 |
increases expression |
ISO |
cypermethrin results in increased expression of MAP9 protein |
CTD |
PMID:36063984 |
|
NCBI chr 3:82,265,379...82,302,575
Ensembl chr 3:82,265,351...82,302,575
|
|
G |
Mapk1 |
mitogen-activated protein kinase 1 |
multiple interactions |
EXP |
1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [cypermethrin results in increased phosphorylation of and results in increased activity of MAPK1 protein]; [cypermethrin results in decreased susceptibility to Dihydrotestosterone] which results in decreased phosphorylation of MAPK1 protein; bisindolylmaleimide I inhibits the reaction [cypermethrin results in increased phosphorylation of MAPK1 protein]; cypermethrin results in increased phosphorylation of and results in increased activity of MAPK1 protein; Egtazic Acid inhibits the reaction [cypermethrin results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Nimodipine inhibits the reaction [cypermethrin results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Thapsigargin inhibits the reaction [cypermethrin results in increased phosphorylation of and results in increased activity of MAPK1 protein] |
CTD |
PMID:29149324 PMID:30974244 |
|
NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317
|
|
G |
Mapk10 |
mitogen-activated protein kinase 10 |
increases expression |
EXP |
cypermethrin results in increased expression of MAPK10 mRNA |
CTD |
PMID:29020013 |
|
NCBI chr 5:103,056,413...103,359,200
Ensembl chr 5:103,055,814...103,359,200
|
|
G |
Mapk14 |
mitogen-activated protein kinase 14 |
multiple interactions increases expression |
ISO |
Quercetin inhibits the reaction [cypermethrin results in increased expression of MAPK14 mRNA] |
CTD |
PMID:35876585 |
|
NCBI chr17:28,910,316...28,967,379
Ensembl chr17:28,910,303...28,967,380
|
|
G |
Mapk3 |
mitogen-activated protein kinase 3 |
multiple interactions |
EXP |
1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [cypermethrin results in increased phosphorylation of and results in increased activity of MAPK3 protein]; [cypermethrin results in decreased susceptibility to Dihydrotestosterone] which results in decreased phosphorylation of MAPK3 protein; bisindolylmaleimide I inhibits the reaction [cypermethrin results in increased phosphorylation of MAPK3 protein]; cypermethrin results in increased phosphorylation of and results in increased activity of MAPK3 protein; Egtazic Acid inhibits the reaction [cypermethrin results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Nimodipine inhibits the reaction [cypermethrin results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Thapsigargin inhibits the reaction [cypermethrin results in increased phosphorylation of and results in increased activity of MAPK3 protein]; W 7 inhibits the reaction [cypermethrin results in increased phosphorylation of and results in increased activity of MAPK3 protein] |
CTD |
PMID:29149324 PMID:30974244 |
|
NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991
|
|
G |
Mapk4 |
mitogen-activated protein kinase 4 |
decreases expression |
ISO |
cypermethrin results in decreased expression of MAPK4 mRNA |
CTD |
PMID:22528246 |
|
NCBI chr18:74,061,557...74,198,643
Ensembl chr18:74,061,557...74,198,430
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
increases expression multiple interactions decreases phosphorylation increases phosphorylation |
ISO EXP |
cypermethrin results in increased expression of MAPK8 mRNA [[[cypermethrin results in decreased expression of MIR155 mRNA] which results in increased expression of BCL6 mRNA] which results in decreased expression of MAP2K4 protein] which results in decreased phosphorylation of and results in decreased activity of MAPK8 protein [cypermethrin co-treated with pyrazolanthrone] results in decreased phosphorylation of MAPK8 protein; Acetylcysteine inhibits the reaction [cypermethrin results in increased phosphorylation of MAPK8 protein]; diallyl tetrasulfide inhibits the reaction [cypermethrin results in decreased phosphorylation of MAPK8 protein]; pyrazolanthrone inhibits the reaction [cypermethrin results in increased phosphorylation of MAPK8 protein] |
CTD |
PMID:27704156 PMID:29471534 PMID:34794910 PMID:35512476 |
|
NCBI chr14:33,099,855...33,169,213
Ensembl chr14:33,099,855...33,169,115
|
|
G |
Mapk9 |
mitogen-activated protein kinase 9 |
multiple interactions |
EXP |
[[[cypermethrin results in decreased expression of MIR155 mRNA] which results in increased expression of BCL6 mRNA] which results in decreased expression of MAP2K4 protein] which results in decreased phosphorylation of and results in decreased activity of MAPK9 protein |
CTD |
PMID:29471534 |
|
NCBI chr11:49,737,558...49,777,248
Ensembl chr11:49,737,578...49,777,248
|
|
G |
Mapkapk5 |
MAP kinase-activated protein kinase 5 |
multiple interactions |
ISO |
Minocycline inhibits the reaction [cypermethrin results in increased expression of MAPKAPK5 protein] |
CTD |
PMID:21561882 |
|
NCBI chr 5:121,663,114...121,683,955
Ensembl chr 5:121,663,101...121,683,968
|
|
G |
Mapt |
microtubule-associated protein tau |
decreases expression increases expression |
ISO EXP |
cypermethrin results in decreased expression of MAPT mRNA cypermethrin results in increased expression of MAPT protein |
CTD |
PMID:22528246 PMID:26143737 |
|
NCBI chr11:104,120,235...104,222,916
Ensembl chr11:104,122,216...104,222,916
|
|
G |
Mark1 |
MAP/microtubule affinity regulating kinase 1 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MARK1 protein |
CTD |
PMID:34896426 |
|
NCBI chr 1:184,628,621...184,732,152
Ensembl chr 1:184,628,986...184,731,767
|
|
G |
Mark4 |
MAP/microtubule affinity regulating kinase 4 |
decreases expression |
ISO |
cypermethrin results in decreased expression of MARK4 protein |
CTD |
PMID:36063984 |
|
NCBI chr 7:19,159,027...19,193,255
Ensembl chr 7:19,158,700...19,192,746
|
|
G |
Mast1 |
microtubule associated serine/threonine kinase 1 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MAST1 protein |
CTD |
PMID:34896426 |
|
NCBI chr 8:85,638,482...85,672,811
Ensembl chr 8:85,638,532...85,663,988
|
|
G |
Mb |
myoglobin |
increases expression |
EXP |
cypermethrin results in increased expression of MB mRNA |
CTD |
PMID:21142847 |
|
NCBI chr15:76,899,687...76,934,868
Ensembl chr15:76,899,687...76,934,870
|
|
G |
Mbd4 |
methyl-CpG binding domain protein 4 |
increases expression |
EXP |
cypermethrin results in increased expression of MBD4 mRNA |
CTD |
PMID:21142847 |
|
NCBI chr 6:115,817,658...115,830,361
Ensembl chr 6:115,817,658...115,830,332
|
|
G |
Mcm9 |
minichromosome maintenance 9 homologous recombination repair factor |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MCM9 protein |
CTD |
PMID:34896426 |
|
NCBI chr10:53,412,411...53,507,251
Ensembl chr10:53,412,411...53,506,535
|
|
G |
Mcmdc2 |
minichromosome maintenance domain containing 2 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MCMDC2 protein |
CTD |
PMID:34896426 |
|
NCBI chr 1:9,978,863...10,011,179
Ensembl chr 1:9,978,863...10,012,310
|
|
G |
Mdga2 |
MAM domain containing glycosylphosphatidylinositol anchor 2 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of MDGA2 protein |
CTD |
PMID:34896426 |
|
NCBI chr12:66,512,832...67,269,323
Ensembl chr12:66,512,834...67,269,323
|
|
G |
Med23 |
mediator complex subunit 23 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MED23 protein |
CTD |
PMID:34896426 |
|
NCBI chr10:24,745,889...24,789,358
Ensembl chr10:24,745,884...24,789,579
|
|
G |
Mertk |
MER proto-oncogene tyrosine kinase |
affects expression |
EXP |
cypermethrin affects the expression of MERTK mRNA |
CTD |
PMID:29020013 |
|
NCBI chr 2:128,540,836...128,645,082
Ensembl chr 2:128,540,876...128,644,814
|
|
G |
Mgl2 |
macrophage galactose N-acetyl-galactosamine specific lectin 2 |
multiple interactions |
EXP |
cypermethrin promotes the reaction [Lipopolysaccharides results in increased expression of MGL2 mRNA] |
CTD |
PMID:29471534 |
|
NCBI chr11:70,020,953...70,028,368
Ensembl chr11:70,021,155...70,028,376
|
|
G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
increases expression |
EXP |
cypermethrin results in increased expression of MGMT mRNA |
CTD |
PMID:21142847 |
|
NCBI chr 7:136,496,315...136,732,001
Ensembl chr 7:136,496,343...136,731,995
|
|
G |
Mir140 |
microRNA 140 |
multiple interactions increases expression |
ISO EXP |
DNMT3A protein inhibits the reaction [cypermethrin results in increased expression of MIR140 mRNA]; MIR140 mRNA affects the reaction [cypermethrin results in decreased expression of CYP11A1 protein]; MIR140 mRNA affects the reaction [cypermethrin results in decreased expression of STAR protein] MIR140 affects the reaction [cypermethrin results in decreased expression of SF1 protein] cypermethrin results in increased expression of MIR140; cypermethrin results in increased expression of MIR140 mRNA |
CTD |
PMID:34794910 PMID:35512476 |
|
NCBI chr 8:108,277,876...108,277,945
Ensembl chr 8:108,277,876...108,277,945
|
|
G |
Mir155 |
microRNA 155 |
multiple interactions decreases expression |
EXP |
[[[cypermethrin results in decreased expression of MIR155 mRNA] which results in increased expression of BCL6 mRNA] which results in decreased expression of MAP2K4 protein] which results in decreased phosphorylation of and results in decreased activity of MAPK8 protein; [[[cypermethrin results in decreased expression of MIR155 mRNA] which results in increased expression of BCL6 mRNA] which results in decreased expression of MAP2K4 protein] which results in decreased phosphorylation of and results in decreased activity of MAPK9 protein; [[cypermethrin results in decreased expression of MIR155 mRNA] which results in increased expression of BCL6 mRNA] which results in decreased expression of MAP2K4 protein; [cypermethrin results in decreased expression of MIR155 mRNA] which results in increased expression of BCL6 mRNA |
CTD |
PMID:29471534 |
|
NCBI chr16:84,511,028...84,511,092
Ensembl chr16:84,511,028...84,511,092
|
|
G |
Mir21a |
microRNA 21a |
multiple interactions increases expression |
ISO |
MIR21 promotes the reaction [cypermethrin results in decreased expression of HES1 protein]; MIR21 promotes the reaction [cypermethrin results in decreased expression of JAG1 protein]; MIR21 promotes the reaction [cypermethrin results in decreased expression of NOTCH2 protein] cypermethrin results in increased expression of MIR21 |
CTD |
PMID:35512476 |
|
NCBI chr11:86,474,893...86,474,984
Ensembl chr11:86,474,893...86,474,984
|
|
G |
Mki67 |
antigen identified by monoclonal antibody Ki 67 |
decreases expression |
ISO EXP |
cypermethrin results in decreased expression of MKI67 protein cypermethrin results in decreased expression of MKI67 mRNA; cypermethrin results in decreased expression of MKI67 protein |
CTD |
PMID:36063984 PMID:37011868 |
|
NCBI chr 7:135,291,513...135,318,286
Ensembl chr 7:135,291,513...135,318,090
|
|
G |
Mlec |
malectin |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MLEC protein |
CTD |
PMID:34896426 |
|
NCBI chr 5:115,281,040...115,296,235
Ensembl chr 5:115,281,040...115,296,238
|
|
G |
Mlh1 |
mutL homolog 1 |
increases expression |
EXP |
cypermethrin results in increased expression of MLH1 mRNA |
CTD |
PMID:21142847 |
|
NCBI chr 9:111,057,296...111,100,854
Ensembl chr 9:111,057,296...111,100,859
|
|
G |
Mmel1 |
membrane metallo-endopeptidase-like 1 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MMEL1 protein |
CTD |
PMID:34896426 |
|
NCBI chr 4:154,954,042...154,979,987
Ensembl chr 4:154,954,042...154,979,985
|
|
G |
Mmp10 |
matrix metallopeptidase 10 |
multiple interactions decreases expression |
EXP |
cypermethrin promotes the reaction [Lipopolysaccharides results in increased expression of MMP10 mRNA] cypermethrin results in decreased expression of MMP10 mRNA |
CTD |
PMID:29020013 PMID:29471534 |
|
NCBI chr 9:7,502,343...7,510,243
Ensembl chr 9:7,502,353...7,510,241
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
multiple interactions decreases expression |
EXP |
4,6-dimorpholino-N-(4-nitrophenyl)-1,3,5-triazin-2-amine inhibits the reaction [cypermethrin results in decreased expression of MMP9 protein]; cypermethrin promotes the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA]; Sirolimus promotes the reaction [cypermethrin results in decreased expression of MMP9 protein] cypermethrin results in decreased expression of MMP9 mRNA; cypermethrin results in decreased expression of MMP9 protein |
CTD |
PMID:29471534 PMID:37011868 |
|
NCBI chr 2:164,782,246...164,797,770
Ensembl chr 2:164,782,700...164,797,770
|
|
G |
Mpo |
myeloperoxidase |
increases expression decreases expression |
EXP |
cypermethrin results in increased expression of MPO mRNA cypermethrin results in decreased expression of MPO mRNA |
CTD |
PMID:21142847 PMID:35031408 |
|
NCBI chr11:87,684,610...87,695,238
Ensembl chr11:87,684,407...87,695,239
|
|
G |
Mpp4 |
membrane protein, palmitoylated 4 (MAGUK p55 subfamily member 4) |
increases expression |
EXP |
cypermethrin results in increased expression of MPP4 mRNA |
CTD |
PMID:21142847 |
|
NCBI chr 1:59,160,094...59,202,548
Ensembl chr 1:59,160,094...59,202,548
|
|
G |
Mrc2 |
mannose receptor, C type 2 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MRC2 protein |
CTD |
PMID:34896426 |
|
NCBI chr11:105,183,440...105,241,971
Ensembl chr11:105,183,469...105,241,965
|
|
G |
Mrpl14 |
mitochondrial ribosomal protein L14 |
decreases expression |
EXP |
cypermethrin results in decreased expression of MRPL14 mRNA |
CTD |
PMID:29020013 |
|
NCBI chr17:45,991,689...46,009,421
Ensembl chr17:45,997,248...46,009,421
|
|
G |
Mt2 |
metallothionein 2 |
increases expression decreases expression |
EXP |
cypermethrin results in increased expression of MT2 mRNA cypermethrin results in decreased expression of MT2 mRNA |
CTD |
PMID:21142847 PMID:29020013 |
|
NCBI chr 8:94,899,246...94,900,195
Ensembl chr 8:94,899,292...94,900,196
|
|
G |
Mterf1b |
mitochondrial transcription termination factor 1b |
increases expression |
EXP |
cypermethrin results in increased expression of MTERF1B mRNA |
CTD |
PMID:29020013 |
|
NCBI chr 5:4,242,329...4,247,652
Ensembl chr 5:4,242,367...4,247,651
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
multiple interactions decreases phosphorylation |
EXP |
Sirolimus promotes the reaction [cypermethrin results in decreased phosphorylation of MTOR protein] |
CTD |
PMID:37011868 |
|
NCBI chr 4:148,533,039...148,642,142
Ensembl chr 4:148,533,068...148,642,140
|
|
G |
Mylip |
myosin regulatory light chain interacting protein |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MYLIP protein |
CTD |
PMID:34896426 |
|
NCBI chr13:45,543,197...45,565,498
Ensembl chr13:45,543,218...45,565,498
|
|
G |
Myo1a |
myosin IA |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MYO1A protein |
CTD |
PMID:34896426 |
|
NCBI chr10:127,539,306...127,556,809
Ensembl chr10:127,541,039...127,556,809
|
|
G |
Nanog |
Nanog homeobox |
increases expression |
EXP |
cypermethrin results in increased expression of NANOG mRNA |
CTD |
PMID:32214279 |
|
NCBI chr 6:122,684,448...122,691,592
Ensembl chr 6:122,684,448...122,691,592
|
|
G |
Nanos3 |
nanos C2HC-type zinc finger 3 |
decreases expression |
EXP |
cypermethrin results in decreased expression of NANOS3 mRNA |
CTD |
PMID:24810582 |
|
NCBI chr 8:84,900,359...84,911,396
Ensembl chr 8:84,900,360...84,911,846
|
|
G |
Nanp |
N-acetylneuraminic acid phosphatase |
decreases expression |
EXP |
cypermethrin results in decreased expression of NANP mRNA |
CTD |
PMID:29020013 |
|
NCBI chr 2:150,871,605...150,881,299
Ensembl chr 2:150,871,605...150,881,318
|
|
G |
Nbr1 |
NBR1, autophagy cargo receptor |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of NBR1 protein |
CTD |
PMID:34896426 |
|
NCBI chr11:101,442,933...101,472,777
Ensembl chr11:101,442,975...101,472,777
|
|
G |
Ncam1 |
neural cell adhesion molecule 1 |
decreases expression |
ISO |
cypermethrin results in decreased expression of NCAM1 mRNA |
CTD |
PMID:22528246 |
|
NCBI chr 9:49,413,434...49,710,909
Ensembl chr 9:49,413,436...49,710,225
|
|
G |
Ncf2 |
neutrophil cytosolic factor 2 |
increases expression |
EXP |
cypermethrin results in increased expression of NCF2 mRNA |
CTD |
PMID:21142847 |
|
NCBI chr 1:152,675,904...152,712,743
Ensembl chr 1:152,675,945...152,712,742
|
|
G |
Ncoa7 |
nuclear receptor coactivator 7 |
multiple interactions |
ISO |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of NCOA7 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of NCOA7 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of NCOA7 mRNA |
CTD |
PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783 |
|
NCBI chr10:30,521,578...30,683,401
Ensembl chr10:30,504,995...30,679,322
|
|
G |
Ndufv2 |
NADH:ubiquinone oxidoreductase core subunit V2 |
decreases expression |
ISO |
cypermethrin results in decreased expression of NDUFV2 protein |
CTD |
PMID:21561882 |
|
NCBI chr17:66,385,790...66,408,554
Ensembl chr17:66,385,633...66,408,554
|
|
G |
Neb |
nebulin |
decreases expression |
ISO |
cypermethrin results in decreased expression of NEB mRNA |
CTD |
PMID:22528246 |
|
NCBI chr 2:52,026,652...52,228,810
Ensembl chr 2:52,026,659...52,268,486
|
|
G |
Nefh |
neurofilament, heavy polypeptide |
increases expression |
ISO |
cypermethrin results in increased expression of NEFH mRNA |
CTD |
PMID:32028016 |
|
NCBI chr11:4,888,754...4,898,064
Ensembl chr11:4,888,754...4,898,064
|
|
G |
Nefl |
neurofilament, light polypeptide |
decreases expression |
ISO |
cypermethrin results in decreased expression of NEFL mRNA |
CTD |
PMID:32028016 |
|
NCBI chr14:68,321,312...68,326,544
Ensembl chr14:68,321,312...68,326,544
|
|
G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
increases expression decreases expression multiple interactions |
ISO EXP |
cypermethrin results in increased expression of NFE2L2 mRNA cypermethrin results in decreased expression of NFE2L2 mRNA; cypermethrin results in decreased expression of NFE2L2 protein [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of NFE2L2 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of NFE2L2 mRNA; Quercetin inhibits the reaction [cypermethrin results in decreased expression of NFE2L2 mRNA] |
CTD |
PMID:31907151 PMID:32028016 PMID:33396045 PMID:34896426 PMID:35876585 |
|
NCBI chr 2:75,505,860...75,535,007
Ensembl chr 2:75,505,857...75,534,985
|
|
G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 |
increases expression multiple interactions |
ISO |
cypermethrin results in increased expression of NFKB1 mRNA Quercetin inhibits the reaction [cypermethrin results in increased expression of NFKB1 mRNA] |
CTD |
PMID:27704156 PMID:35876585 |
|
NCBI chr 3:135,290,416...135,397,422
Ensembl chr 3:135,290,416...135,397,308
|
|
G |
Ngb |
neuroglobin |
increases expression |
EXP |
cypermethrin results in increased expression of NGB mRNA |
CTD |
PMID:21142847 |
|
NCBI chr12:87,144,305...87,149,313
Ensembl chr12:87,144,305...87,149,313
|
|
G |
Ngfr |
nerve growth factor receptor (TNFR superfamily, member 16) |
increases expression |
EXP |
cypermethrin results in increased expression of NGFR mRNA |
CTD |
PMID:35031408 |
|
NCBI chr11:95,459,644...95,478,524
Ensembl chr11:95,459,644...95,478,561
|
|
G |
Nherf1 |
NHERF family PDZ scaffold protein 1 |
decreases expression |
EXP |
cypermethrin results in decreased expression of SLC9A3R1 mRNA |
CTD |
PMID:35031408 |
|
NCBI chr11:115,054,138...115,072,009
Ensembl chr11:115,054,167...115,072,007
|
|
G |
Nhsl1 |
NHS like 1 |
increases expression |
EXP |
cypermethrin results in increased expression of NHSL1 mRNA |
CTD |
PMID:29020013 |
|
NCBI chr10:18,193,419...18,409,640
Ensembl chr10:18,194,733...18,409,640
|
|
G |
Nlk |
nemo like kinase |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of NLK protein |
CTD |
PMID:34896426 |
|
NCBI chr11:78,457,994...78,588,848
Ensembl chr11:78,457,994...78,588,199
|
|
G |
Noc4l |
NOC4 like |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of NOC4L protein |
CTD |
PMID:34896426 |
|
NCBI chr 5:110,796,285...110,801,248
Ensembl chr 5:110,796,284...110,801,283
|
|
G |
Nol3 |
nucleolar protein 3 (apoptosis repressor with CARD domain) |
increases expression |
ISO |
cypermethrin results in increased expression of NOL3 mRNA |
CTD |
PMID:27704156 |
|
NCBI chr 8:106,002,777...106,008,571
Ensembl chr 8:106,002,772...106,008,571
|
|
G |
Nos1 |
nitric oxide synthase 1, neuronal |
decreases expression |
ISO |
cypermethrin results in decreased expression of NOS1 protein |
CTD |
PMID:36063984 |
|
NCBI chr 5:118,004,904...118,096,905
Ensembl chr 5:117,919,097...118,096,905
|
|
G |
Nos2 |
nitric oxide synthase 2, inducible |
multiple interactions increases expression |
ISO EXP |
Acetylcysteine inhibits the reaction [cypermethrin results in increased expression of NOS2 mRNA]; Quercetin inhibits the reaction [cypermethrin results in increased expression of NOS2 mRNA] cypermethrin results in increased expression of NOS2 mRNA; cypermethrin results in increased expression of NOS2 protein cypermethrin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA] |
CTD |
PMID:22528246 PMID:23900960 PMID:29471534 PMID:35876585 |
|
NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080
|
|
G |
Notch2 |
notch 2 |
multiple interactions decreases expression |
ISO |
MIR21 promotes the reaction [cypermethrin results in decreased expression of NOTCH2 protein] cypermethrin results in decreased expression of NOTCH2 mRNA; cypermethrin results in decreased expression of NOTCH2 protein |
CTD |
PMID:35512476 |
|
NCBI chr 3:97,920,854...98,057,683
Ensembl chr 3:97,920,843...98,057,677
|
|
G |
Nox4 |
NADPH oxidase 4 |
increases expression |
EXP |
cypermethrin results in increased expression of NOX4 mRNA |
CTD |
PMID:21142847 |
|
NCBI chr 7:86,893,638...87,047,918
Ensembl chr 7:86,895,304...87,047,918
|
|
G |
Npl |
N-acetylneuraminate pyruvate lyase |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of NPL protein |
CTD |
PMID:34896426 |
|
NCBI chr 1:153,378,762...153,425,460
Ensembl chr 1:153,378,761...153,425,791
|
|
G |
Npr2 |
natriuretic peptide receptor 2 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of NPR2 protein |
CTD |
PMID:34896426 |
|
NCBI chr 4:43,629,015...43,651,437
Ensembl chr 4:43,631,935...43,651,244
|
|
G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
increases expression decreases expression multiple interactions |
EXP ISO |
cypermethrin results in increased expression of NQO1; cypermethrin results in increased expression of NQO1 mRNA cypermethrin results in decreased expression of NQO1 mRNA; cypermethrin results in decreased expression of NQO1 protein [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of NQO1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of NQO1 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of NQO1 mRNA |
CTD |
PMID:31907151 PMID:32214279 PMID:33396045 PMID:34896426 PMID:36053783 |
|
NCBI chr 8:108,114,856...108,139,012
Ensembl chr 8:108,114,857...108,129,838
|
|
G |
Nr0b1 |
nuclear receptor subfamily 0, group B, member 1 |
multiple interactions |
ISO |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of NR0B1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of NR0B1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of NR0B1 mRNA |
CTD |
PMID:33051911 PMID:33396045 PMID:34896426 |
|
NCBI chr X:85,235,381...85,239,553
Ensembl chr X:85,235,370...85,239,553
|
|
G |
Nr1d1 |
nuclear receptor subfamily 1, group D, member 1 |
decreases expression |
EXP |
cypermethrin results in decreased expression of NR1D1 mRNA |
CTD |
PMID:29020013 |
|
NCBI chr11:98,658,758...98,666,233
Ensembl chr11:98,658,758...98,666,159
|
|
G |
Nr1h4 |
nuclear receptor subfamily 1, group H, member 4 |
multiple interactions |
ISO |
cypermethrin inhibits the reaction [pregna-4,17-diene-3,16-dione results in decreased activity of NR1H4 protein] |
CTD |
PMID:25257666 |
|
NCBI chr10:89,290,096...89,369,484
Ensembl chr10:89,290,096...89,369,447
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
multiple interactions increases expression increases activity |
ISO EXP |
cypermethrin binds to and results in increased activity of NR1I2 protein cypermethrin results in increased expression of NR1I2 mRNA cypermethrin results in increased activity of NR1I2 protein |
CTD |
PMID:15548381 PMID:16054614 PMID:21115097 PMID:22206814 PMID:22310298 PMID:31538121 PMID:33049310 More...
|
|
NCBI chr16:38,068,711...38,115,211
Ensembl chr16:38,068,685...38,115,186
|
|
G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
multiple interactions increases expression |
EXP ISO |
cypermethrin binds to and results in increased activity of NR1I3 protein; cypermethrin inhibits the reaction [Androstane-3,17-diol binds to and results in decreased activity of NR1I3 protein] cypermethrin results in increased expression of NR1I3 mRNA |
CTD |
PMID:16929008 PMID:18832183 PMID:22310298 |
|
NCBI chr 1:171,041,503...171,046,414
Ensembl chr 1:171,041,539...171,048,270
|
|
G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
multiple interactions |
ISO |
cypermethrin inhibits the reaction [Hydrocortisone results in increased activity of NR3C1 protein] |
CTD |
PMID:26647222 |
|
NCBI chr18:39,543,598...39,652,485
Ensembl chr18:39,543,598...39,652,474
|
|
G |
Nr3c2 |
nuclear receptor subfamily 3, group C, member 2 |
multiple interactions |
ISO |
cypermethrin inhibits the reaction [Aldosterone affects the localization of NR3C2 protein]; cypermethrin inhibits the reaction [Aldosterone results in increased activity of NR3C2 protein] [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of NR3C2 protein |
CTD |
PMID:29149346 PMID:34896426 |
|
NCBI chr 8:77,626,422...77,971,641
Ensembl chr 8:77,626,070...77,971,641
|
|
G |
Nr4a1 |
nuclear receptor subfamily 4, group A, member 1 |
decreases expression |
EXP |
cypermethrin results in decreased expression of NR4A1 mRNA |
CTD |
PMID:35031408 |
|
NCBI chr15:101,151,783...101,172,676
Ensembl chr15:101,152,150...101,172,676
|
|
G |
Nr5a1 |
nuclear receptor subfamily 5, group A, member 1 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of NR5A1 mRNA |
CTD |
PMID:33396045 |
|
NCBI chr 2:38,582,668...38,604,554
Ensembl chr 2:38,582,668...38,604,554
|
|
G |
Nrarp |
Notch-regulated ankyrin repeat protein |
increases expression |
EXP |
cypermethrin results in increased expression of NRARP mRNA |
CTD |
PMID:29020013 |
|
NCBI chr 2:25,070,770...25,073,351
Ensembl chr 2:25,070,770...25,073,351
|
|
G |
Nrxn2 |
neurexin II |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of NRXN2 protein |
CTD |
PMID:34896426 |
|
NCBI chr19:6,468,786...6,583,247
Ensembl chr19:6,468,761...6,594,199
|
|
G |
Ntrk2 |
neurotrophic tyrosine kinase, receptor, type 2 |
decreases expression |
ISO |
cypermethrin results in decreased expression of NTRK2 mRNA |
CTD |
PMID:22528246 |
|
NCBI chr13:58,954,363...59,281,782
Ensembl chr13:58,954,383...59,281,784
|
|
G |
Nudt15 |
nudix hydrolase 15 |
increases expression |
EXP |
cypermethrin results in increased expression of NUDT15 mRNA |
CTD |
PMID:21142847 |
|
NCBI chr14:73,756,320...73,785,682
Ensembl chr14:73,756,317...73,785,682
|
|
G |
Nudt18 |
nudix hydrolase 18 |
decreases expression |
EXP |
cypermethrin results in decreased expression of NUDT18 mRNA |
CTD |
PMID:29020013 |
|
NCBI chr14:70,815,264...70,820,128
Ensembl chr14:70,815,077...70,820,128
|
|
G |
Nxph4 |
neurexophilin 4 |
increases expression |
EXP |
cypermethrin results in increased expression of NXPH4 mRNA |
CTD |
PMID:29020013 |
|
NCBI chr10:127,361,342...127,370,428
Ensembl chr10:127,361,342...127,370,428
|
|
G |
Oas3 |
2'-5' oligoadenylate synthetase 3 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of OAS3 protein |
CTD |
PMID:34896426 |
|
NCBI chr 5:120,891,163...120,915,755
Ensembl chr 5:120,891,163...120,915,726
|
|
G |
Odf2 |
outer dense fiber of sperm tails 2 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ODF2 protein |
CTD |
PMID:34896426 |
|
NCBI chr 2:29,779,026...29,821,758
Ensembl chr 2:29,779,233...29,821,758
|
|
G |
Oosp1 |
oocyte secreted protein 1 |
increases expression |
EXP |
cypermethrin results in increased expression of OOSP1 mRNA |
CTD |
PMID:35031408 |
|
NCBI chr19:11,644,824...11,668,415
Ensembl chr19:11,644,824...11,668,514
|
|
G |
Or10ak14 |
olfactory receptor family 10 subfamily AK member 14 |
increases expression |
EXP |
cypermethrin results in increased expression of OR10AK14 mRNA |
CTD |
PMID:29020013 |
|
NCBI chr 4:118,610,386...118,614,155
Ensembl chr 4:118,609,172...118,615,934
|
|
G |
Or11g25 |
olfactory receptor family 11 subfamily G member 25 |
increases expression |
EXP |
cypermethrin results in increased expression of OR11G25 mRNA |
CTD |
PMID:29020013 |
|
NCBI chr14:50,710,514...50,723,852
Ensembl chr14:50,710,195...50,725,795
|
|
G |
Or13a25 |
olfactory receptor family 13 subfamily A member 25 |
increases expression |
EXP |
cypermethrin results in increased expression of OR13A25 mRNA |
CTD |
PMID:29020013 |
|
NCBI chr 7:140,247,202...140,248,161
Ensembl chr 7:140,239,843...140,258,493
|
|
G |
Or2a25 |
olfactory receptor family 2 subfamily A member 25 |
decreases expression |
EXP |
cypermethrin results in decreased expression of OR2A25 mRNA |
CTD |
PMID:29020013 |
|
NCBI chr 6:42,888,459...42,889,391
Ensembl chr 6:42,885,812...42,891,207
|
|
G |
Or2y1b |
olfactory receptor family 2 subfamily Y member 1B |
increases expression |
EXP |
cypermethrin results in increased expression of OR2Y1B mRNA |
CTD |
PMID:29020013 |
|
NCBI chr11:49,208,375...49,209,310
Ensembl chr11:49,195,568...49,210,848
|
|
G |
Or4b1d |
olfactory receptor family 4 subfamily B member 1D |
decreases expression |
EXP |
cypermethrin results in decreased expression of OR4B1D mRNA |
CTD |
PMID:29020013 |
|
NCBI chr 2:89,968,425...89,980,334
Ensembl chr 2:89,966,617...89,972,640
|
|
G |
Or52ab4 |
olfactory receptor family 52 subfamily AB member 4 |
decreases expression |
EXP |
cypermethrin results in decreased expression of OR52AB4 mRNA |
CTD |
PMID:29020013 |
|
NCBI chr 7:102,987,219...102,988,268
Ensembl chr 7:102,985,124...102,988,771
|
|
G |
Or52n2 |
olfactory receptor family 52 subfamily N member 2 |
increases expression |
EXP |
cypermethrin results in increased expression of OR52N2 mRNA |
CTD |
PMID:29020013 |
|
NCBI chr 7:104,541,877...104,542,833
Ensembl chr 7:104,541,029...104,545,159
|
|
G |
Or52n2b |
olfactory receptor family 52 subfamily N member 2B |
decreases expression |
EXP |
cypermethrin results in decreased expression of OR52N2B mRNA |
CTD |
PMID:29020013 |
|
NCBI chr 7:104,565,521...104,566,501
Ensembl chr 7:104,563,949...104,570,689
|
|
G |
Or5d16 |
olfactory receptor family 5 subfamily D member 16 |
decreases expression |
EXP |
cypermethrin results in decreased expression of OR5D16 mRNA |
CTD |
PMID:29020013 |
|
NCBI chr 2:87,773,026...87,773,970
Ensembl chr 2:87,771,989...87,775,481
|
|
G |
Or5g9 |
olfactory receptor family 5 subfamily G member 9 |
decreases expression |
EXP |
cypermethrin results in decreased expression of OR5G9 mRNA |
CTD |
PMID:29020013 |
|
NCBI chr 2:85,551,751...85,552,695
Ensembl chr 2:85,545,763...85,555,480
|
|
G |
Or5w15 |
olfactory receptor family 5 subfamily W member 15 |
decreases expression |
EXP |
cypermethrin results in decreased expression of OR5W15 mRNA |
CTD |
PMID:29020013 |
|
NCBI chr 2:87,567,731...87,568,666
Ensembl chr 2:87,567,091...87,570,322
|
|
G |
Or6a2 |
olfactory receptor family 6 subfamily A member 2 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of OR6A2 protein |
CTD |
PMID:34896426 |
|
NCBI chr 7:106,600,082...106,601,812
Ensembl chr 7:106,594,606...106,605,279
|
|
G |
Or6k2 |
olfactory receptor family 6 subfamily K member 2 |
decreases expression |
EXP |
cypermethrin results in decreased expression of OR6K2 mRNA |
CTD |
PMID:29020013 |
|
NCBI chr 1:173,986,288...173,987,333
Ensembl chr 1:173,983,199...173,989,761
|
|
G |
Or7a35 |
olfactory receptor family 7 subfamily A member 35 |
increases expression |
EXP |
cypermethrin results in increased expression of OR7A35 mRNA |
CTD |
PMID:29020013 |
|
NCBI chr10:78,853,158...78,854,117
Ensembl chr10:78,848,306...78,855,479
|
|
G |
Or8g51 |
olfactory receptor family 8 subfamily G member 51 |
decreases expression |
EXP |
cypermethrin results in decreased expression of OR8G51 mRNA |
CTD |
PMID:29020013 |
|
NCBI chr 9:38,608,725...38,609,672
Ensembl chr 9:38,608,100...38,614,969
|
|
G |
Orc4 |
origin recognition complex, subunit 4 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ORC4 protein |
CTD |
PMID:34896426 |
|
NCBI chr 2:48,792,836...48,840,287
Ensembl chr 2:48,792,836...48,840,289
|
|
G |
Otub2 |
OTU domain, ubiquitin aldehyde binding 2 |
increases expression |
EXP |
cypermethrin results in increased expression of OTUB2 mRNA |
CTD |
PMID:29020013 |
|
NCBI chr12:103,343,244...103,372,609
Ensembl chr12:103,354,941...103,372,609
|
|
G |
Ovol1 |
ovo like zinc finger 1 |
multiple interactions |
ISO |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of OVOL1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of OVOL1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of OVOL1 mRNA |
CTD |
PMID:33051911 PMID:33396045 PMID:34896426 |
|
NCBI chr19:5,599,165...5,610,603
Ensembl chr19:5,599,164...5,610,674
|
|
G |
P4htm |
prolyl 4-hydroxylase, transmembrane (endoplasmic reticulum) |
increases expression |
ISO |
cypermethrin results in increased expression of P4HTM mRNA |
CTD |
PMID:32573024 |
|
NCBI chr 9:108,456,025...108,475,482
Ensembl chr 9:108,456,061...108,474,866
|
|
G |
Pacs1 |
phosphofurin acidic cluster sorting protein 1 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of PACS1 protein |
CTD |
PMID:34896426 |
|
NCBI chr19:5,183,714...5,323,138
Ensembl chr19:5,183,186...5,323,147
|
|
G |
Paf1 |
Paf1, RNA polymerase II complex component |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PAF1 protein |
CTD |
PMID:34896426 |
|
NCBI chr 7:28,074,998...28,098,813
Ensembl chr 7:28,092,376...28,098,813
|
|
G |
Pafah1b2 |
platelet-activating factor acetylhydrolase, isoform 1b, subunit 2 |
decreases expression multiple interactions |
ISO |
cypermethrin results in decreased expression of PAFAH1B2 protein Minocycline inhibits the reaction [cypermethrin results in decreased expression of PAFAH1B2 protein] |
CTD |
PMID:21561882 |
|
NCBI chr 9:45,876,609...45,923,988
Ensembl chr 9:45,874,157...45,923,988
|
|
G |
Palm |
paralemmin |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PALM protein |
CTD |
PMID:34896426 |
|
NCBI chr10:79,629,406...79,656,749
Ensembl chr10:79,629,406...79,656,730
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase family, member 1 |
multiple interactions decreases expression |
ISO |
cypermethrin inhibits the reaction [Docosahexaenoic Acids results in increased degradation of PARP1 protein] cypermethrin results in decreased expression of PARP1 mRNA |
CTD |
PMID:11341974 PMID:27704156 |
|
NCBI chr 1:180,396,456...180,428,564
Ensembl chr 1:180,396,489...180,428,819
|
|
G |
Parp2 |
poly (ADP-ribose) polymerase family, member 2 |
increases expression |
ISO |
cypermethrin results in increased expression of PARP2 mRNA |
CTD |
PMID:27704156 |
|
NCBI chr14:51,045,347...51,058,758
Ensembl chr14:51,045,298...51,058,758
|
|
G |
Pbk |
PDZ binding kinase |
increases expression |
EXP |
cypermethrin results in increased expression of PBK mRNA |
CTD |
PMID:29020013 |
|
NCBI chr14:66,043,337...66,055,271
Ensembl chr14:66,043,286...66,055,271
|
|
G |
Pcna |
proliferating cell nuclear antigen |
affects expression decreases expression multiple interactions |
EXP ISO |
cypermethrin affects the expression of PCNA mRNA; cypermethrin affects the expression of PCNA protein cypermethrin results in decreased expression of PCNA mRNA; cypermethrin results in decreased expression of PCNA protein [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of PCNA mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PCNA mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of PCNA mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of PCNA mRNA |
CTD |
PMID:24810582 PMID:33051911 PMID:33396045 PMID:34896426 PMID:35605701 PMID:36053783 PMID:37011868 More...
|
|
NCBI chr 2:132,091,206...132,095,100
Ensembl chr 2:132,091,082...132,095,234
|
|
G |
Pde4b |
phosphodiesterase 4B, cAMP specific |
multiple interactions |
ISO |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of PDE4B mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PDE4B mRNA |
CTD |
PMID:33051911 PMID:33396045 |
|
NCBI chr 4:101,944,529...102,464,459
Ensembl chr 4:101,944,740...102,464,456
|
|
G |
Pdgfa |
platelet derived growth factor, alpha |
increases expression |
ISO |
cypermethrin results in increased expression of PDGFA mRNA |
CTD |
PMID:22528246 |
|
NCBI chr 5:138,961,761...138,986,336
Ensembl chr 5:138,961,769...138,983,125
|
|
G |
Pdia3 |
protein disulfide isomerase associated 3 |
decreases expression |
ISO |
cypermethrin results in decreased expression of PDIA3 protein |
CTD |
PMID:21561882 |
|
NCBI chr 2:121,244,383...121,269,168
Ensembl chr 2:121,244,256...121,269,168
|
|
G |
Pds5a |
PDS5 cohesin associated factor A |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PDS5A protein |
CTD |
PMID:34896426 |
|
NCBI chr 5:65,763,062...65,855,579
Ensembl chr 5:65,763,064...65,855,616
|
|
G |
Pebp1 |
phosphatidylethanolamine binding protein 1 |
increases expression |
ISO |
cypermethrin results in increased expression of PEBP1 protein |
CTD |
PMID:21561882 |
|
NCBI chr 5:117,420,716...117,425,629
Ensembl chr 5:117,420,719...117,425,690
|
|
G |
Pelp1 |
proline, glutamic acid and leucine rich protein 1 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PELP1 protein |
CTD |
PMID:34896426 |
|
NCBI chr11:70,283,709...70,300,862
Ensembl chr11:70,283,709...70,300,857
|
|
G |
Pex6 |
peroxisomal biogenesis factor 6 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of PEX6 protein |
CTD |
PMID:34896426 |
|
NCBI chr17:47,022,402...47,036,469
Ensembl chr17:47,022,389...47,036,467
|
|
G |
Pgap1 |
post-GPI attachment to proteins 1 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PGAP1 protein |
CTD |
PMID:34896426 |
|
NCBI chr 1:54,512,159...54,596,843
Ensembl chr 1:54,512,153...54,596,843
|
|
G |
Pgr |
progesterone receptor |
increases expression affects binding decreases expression |
EXP ISO |
cypermethrin results in increased expression of PGR mRNA; cypermethrin results in increased expression of PGR protein cypermethrin binds to PGR protein cypermethrin results in decreased expression of PGR protein |
CTD |
PMID:29253587 PMID:32278787 PMID:36116546 |
|
NCBI chr 9:8,890,017...8,968,612
Ensembl chr 9:8,899,834...8,968,612
|
|
G |
Phactr1 |
phosphatase and actin regulator 1 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PHACTR1 protein |
CTD |
PMID:34896426 |
|
NCBI chr13:42,833,909...43,292,002
Ensembl chr13:42,834,099...43,292,002
|
|
G |
Phb1 |
prohibitin 1 |
decreases expression |
ISO |
cypermethrin results in decreased expression of PHB1 protein |
CTD |
PMID:21561882 |
|
NCBI chr11:95,557,783...95,571,599
Ensembl chr11:95,557,783...95,571,599
|
|
G |
Pik3c3 |
phosphatidylinositol 3-kinase catalytic subunit type 3 |
increases expression |
ISO |
cypermethrin results in increased expression of PIK3C3 mRNA |
CTD |
PMID:32028016 |
|
NCBI chr18:30,390,441...30,481,179
Ensembl chr18:30,405,800...30,481,179
|
|
G |
Pik3ca |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PIK3CA protein |
CTD |
PMID:34896426 |
|
NCBI chr 3:32,451,203...32,520,256
Ensembl chr 3:32,451,820...32,522,635
|
|
G |
Pik3cb |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PIK3CB protein |
CTD |
PMID:34896426 |
|
NCBI chr 9:98,920,455...99,022,264
Ensembl chr 9:98,918,707...99,022,674
|
|
G |
Pinx1 |
PIN2/TERF1 interacting, telomerase inhibitor 1 |
increases expression |
EXP |
cypermethrin results in increased expression of PINX1 mRNA |
CTD |
PMID:21142847 |
|
NCBI chr14:64,097,728...64,157,311
Ensembl chr14:64,097,813...64,157,308
|
|
G |
Pip5k1a |
phosphatidylinositol-4-phosphate 5-kinase, type 1 alpha |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PIP5K1A protein |
CTD |
PMID:34896426 |
|
NCBI chr 3:94,965,841...95,014,241
Ensembl chr 3:94,965,841...95,014,241
|
|
G |
Pklr |
pyruvate kinase liver and red blood cell |
multiple interactions |
EXP |
[lard co-treated with Cholesterol co-treated with Sucrose co-treated with cypermethrin] results in increased expression of PKLR mRNA |
CTD |
PMID:24440342 |
|
NCBI chr 3:89,043,429...89,054,122
Ensembl chr 3:89,043,449...89,054,091
|
|
G |
Pkmyt1 |
protein kinase, membrane associated tyrosine/threonine 1 |
decreases expression |
ISO |
cypermethrin results in decreased expression of PKMYT1 protein |
CTD |
PMID:36063984 |
|
NCBI chr17:23,945,385...23,955,709
Ensembl chr17:23,945,310...23,955,709
|
|
G |
Plcb2 |
phospholipase C, beta 2 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PLCB2 protein |
CTD |
PMID:34896426 |
|
NCBI chr 2:118,535,484...118,559,140
Ensembl chr 2:118,537,998...118,558,919
|
|
G |
Pld1 |
phospholipase D1 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PLD1 protein |
CTD |
PMID:34896426 |
|
NCBI chr 3:27,992,636...28,187,388
Ensembl chr 3:27,992,844...28,187,511
|
|
G |
Plekhf1 |
pleckstrin homology domain containing, family F (with FYVE domain) member 1 |
decreases expression |
EXP |
cypermethrin results in decreased expression of PLEKHF1 mRNA |
CTD |
PMID:29020013 |
|
NCBI chr 7:37,920,078...37,927,418
Ensembl chr 7:37,916,396...37,927,440
|
|
G |
Plk3 |
polo like kinase 3 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PLK3 protein |
CTD |
PMID:34896426 |
|
NCBI chr 4:116,985,852...116,991,244
Ensembl chr 4:116,985,852...116,991,160
|
|
G |
Plod3 |
procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PLOD3 protein |
CTD |
PMID:34896426 |
|
NCBI chr 5:137,015,873...137,025,500
Ensembl chr 5:137,015,873...137,025,502
|
|
G |
Pmch |
pro-melanin-concentrating hormone |
decreases expression |
EXP |
cypermethrin results in decreased expression of PMCH mRNA |
CTD |
PMID:29020013 |
|
NCBI chr10:87,926,934...87,928,236
Ensembl chr10:87,926,934...87,928,237
|
|
G |
Pms1 |
PMS1 homolog 1, mismatch repair system component |
increases expression |
EXP |
cypermethrin results in increased expression of PMS1 mRNA |
CTD |
PMID:21142847 |
|
NCBI chr 1:53,225,794...53,336,190
Ensembl chr 1:53,228,346...53,336,177
|
|
G |
Pnlip |
pancreatic lipase |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PNLIP protein |
CTD |
PMID:34896426 |
|
NCBI chr19:58,658,797...58,670,231
Ensembl chr19:58,640,930...58,670,220
|
|
G |
Pold3 |
polymerase (DNA-directed), delta 3, accessory subunit |
increases expression |
EXP |
cypermethrin results in increased expression of POLD3 mRNA |
CTD |
PMID:21142847 |
|
NCBI chr 7:99,731,317...99,770,709
Ensembl chr 7:99,731,318...99,770,772
|
|
G |
Polh |
polymerase (DNA directed), eta (RAD 30 related) |
increases expression |
EXP |
cypermethrin results in increased expression of POLH mRNA |
CTD |
PMID:21142847 |
|
NCBI chr17:46,482,281...46,513,567
Ensembl chr17:46,482,281...46,513,571
|
|
G |
Poli |
polymerase (DNA directed), iota |
increases expression |
EXP |
cypermethrin results in increased expression of POLI mRNA |
CTD |
PMID:21142847 |
|
NCBI chr18:70,641,754...70,668,021
Ensembl chr18:70,641,751...70,663,691
|
|
G |
Polq |
polymerase (DNA directed), theta |
decreases expression |
ISO |
cypermethrin results in decreased expression of POLQ protein |
CTD |
PMID:36063984 |
|
NCBI chr16:36,832,104...36,922,321
Ensembl chr16:36,832,148...36,915,779
|
|
G |
Pou5f1 |
POU domain, class 5, transcription factor 1 |
increases expression |
EXP |
cypermethrin results in increased expression of POU5F1 mRNA |
CTD |
PMID:32214279 |
|
NCBI chr17:35,816,929...35,821,674
Ensembl chr17:35,816,915...35,821,669
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
multiple interactions |
EXP |
cypermethrin promotes the reaction [[lard co-treated with Cholesterol co-treated with Sucrose] results in increased expression of PPARA mRNA] |
CTD |
PMID:24440342 |
|
NCBI chr15:85,619,112...85,691,052
Ensembl chr15:85,619,184...85,687,020
|
|
G |
Pparg |
peroxisome proliferator activated receptor gamma |
multiple interactions |
ISO EXP |
cypermethrin binds to and results in increased activity of PPARG protein |
CTD |
PMID:33049310 |
|
NCBI chr 6:115,337,828...115,467,365
Ensembl chr 6:115,337,912...115,467,360
|
|
G |
Ppfia4 |
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 4 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PPFIA4 protein |
CTD |
PMID:34896426 |
|
NCBI chr 1:134,224,521...134,272,493
Ensembl chr 1:134,224,521...134,260,666
|
|
G |
Ppig |
peptidyl-prolyl isomerase G (cyclophilin G) |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of PPIG protein |
CTD |
PMID:34896426 |
|
NCBI chr 2:69,553,152...69,584,356
Ensembl chr 2:69,552,889...69,584,356
|
|
G |
Ppp1r13b |
protein phosphatase 1, regulatory subunit 13B |
increases expression |
ISO |
cypermethrin results in increased expression of PPP1R13B protein |
CTD |
PMID:36063984 |
|
NCBI chr12:111,794,892...111,874,549
Ensembl chr12:111,794,891...111,874,544
|
|
G |
Ppp1r15b |
protein phosphatase 1, regulatory subunit 15B |
increases expression |
EXP |
cypermethrin results in increased expression of PPP1R15B mRNA |
CTD |
PMID:21142847 |
|
NCBI chr 1:133,058,904...133,067,538
Ensembl chr 1:133,058,881...133,067,521
|
|
G |
Ppp3ca |
protein phosphatase 3, catalytic subunit, alpha isoform |
multiple interactions |
ISO |
[cypermethrin results in decreased activity of PPP3CA protein] which results in decreased susceptibility to Thapsigargin |
CTD |
PMID:10898953 |
|
NCBI chr 3:136,375,778...136,643,488
Ensembl chr 3:136,375,885...136,643,488
|
|
G |
Ppt1 |
palmitoyl-protein thioesterase 1 |
decreases expression |
EXP |
cypermethrin results in decreased expression of PPT1 mRNA |
CTD |
PMID:29020013 |
|
NCBI chr 4:122,729,879...122,752,968
Ensembl chr 4:122,730,035...122,752,968
|
|
G |
Prdx2 |
peroxiredoxin 2 |
increases expression |
EXP |
cypermethrin results in increased expression of PRDX2 mRNA |
CTD |
PMID:21142847 |
|
NCBI chr 8:85,696,251...85,701,440
Ensembl chr 8:85,696,216...85,701,463
|
|
G |
Prdx4 |
peroxiredoxin 4 |
increases expression |
EXP |
cypermethrin results in increased expression of PRDX4 mRNA |
CTD |
PMID:21142847 |
|
NCBI chr X:154,106,914...154,125,268
Ensembl chr X:154,106,914...154,123,750
|
|
G |
Prdx5 |
peroxiredoxin 5 |
increases expression |
EXP |
cypermethrin results in increased expression of PRDX5 mRNA |
CTD |
PMID:21142847 |
|
NCBI chr19:6,884,065...6,887,474
Ensembl chr19:6,884,065...6,887,474
|
|
G |
Prdx6b |
peroxiredoxin 6B |
increases expression |
EXP |
cypermethrin results in increased expression of PRDX6B mRNA |
CTD |
PMID:21142847 |
|
NCBI chr 2:80,122,814...80,125,702
Ensembl chr 2:80,122,816...80,125,700
|
|
G |
Prkar1b |
protein kinase, cAMP dependent regulatory, type I beta |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of PRKAR1B protein |
CTD |
PMID:34896426 |
|
NCBI chr 5:139,003,059...139,136,458
Ensembl chr 5:139,003,061...139,135,756
|
|
G |
Prl |
prolactin |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of PRL protein |
CTD |
PMID:34896426 |
|
NCBI chr13:27,241,553...27,249,187
Ensembl chr13:27,241,553...27,249,188
|
|
G |
Prm1 |
protamine 1 |
multiple interactions |
ISO |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of PRM1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of PRM1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PRM1 mRNA |
CTD |
PMID:33051911 PMID:33396045 PMID:34896426 |
|
NCBI chr16:10,614,196...10,614,687
Ensembl chr16:10,614,190...10,623,703
|
|
G |
Prm2 |
protamine 2 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of PRM2 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PRM2 mRNA |
CTD |
PMID:33396045 PMID:34896426 |
|
NCBI chr16:10,609,241...10,609,969
Ensembl chr16:10,609,244...10,613,998
|
|
G |
Prxl2a |
peroxiredoxin like 2A |
decreases expression |
EXP |
cypermethrin results in decreased expression of PRXL2A mRNA |
CTD |
PMID:29020013 |
|
NCBI chr14:40,715,692...40,735,790
Ensembl chr14:40,715,697...40,735,745
|
|
G |
Psen1 |
presenilin 1 |
increases expression |
ISO |
cypermethrin results in increased expression of PSEN1 mRNA |
CTD |
PMID:22528246 |
|
NCBI chr12:83,734,926...83,781,869
Ensembl chr12:83,734,926...83,781,973
|
|
G |
Psmb5 |
proteasome (prosome, macropain) subunit, beta type 5 |
increases expression |
EXP |
cypermethrin results in increased expression of PSMB5 mRNA |
CTD |
PMID:21142847 |
|
NCBI chr14:54,851,577...54,855,452
Ensembl chr14:54,851,576...54,855,479
|
|
G |
Psmd2 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 2 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PSMD2 protein |
CTD |
PMID:34896426 |
|
NCBI chr16:20,469,872...20,482,164
Ensembl chr16:20,470,402...20,482,164
|
|
G |
Ptdss2 |
phosphatidylserine synthase 2 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PTDSS2 protein |
CTD |
PMID:34896426 |
|
NCBI chr 7:140,711,181...140,736,071
Ensembl chr 7:140,702,295...140,737,519
|
|
G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of PTGS1 protein |
CTD |
PMID:34896426 |
|
NCBI chr 2:36,106,758...36,142,287
Ensembl chr 2:36,120,438...36,142,284
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions increases expression |
EXP |
[cypermethrin binds to and results in decreased activity of PTGS2 protein] which results in decreased chemical synthesis of and results in decreased secretion of Prostaglandin D2 cypermethrin results in increased expression of PTGS2 mRNA |
CTD |
PMID:26359731 PMID:34714723 |
|
NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978
|
|
G |
Pth1r |
parathyroid hormone 1 receptor |
increases expression |
EXP |
cypermethrin results in increased expression of PTH1R mRNA |
CTD |
PMID:35031408 |
|
NCBI chr 9:110,551,132...110,576,213
Ensembl chr 9:110,551,153...110,576,213
|
|
G |
Ptprs |
protein tyrosine phosphatase receptor type S |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PTPRS protein |
CTD |
PMID:34896426 |
|
NCBI chr17:56,719,426...56,783,480
Ensembl chr17:56,719,426...56,783,483
|
|
G |
Pygo2 |
pygopus 2 |
multiple interactions |
ISO |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of PYGO2 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PYGO2 mRNA |
CTD |
PMID:33051911 PMID:33396045 |
|
NCBI chr 3:89,337,521...89,342,438
Ensembl chr 3:89,337,521...89,342,435
|
|
G |
Rad51 |
RAD51 recombinase |
increases expression |
EXP |
cypermethrin results in increased expression of RAD51 mRNA |
CTD |
PMID:21142847 |
|
NCBI chr 2:118,943,295...118,966,554
Ensembl chr 2:118,943,274...118,977,926
|
|
G |
Rad51b |
RAD51 paralog B |
increases expression |
EXP |
cypermethrin results in increased expression of RAD51B mRNA |
CTD |
PMID:21142847 |
|
NCBI chr12:79,344,032...79,895,034
Ensembl chr12:79,344,056...79,861,464
|
|
G |
Rad51c |
RAD51 paralog C |
increases expression |
EXP |
cypermethrin results in increased expression of RAD51C mRNA |
CTD |
PMID:21142847 |
|
NCBI chr11:87,267,471...87,295,780
Ensembl chr11:87,267,471...87,295,780
|
|
G |
Raf1 |
v-raf-leukemia viral oncogene 1 |
multiple interactions |
EXP |
1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [cypermethrin results in increased phosphorylation of and results in increased activity of RAF1 protein]; bisindolylmaleimide I inhibits the reaction [cypermethrin results in increased phosphorylation of RAF1 protein]; cypermethrin promotes the reaction [[Hydrogen Peroxide co-treated with Tetradecanoylphorbol Acetate] results in increased activity of RAF1 protein]; cypermethrin results in increased phosphorylation of and results in increased activity of RAF1 protein; Egtazic Acid inhibits the reaction [cypermethrin results in increased phosphorylation of and results in increased activity of RAF1 protein]; Nimodipine inhibits the reaction [cypermethrin results in increased phosphorylation of and results in increased activity of RAF1 protein]; Thapsigargin inhibits the reaction [cypermethrin results in increased phosphorylation of and results in increased activity of RAF1 protein]; W 7 inhibits the reaction [cypermethrin results in increased phosphorylation of and results in increased activity of RAF1 protein] |
CTD |
PMID:14623285 PMID:29149324 |
|
NCBI chr 6:115,595,530...115,653,596
Ensembl chr 6:115,595,028...115,653,596
|
|
G |
Rag2 |
recombination activating gene 2 |
increases expression |
EXP |
cypermethrin results in increased expression of RAG2 mRNA |
CTD |
PMID:21142847 |
|
NCBI chr 2:101,455,057...101,462,873
Ensembl chr 2:101,455,063...101,462,874
|
|
G |
Rapgef2 |
Rap guanine nucleotide exchange factor (GEF) 2 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of RAPGEF2 protein |
CTD |
PMID:34896426 |
|
NCBI chr 3:78,969,818...79,194,681
Ensembl chr 3:78,969,823...79,193,824
|
|
G |
Rbck1 |
RanBP-type and C3HC4-type zinc finger containing 1 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of RBCK1 protein |
CTD |
PMID:34896426 |
|
NCBI chr 2:152,158,254...152,174,592
Ensembl chr 2:152,158,254...152,174,573
|
|
G |
Rdh14 |
retinol dehydrogenase 14 (all-trans and 9-cis) |
increases expression |
EXP |
cypermethrin results in increased expression of RDH14 mRNA |
CTD |
PMID:29020013 |
|
NCBI chr12:10,440,752...10,445,562
Ensembl chr12:10,440,772...10,445,562
|
|
G |
Recql |
RecQ protein-like |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of RECQL protein |
CTD |
PMID:34896426 |
|
NCBI chr 6:142,296,068...142,332,802
Ensembl chr 6:142,296,068...142,332,813
|
|
G |
Retnla |
resistin like alpha |
multiple interactions |
EXP |
cypermethrin promotes the reaction [Lipopolysaccharides results in increased expression of RETNLA mRNA] |
CTD |
PMID:29471534 |
|
NCBI chr16:48,662,972...48,664,824
Ensembl chr16:48,662,914...48,664,824
|
|
G |
Retsat |
retinol saturase (all trans retinol 13,14 reductase) |
multiple interactions decreases expression |
EXP |
Sodium Selenite inhibits the reaction [cypermethrin results in decreased expression of RETSAT mRNA] |
CTD |
PMID:31659573 |
|
NCBI chr 6:72,575,585...72,584,471
Ensembl chr 6:72,575,458...72,585,408
|
|
G |
Rexo5 |
RNA exonuclease 5 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of REXO5 protein |
CTD |
PMID:34896426 |
|
NCBI chr 7:119,393,331...119,488,130
Ensembl chr 7:119,393,229...119,448,166
|
|
G |
Rimbp2 |
RIMS binding protein 2 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of RIMBP2 protein |
CTD |
PMID:34896426 |
|
NCBI chr 5:128,834,852...129,030,636
Ensembl chr 5:128,834,855...129,030,550
|
|
G |
Ripor2 |
RHO family interacting cell polarization regulator 2 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of RIPOR2 protein |
CTD |
PMID:34896426 |
|
NCBI chr13:24,685,513...24,917,789
Ensembl chr13:24,685,508...24,917,799
|
|
G |
Rnf157 |
ring finger protein 157 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of RNF157 protein |
CTD |
PMID:34896426 |
|
NCBI chr11:116,227,179...116,303,859
Ensembl chr11:116,227,179...116,303,858
|
|
G |
Rnf2 |
ring finger protein 2 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of RNF2 protein |
CTD |
PMID:34896426 |
|
NCBI chr 1:151,345,159...151,376,562
Ensembl chr 1:151,333,755...151,376,706
|
|
G |
Rnf8 |
ring finger protein 8 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of RNF8 protein |
CTD |
PMID:34896426 |
|
NCBI chr17:29,833,763...29,860,638
Ensembl chr17:29,833,764...29,863,965
|
|
G |
Rpl13 |
ribosomal protein L13 |
decreases expression |
EXP |
cypermethrin results in decreased expression of RPL13 mRNA |
CTD |
PMID:29020013 |
|
NCBI chr 8:123,829,089...123,831,983
Ensembl chr 8:123,829,089...123,831,983
|
|
G |
Rpl15 |
ribosomal protein L15 |
decreases expression |
EXP |
cypermethrin results in decreased expression of RPL15 mRNA |
CTD |
PMID:29020013 |
|
NCBI chr14:4,198,710...4,201,873
Ensembl chr14:4,198,305...4,201,873
|
|
G |
Rpl29 |
ribosomal protein L29 |
decreases expression |
EXP |
cypermethrin results in decreased expression of RPL29 mRNA |
CTD |
PMID:29020013 |
|
NCBI chr 9:106,306,631...106,308,768
Ensembl chr 9:106,306,653...106,308,767
|
|
G |
Rpl32l |
ribosomal protein L32-like |
decreases expression |
EXP |
cypermethrin results in decreased expression of RPL32L mRNA |
CTD |
PMID:29020013 |
|
NCBI chr10:20,084,185...20,084,776
Ensembl chr10:20,084,236...20,084,634
|
|
G |
Rpl35 |
ribosomal protein L35 |
increases expression |
EXP |
cypermethrin results in increased expression of RPL35 mRNA |
CTD |
PMID:29020013 |
|
NCBI chr 2:38,891,593...38,895,143
Ensembl chr 2:38,891,592...38,895,636
|
|
G |
Rpl37rt |
ribosomal protein L37, retrotransposed |
increases expression |
EXP |
cypermethrin results in increased expression of RPL37RT mRNA |
CTD |
PMID:29020013 |
|
NCBI chr 5:115,240,981...115,248,327
Ensembl chr15:5,146,127...5,148,622 Ensembl chr 5:5,146,127...5,148,622 Ensembl chr 5:5,146,127...5,148,622
|
|
G |
Rpl9 |
ribosomal protein L9 |
decreases expression |
EXP |
cypermethrin results in decreased expression of RPL9 mRNA |
CTD |
PMID:29020013 |
|
NCBI chr 5:65,545,707...65,548,774
Ensembl chr 5:65,545,707...65,548,787
|
|
G |
Rps18 |
ribosomal protein S18 |
decreases expression |
EXP |
cypermethrin results in decreased expression of RPS18 mRNA |
CTD |
PMID:29020013 |
|
NCBI chr17:34,170,972...34,174,639
Ensembl chr17:34,170,973...34,174,975
|
|
G |
Rps27a |
ribosomal protein S27A |
decreases expression |
EXP |
cypermethrin results in decreased expression of RPS27A mRNA |
CTD |
PMID:29020013 |
|
NCBI chr11:29,495,842...29,498,040
Ensembl chr11:29,495,846...29,498,109
|
|
G |
Rps29 |
ribosomal protein S29 |
decreases expression |
ISO |
cypermethrin results in decreased expression of RPS29 mRNA |
CTD |
PMID:22528246 |
|
NCBI chr12:69,204,495...69,205,891
Ensembl chr12:69,204,496...69,205,960
|
|
G |
Rps6kb1 |
ribosomal protein S6 kinase, polypeptide 1 |
decreases phosphorylation |
EXP |
cypermethrin results in decreased phosphorylation of RPS6KB1 protein |
CTD |
PMID:37011868 |
|
NCBI chr11:86,389,695...86,435,711
Ensembl chr11:86,389,697...86,435,631
|
|
G |
Rpsa |
ribosomal protein SA |
increases expression |
ISO |
cypermethrin results in increased expression of RPSA mRNA |
CTD |
PMID:22528246 |
|
NCBI chr 9:119,956,832...119,961,435
Ensembl chr 9:119,956,755...119,961,435
|
|
G |
Rtel1 |
regulator of telomere elongation helicase 1 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of RTEL1 protein |
CTD |
PMID:34896426 |
|
NCBI chr 2:180,961,504...180,998,409
Ensembl chr 2:180,961,532...180,998,409
|
|
G |
S100a8 |
S100 calcium binding protein A8 (calgranulin A) |
decreases expression |
EXP |
cypermethrin results in decreased expression of S100A8 mRNA |
CTD |
PMID:35031408 |
|
NCBI chr 3:90,576,378...90,577,341
Ensembl chr 3:90,576,285...90,577,342
|
|
G |
Sart1 |
squamous cell carcinoma antigen recognized by T cells 1 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SART1 protein |
CTD |
PMID:34896426 |
|
NCBI chr19:5,427,551...5,438,731
Ensembl chr19:5,427,551...5,438,731
|
|
G |
Scamp2 |
secretory carrier membrane protein 2 |
decreases expression |
ISO |
cypermethrin results in decreased expression of SCAMP2 mRNA |
CTD |
PMID:22528246 |
|
NCBI chr 9:57,468,227...57,496,081
Ensembl chr 9:57,468,226...57,496,078
|
|
G |
Scarb1 |
scavenger receptor class B, member 1 |
multiple interactions |
ISO |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of SCARB1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of SCARB1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of SCARB1 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of SCARB1 mRNA |
CTD |
PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783 |
|
NCBI chr 5:125,354,151...125,418,082
Ensembl chr 5:125,354,151...125,418,158
|
|
G |
Scd1 |
stearoyl-Coenzyme A desaturase 1 |
multiple interactions |
EXP |
[lard co-treated with Cholesterol co-treated with Sucrose co-treated with cypermethrin] results in increased expression of SCD1 mRNA |
CTD |
PMID:24440342 |
|
NCBI chr19:44,382,889...44,396,148
Ensembl chr19:44,382,894...44,396,318
|
|
G |
Scg2 |
secretogranin II |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SCG2 protein |
CTD |
PMID:34896426 |
|
NCBI chr 1:79,412,083...79,417,743
Ensembl chr 1:79,412,386...79,417,837
|
|
G |
Scn10a |
sodium channel, voltage-gated, type X, alpha |
multiple interactions affects activity |
ISO |
cypermethrin affects the reaction [SCN10A protein results in increased transport of Sodium] cypermethrin affects the activity of SCN10A protein |
CTD |
PMID:16051293 PMID:19766671 |
|
NCBI chr 9:119,437,522...119,548,388
Ensembl chr 9:119,437,522...119,548,388
|
|
G |
Scn11a |
sodium channel, voltage-gated, type XI, alpha |
decreases expression |
ISO |
cypermethrin results in decreased expression of SCN11A protein |
CTD |
PMID:36063984 |
|
NCBI chr 9:119,582,829...119,654,522
Ensembl chr 9:119,582,825...119,654,522
|
|
G |
Scn1a |
sodium channel, voltage-gated, type I, alpha |
increases expression |
ISO |
cypermethrin results in increased expression of SCN1A protein |
CTD |
PMID:36063984 |
|
NCBI chr 2:66,101,125...66,271,181
Ensembl chr 2:66,101,122...66,271,184
|
|
G |
Scn1b |
sodium channel, voltage-gated, type I, beta |
multiple interactions |
ISO |
cypermethrin affects the reaction [[SCN2A protein binds to SCN1B protein] which results in increased transport of Sodium]; SCN1B protein promotes the reaction [cypermethrin binds to SCN2A protein] |
CTD |
PMID:9863771 PMID:18538810 |
|
NCBI chr 7:30,815,949...30,826,436
Ensembl chr 7:30,815,949...30,826,428
|
|
G |
Scn2a |
sodium channel, voltage-gated, type II, alpha |
affects binding multiple interactions |
ISO |
cypermethrin binds to SCN2A protein cypermethrin affects the reaction [[SCN2A protein binds to SCN1B protein] which results in increased transport of Sodium]; SCN1B protein promotes the reaction [cypermethrin binds to SCN2A protein] |
CTD |
PMID:9863771 PMID:18538810 |
|
NCBI chr 2:65,451,108...65,597,791
Ensembl chr 2:65,451,115...65,597,791
|
|
G |
Scn3a |
sodium channel, voltage-gated, type III, alpha |
multiple interactions |
ISO |
cypermethrin affects the reaction [[SCN3A protein binds to SCN3B protein] which results in increased transport of Sodium] |
CTD |
PMID:18538810 |
|
NCBI chr 2:65,287,462...65,397,935
Ensembl chr 2:65,288,607...65,397,971
|
|
G |
Scn3b |
sodium channel, voltage-gated, type III, beta |
multiple interactions |
ISO |
cypermethrin affects the reaction [[SCN3A protein binds to SCN3B protein] which results in increased transport of Sodium] |
CTD |
PMID:18538810 |
|
NCBI chr 9:40,180,512...40,202,914
Ensembl chr 9:40,180,513...40,202,914
|
|
G |
Scn4a |
sodium channel, voltage-gated, type IV, alpha |
decreases expression |
ISO |
cypermethrin results in decreased expression of SCN4A protein |
CTD |
PMID:36063984 |
|
NCBI chr11:106,208,374...106,256,385
Ensembl chr11:106,209,418...106,244,114
|
|
G |
Scn4b |
sodium channel, type IV, beta |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SCN4B protein |
CTD |
PMID:34896426 |
|
NCBI chr 9:45,049,922...45,065,453
Ensembl chr 9:45,049,693...45,065,450
|
|
G |
Scnn1a |
sodium channel, nonvoltage-gated 1 alpha |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SCNN1A protein |
CTD |
PMID:34896426 |
|
NCBI chr 6:125,286,657...125,321,906
Ensembl chr 6:125,297,622...125,321,906
|
|
G |
Sec16b |
SEC16 homolog B, endoplasmic reticulum export factor |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SEC16B protein |
CTD |
PMID:34896426 |
|
NCBI chr 1:157,334,303...157,395,995
Ensembl chr 1:157,334,298...157,395,995
|
|
G |
Sema6c |
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6C |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SEMA6C protein |
CTD |
PMID:34896426 |
|
NCBI chr 3:95,067,731...95,081,361
Ensembl chr 3:95,067,768...95,081,335
|
|
G |
Senp8 |
SUMO peptidase family member, NEDD8 specific |
increases expression |
EXP |
cypermethrin results in increased expression of SENP8 mRNA |
CTD |
PMID:29020013 |
|
NCBI chr 9:59,641,542...59,657,932
Ensembl chr 9:59,641,542...59,657,993
|
|
G |
Sf1 |
splicing factor 1 |
multiple interactions decreases expression |
EXP ISO |
MIR140 affects the reaction [cypermethrin results in decreased expression of SF1 protein] SF1 protein inhibits the reaction [cypermethrin results in decreased expression of CYP11A1 protein]; SF1 protein inhibits the reaction [cypermethrin results in decreased expression of STAR protein] cypermethrin results in decreased expression of SF1 mRNA; cypermethrin results in decreased expression of SF1 protein |
CTD |
PMID:34794910 |
|
NCBI chr19:6,413,952...6,428,060
Ensembl chr19:6,413,720...6,428,060
|
|
G |
Shbg |
sex hormone binding globulin |
affects binding increases expression |
ISO EXP |
cypermethrin binds to SHBG protein cypermethrin results in increased expression of SHBG protein |
CTD |
PMID:30974244 PMID:32278787 |
|
NCBI chr11:69,501,108...69,508,852
Ensembl chr11:69,505,630...69,508,731
|
|
G |
Sidt2 |
SID1 transmembrane family, member 2 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SIDT2 protein |
CTD |
PMID:34896426 |
|
NCBI chr 9:45,849,155...45,869,299
Ensembl chr 9:45,849,155...45,866,556
|
|
G |
Sirt1 |
sirtuin 1 |
multiple interactions decreases expression |
ISO EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of SIRT1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of SIRT1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of SIRT1 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of SIRT1 mRNA cypermethrin results in decreased expression of SIRT1 mRNA |
CTD |
PMID:33051911 PMID:33396045 PMID:34714723 PMID:34896426 PMID:36053783 |
|
NCBI chr10:63,154,784...63,174,814
Ensembl chr10:63,154,784...63,217,483
|
|
G |
Slc12a1 |
solute carrier family 12, member 1 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of SLC12A1 protein |
CTD |
PMID:34896426 |
|
NCBI chr 2:124,994,430...125,071,922
Ensembl chr 2:124,994,425...125,071,922
|
|
G |
Slc18a2 |
solute carrier family 18 (vesicular monoamine), member 2 |
decreases expression |
ISO |
cypermethrin results in decreased expression of SLC18A2 mRNA |
CTD |
PMID:20815782 |
|
NCBI chr19:59,249,310...59,284,444
Ensembl chr19:59,249,328...59,284,444
|
|
G |
Slc26a3 |
solute carrier family 26, member 3 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SLC26A3 protein |
CTD |
PMID:34896426 |
|
NCBI chr12:31,483,141...31,523,921
Ensembl chr12:31,440,870...31,523,916
|
|
G |
Slc2a2 |
solute carrier family 2 (facilitated glucose transporter), member 2 |
multiple interactions |
EXP |
cypermethrin promotes the reaction [[lard co-treated with Cholesterol co-treated with Sucrose] results in increased expression of SLC2A2 mRNA] |
CTD |
PMID:24440342 |
|
NCBI chr 3:28,752,052...28,782,510
Ensembl chr 3:28,752,052...28,785,508
|
|
G |
Slc38a5 |
solute carrier family 38, member 5 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SLC38A5 protein |
CTD |
PMID:34896426 |
|
NCBI chr X:8,137,620...8,146,418
Ensembl chr X:8,137,372...8,146,418
|
|
G |
Slc41a3 |
solute carrier family 41, member 3 |
increases expression |
EXP |
cypermethrin results in increased expression of SLC41A3 mRNA |
CTD |
PMID:21142847 |
|
NCBI chr 6:90,579,043...90,623,394
Ensembl chr 6:90,581,707...90,623,394
|
|
G |
Slc44a2 |
solute carrier family 44, member 2 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SLC44A2 protein |
CTD |
PMID:34896426 |
|
NCBI chr 9:21,232,015...21,266,324
Ensembl chr 9:21,231,994...21,266,324
|
|
G |
Slc4a4 |
solute carrier family 4 (anion exchanger), member 4 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SLC4A4 protein |
CTD |
PMID:34896426 |
|
NCBI chr 5:88,941,717...89,387,515
Ensembl chr 5:89,034,345...89,387,512
|
|
G |
Slc52a2 |
solute carrier protein 52, member 2 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SLC52A2 protein |
CTD |
PMID:34896426 |
|
NCBI chr15:76,422,994...76,432,078
Ensembl chr15:76,423,032...76,428,808
|
|
G |
Slc5a5 |
solute carrier family 5 (sodium iodide symporter), member 5 |
multiple interactions |
ISO |
cypermethrin inhibits the reaction [SLC5A5 protein results in increased uptake of Iodine] |
CTD |
PMID:27979590 |
|
NCBI chr 8:71,335,529...71,345,429
Ensembl chr 8:71,335,533...71,345,401
|
|
G |
Slc7a11 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 11 |
increases expression |
ISO |
cypermethrin results in increased expression of SLC7A11 mRNA |
CTD |
PMID:25424538 |
|
NCBI chr 3:50,319,385...50,403,947
Ensembl chr 3:49,846,975...50,398,063
|
|
G |
Slc9a4 |
solute carrier family 9 (sodium/hydrogen exchanger), member 4 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SLC9A4 protein |
CTD |
PMID:34896426 |
|
NCBI chr 1:40,619,146...40,670,188
Ensembl chr 1:40,619,241...40,669,885
|
|
G |
Slfn9 |
schlafen 9 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SLFN13 protein |
CTD |
PMID:34896426 |
|
NCBI chr11:82,865,142...82,883,041
Ensembl chr11:82,869,216...82,882,656
|
|
G |
Smarcad1 |
SWI/SNF-related, matrix-associated actin-dependent regulator of chromatin, subfamily a, containing DEAD/H box 1 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SMARCAD1 protein |
CTD |
PMID:34896426 |
|
NCBI chr 6:65,019,577...65,093,045
Ensembl chr 6:65,019,567...65,093,045
|
|
G |
Smc3 |
structural maintenance of chromosomes 3 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SMC3 protein |
CTD |
PMID:34896426 |
|
NCBI chr19:53,588,827...53,634,262
Ensembl chr19:53,588,829...53,634,264
|
|
G |
Smchd1 |
SMC hinge domain containing 1 |
increases expression |
ISO |
cypermethrin results in increased expression of SMCHD1 protein |
CTD |
PMID:36063984 |
|
NCBI chr17:71,651,484...71,782,361
Ensembl chr17:71,651,484...71,782,338
|
|
G |
Smim12 |
small integral membrane protein 12 |
increases expression |
EXP |
cypermethrin results in increased expression of SMIM12 mRNA |
CTD |
PMID:29020013 |
|
NCBI chr 4:127,137,577...127,141,602
Ensembl chr 4:127,137,577...127,141,602
|
|
G |
Snai1 |
snail family zinc finger 1 |
increases expression |
EXP |
cypermethrin results in increased expression of SNAI1 mRNA |
CTD |
PMID:35031408 |
|
NCBI chr 2:167,380,115...167,384,734
Ensembl chr 2:167,380,115...167,384,734
|
|
G |
Snai2 |
snail family zinc finger 2 |
increases expression |
EXP |
cypermethrin results in increased expression of SNAI2 mRNA |
CTD |
PMID:35031408 |
|
NCBI chr16:14,523,716...14,527,259
Ensembl chr16:14,523,716...14,527,249
|
|
G |
Snap25 |
synaptosomal-associated protein 25 |
decreases expression multiple interactions |
ISO |
cypermethrin results in decreased expression of SNAP25 protein Minocycline inhibits the reaction [cypermethrin results in decreased expression of SNAP25 protein] |
CTD |
PMID:21561882 |
|
NCBI chr 2:136,555,359...136,624,348
Ensembl chr 2:136,555,373...136,624,348
|
|
G |
Snca |
synuclein, alpha |
multiple interactions increases expression |
ISO |
Cyclosporine inhibits the reaction [cypermethrin promotes the reaction [SNCA protein binds to SNCA protein]]; Cyclosporine inhibits the reaction [cypermethrin results in increased expression of SNCA protein]; cypermethrin promotes the reaction [SNCA protein binds to SNCA protein]; Mn(III) 5,10,15,20-tetrakis(N-methylpyridinium-2-yl)porphyrin inhibits the reaction [cypermethrin promotes the reaction [SNCA protein binds to SNCA protein]]; Mn(III) 5,10,15,20-tetrakis(N-methylpyridinium-2-yl)porphyrin inhibits the reaction [cypermethrin results in increased expression of SNCA protein] cypermethrin results in increased expression of SNCA mRNA |
CTD |
PMID:25370934 PMID:27704156 |
|
NCBI chr 6:60,708,557...60,806,839
Ensembl chr 6:60,708,559...60,806,839
|
|
G |
Sned1 |
sushi, nidogen and EGF-like domains 1 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SNED1 protein |
CTD |
PMID:34896426 |
|
NCBI chr 1:93,163,563...93,228,787
Ensembl chr 1:93,163,563...93,228,787
|
|
G |
Sobp |
sine oculis binding protein |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SOBP protein |
CTD |
PMID:34896426 |
|
NCBI chr10:42,878,484...43,059,144
Ensembl chr10:42,878,496...43,050,526
|
|
G |
Socs2 |
suppressor of cytokine signaling 2 |
decreases expression multiple interactions |
EXP |
cypermethrin results in decreased expression of SOCS2 mRNA Sodium Selenite inhibits the reaction [cypermethrin results in decreased expression of SOCS2 mRNA] |
CTD |
PMID:31659573 |
|
NCBI chr10:95,219,765...95,253,176
Ensembl chr10:95,221,224...95,253,042
|
|
G |
Sod1 |
superoxide dismutase 1, soluble |
multiple interactions decreases activity increases activity increases expression decreases expression |
EXP ISO |
[cypermethrin co-treated with Chlorpyrifos] results in decreased activity of SOD1 protein; Plant Extracts inhibits the reaction [[cypermethrin co-treated with Chlorpyrifos] results in decreased activity of SOD1 protein] [cypermethrin co-treated with emamectin benzoate] results in decreased activity of SOD1 protein; [cypermethrin co-treated with fenvalerate] results in increased activity of SOD1 protein cypermethrin results in decreased activity of SOD1 protein cypermethrin results in increased activity of SOD1 protein cypermethrin results in increased expression of SOD1 mRNA cypermethrin results in decreased expression of SOD1 mRNA; cypermethrin results in decreased expression of SOD1 protein CSF2 protein inhibits the reaction [cypermethrin results in decreased activity of SOD1 protein] |
CTD |
PMID:10355540 PMID:12965126 PMID:15365239 PMID:15991261 PMID:21397294 PMID:32214279 PMID:35102696 PMID:35512476 PMID:37871686 PMID:37984602 More...
|
|
NCBI chr16:90,017,650...90,023,221
Ensembl chr16:90,017,642...90,023,217
|
|
G |
Sod2 |
superoxide dismutase 2, mitochondrial |
increases expression affects expression decreases expression |
EXP ISO |
cypermethrin results in increased expression of SOD2 mRNA cypermethrin affects the expression of SOD2 mRNA cypermethrin results in decreased expression of SOD2 mRNA; cypermethrin results in decreased expression of SOD2 protein |
CTD |
PMID:21142847 PMID:21397294 PMID:32214279 PMID:35102696 |
|
NCBI chr17:13,226,726...13,237,006
Ensembl chr17:13,225,733...13,258,950
|
|
G |
Sohlh2 |
spermatogenesis and oogenesis specific basic helix-loop-helix 2 |
increases expression |
ISO |
cypermethrin results in increased expression of SOHLH2 mRNA |
CTD |
PMID:35605701 |
|
NCBI chr 3:55,089,465...55,117,378
Ensembl chr 3:55,089,449...55,117,378
|
|
G |
Sox9 |
SRY (sex determining region Y)-box 9 |
multiple interactions |
ISO |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in increased expression of SOX9 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of SOX9 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SOX9 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of SOX9 mRNA |
CTD |
PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783 |
|
NCBI chr11:112,673,036...112,678,583
Ensembl chr11:112,673,050...112,678,586
|
|
G |
Sp1 |
trans-acting transcription factor 1 |
decreases phosphorylation multiple interactions decreases expression |
EXP ISO |
cypermethrin results in decreased phosphorylation of SP1 protein [cypermethrin co-treated with pyrazolanthrone] results in decreased phosphorylation of SP1 protein; asiatic acid inhibits the reaction [cypermethrin results in decreased phosphorylation of SP1 protein]; cypermethrin results in decreased expression of and results in decreased phosphorylation of SP1 protein; diallyl tetrasulfide inhibits the reaction [cypermethrin results in decreased phosphorylation of SP1 protein] cypermethrin results in decreased expression of SP1 mRNA |
CTD |
PMID:34794910 |
|
NCBI chr15:102,314,751...102,344,839
Ensembl chr15:102,314,578...102,344,839
|
|
G |
Spag1 |
sperm associated antigen 1 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SPAG1 protein |
CTD |
PMID:34896426 |
|
NCBI chr15:36,175,629...36,235,767
Ensembl chr15:36,178,245...36,235,767
|
|
G |
Spata2 |
spermatogenesis associated 2 |
increases expression |
ISO |
cypermethrin results in increased expression of SPATA2 mRNA |
CTD |
PMID:27704156 |
|
NCBI chr 2:167,323,053...167,334,804
Ensembl chr 2:167,323,053...167,334,807
|
|
G |
Spi1 |
Spi-1 proto-oncogene |
multiple interactions |
ISO |
Acetylcysteine inhibits the reaction [cypermethrin inhibits the reaction [Tretinoin results in increased expression of SPI1 mRNA]]; cypermethrin inhibits the reaction [Tretinoin results in increased expression of SPI1 mRNA] |
CTD |
PMID:29945211 |
|
NCBI chr 2:90,912,750...90,946,104
Ensembl chr 2:90,912,735...90,946,101
|
|
G |
Spp1 |
secreted phosphoprotein 1 |
decreases expression |
EXP |
cypermethrin results in decreased expression of SPP1 mRNA |
CTD |
PMID:29020013 |
|
NCBI chr 5:104,582,977...104,588,919
Ensembl chr 5:104,582,984...104,588,916
|
|
G |
Sqstm1 |
sequestosome 1 |
increases expression |
ISO |
cypermethrin results in increased expression of SQSTM1 mRNA |
CTD |
PMID:27704156 |
|
NCBI chr11:50,090,979...50,105,303
Ensembl chr11:50,090,193...50,101,654
|
|
G |
Src |
Rous sarcoma oncogene |
multiple interactions |
EXP |
[cypermethrin results in decreased susceptibility to Dihydrotestosterone] which results in decreased phosphorylation of SRC protein; cypermethrin inhibits the reaction [AR protein binds to SRC protein] |
CTD |
PMID:30974244 |
|
NCBI chr 2:157,265,828...157,313,758
Ensembl chr 2:157,260,364...157,313,782
|
|
G |
Srd5a1 |
steroid 5 alpha-reductase 1 |
decreases expression |
ISO |
cypermethrin results in decreased expression of SRD5A1 mRNA; cypermethrin results in decreased expression of SRD5A1 protein |
CTD |
PMID:34794910 |
|
NCBI chr13:69,721,568...69,759,611
Ensembl chr13:69,721,568...69,759,561
|
|
G |
Srd5a2 |
steroid 5 alpha-reductase 2 |
increases expression decreases expression |
EXP ISO |
cypermethrin results in increased expression of SRD5A2 mRNA cypermethrin results in decreased expression of SRD5A2 mRNA; cypermethrin results in decreased expression of SRD5A2 protein |
CTD |
PMID:21142847 PMID:34794910 |
|
NCBI chr17:74,321,886...74,354,855
Ensembl chr17:74,323,950...74,354,911
|
|
G |
Srebf2 |
sterol regulatory element binding factor 2 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of SREBF2 protein |
CTD |
PMID:34896426 |
|
NCBI chr15:82,031,455...82,089,580
Ensembl chr15:82,031,382...82,089,580
|
|
G |
Srm |
spermidine synthase |
increases expression |
ISO |
cypermethrin results in increased expression of SRM mRNA |
CTD |
PMID:32573024 |
|
NCBI chr 4:148,675,970...148,679,076
Ensembl chr 4:148,675,960...148,679,450
|
|
G |
Srxn1 |
sulfiredoxin 1 homolog (S. cerevisiae) |
increases expression |
EXP |
cypermethrin results in increased expression of SRXN1 mRNA |
CTD |
PMID:21142847 |
|
NCBI chr 2:151,946,738...151,953,296
Ensembl chr 2:151,947,436...151,953,296
|
|
G |
Ssrp1 |
structure specific recognition protein 1 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SSRP1 protein |
CTD |
PMID:34896426 |
|
NCBI chr 2:84,867,519...84,877,453
Ensembl chr 2:84,867,578...84,877,453
|
|
G |
Stab2 |
stabilin 2 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of STAB2 protein |
CTD |
PMID:34896426 |
|
NCBI chr10:86,677,058...86,843,902
Ensembl chr10:86,677,062...86,843,889
|
|
G |
Star |
steroidogenic acute regulatory protein |
decreases expression increases expression multiple interactions |
EXP ISO |
cypermethrin results in decreased expression of STAR mRNA; cypermethrin results in decreased expression of STAR protein cypermethrin results in increased expression of STAR mRNA 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [cypermethrin results in increased expression of STAR mRNA]; Egtazic Acid inhibits the reaction [cypermethrin results in increased expression of STAR mRNA]; Nimodipine inhibits the reaction [cypermethrin results in increased expression of STAR mRNA] [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of STAR mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of STAR mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of STAR mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of STAR mRNA; MIR140 mRNA affects the reaction [cypermethrin results in decreased expression of STAR protein]; SF1 protein inhibits the reaction [cypermethrin results in decreased expression of STAR protein] |
CTD |
PMID:19862501 PMID:21397294 PMID:21560301 PMID:24810582 PMID:28731686 PMID:33051911 PMID:33396045 PMID:34794910 PMID:34896426 PMID:35102696 PMID:35605701 PMID:35931855 PMID:36053783 More...
|
|
NCBI chr 8:26,298,502...26,306,010
Ensembl chr 8:26,296,583...26,306,010
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
multiple interactions increases expression |
ISO |
Quercetin inhibits the reaction [cypermethrin results in increased expression of STAT3 mRNA] |
CTD |
PMID:35876585 |
|
NCBI chr11:100,777,632...100,830,447
Ensembl chr11:100,775,924...100,830,366
|
|
G |
Stat4 |
signal transducer and activator of transcription 4 |
decreases expression multiple interactions |
ISO EXP |
cypermethrin results in decreased expression of STAT4 mRNA Sodium Selenite inhibits the reaction [cypermethrin results in decreased expression of STAT4 mRNA] |
CTD |
PMID:22528246 PMID:31659573 |
|
NCBI chr 1:52,026,265...52,146,348
Ensembl chr 1:52,026,307...52,146,348
|
|
G |
Stat5a |
signal transducer and activator of transcription 5A |
decreases expression |
ISO |
cypermethrin results in decreased expression of STAT5A mRNA |
CTD |
PMID:22528246 |
|
NCBI chr11:100,750,177...100,775,995
Ensembl chr11:100,750,177...100,775,995
|
|
G |
Stmn1 |
stathmin 1 |
decreases expression multiple interactions |
ISO |
cypermethrin results in decreased expression of STMN1 protein Minocycline inhibits the reaction [cypermethrin results in decreased expression of STMN1 protein] |
CTD |
PMID:21561882 |
|
NCBI chr 4:134,195,631...134,201,154
Ensembl chr 4:134,195,631...134,201,154
|
|
G |
Stra8 |
stimulated by retinoic acid gene 8 |
decreases expression |
EXP |
cypermethrin results in decreased expression of STRA8 mRNA |
CTD |
PMID:24810582 |
|
NCBI chr 6:34,897,098...34,916,279
Ensembl chr 6:34,897,098...34,916,279
|
|
G |
Stx12 |
syntaxin 12 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of STX12 protein |
CTD |
PMID:34896426 |
|
NCBI chr 4:132,581,375...132,611,769
Ensembl chr 4:132,580,812...132,611,820
|
|
G |
Sult1a1 |
sulfotransferase family 1A, phenol-preferring, member 1 |
decreases expression |
EXP |
cypermethrin results in decreased expression of SULT1A1 mRNA |
CTD |
PMID:29020013 |
|
NCBI chr 7:126,272,042...126,289,615
Ensembl chr 7:126,272,037...126,275,604
|
|
G |
Sycp1 |
synaptonemal complex protein 1 |
decreases expression |
ISO |
cypermethrin results in decreased expression of SYCP1 mRNA |
CTD |
PMID:35605701 |
|
NCBI chr 3:102,725,815...102,843,416
Ensembl chr 3:102,725,815...102,843,416
|
|
G |
Sycp2 |
synaptonemal complex protein 2 |
increases expression |
ISO |
cypermethrin results in increased expression of SYCP2 mRNA |
CTD |
PMID:27704156 |
|
NCBI chr 2:177,987,088...178,051,580
Ensembl chr 2:177,987,086...178,049,478
|
|
G |
Syn1 |
synapsin I |
decreases expression |
ISO |
cypermethrin results in decreased expression of SYN1 mRNA |
CTD |
PMID:32028016 |
|
NCBI chr X:20,726,750...20,787,157
Ensembl chr X:20,726,750...20,787,243
|
|
G |
Synj2 |
synaptojanin 2 |
decreases expression |
ISO |
cypermethrin results in decreased expression of SYNJ2 protein |
CTD |
PMID:36063984 |
|
NCBI chr17:5,991,555...6,106,041
Ensembl chr17:5,991,555...6,094,565
|
|
G |
Synrg |
synergin, gamma |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of SYNRG protein |
CTD |
PMID:34896426 |
|
NCBI chr11:83,855,217...83,935,404
Ensembl chr11:83,855,254...83,935,404
|
|
G |
Syt17 |
synaptotagmin XVII |
decreases expression |
ISO |
cypermethrin results in decreased expression of SYT17 protein |
CTD |
PMID:36063984 |
|
NCBI chr 7:117,979,936...118,048,120
Ensembl chr 7:117,979,940...118,047,445
|
|
G |
T |
brachyury, T-box transcription factor T |
affects expression |
EXP |
cypermethrin affects the expression of T mRNA |
CTD |
PMID:32214279 |
|
NCBI chr17:8,653,255...8,661,328
Ensembl chr17:8,653,255...8,661,328
|
|
G |
Tab2 |
TGF-beta activated kinase 1/MAP3K7 binding protein 2 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TAB2 protein |
CTD |
PMID:34896426 |
|
NCBI chr10:7,781,412...7,832,039
Ensembl chr10:7,781,417...7,831,994
|
|
G |
Taf7 |
TATA-box binding protein associated factor 7 |
increases expression |
EXP |
cypermethrin results in increased expression of TAF7 mRNA |
CTD |
PMID:29020013 |
|
NCBI chr18:37,773,544...37,777,257
Ensembl chr18:37,773,544...37,777,257
|
|
G |
Tas2r102 |
taste receptor, type 2, member 102 |
decreases expression |
EXP |
cypermethrin results in decreased expression of TAS2R102 mRNA |
CTD |
PMID:29020013 |
|
NCBI chr 6:132,739,094...132,740,137
Ensembl chr 6:132,739,094...132,740,137
|
|
G |
Tat |
tyrosine aminotransferase |
multiple interactions |
ISO |
cypermethrin inhibits the reaction [Hydrocortisone results in increased expression of TAT mRNA] |
CTD |
PMID:26647222 |
|
NCBI chr 8:110,712,710...110,726,436
Ensembl chr 8:110,717,069...110,726,435
|
|
G |
Tbc1d2 |
TBC1 domain family, member 2 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TBC1D2 protein |
CTD |
PMID:34896426 |
|
NCBI chr 4:46,604,390...46,650,396
Ensembl chr 4:46,604,390...46,650,209
|
|
G |
Tbx5 |
T-box 5 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TBX5 protein |
CTD |
PMID:34896426 |
|
NCBI chr 5:119,934,581...120,023,285
Ensembl chr 5:119,970,733...120,023,284
|
|
G |
Terf1 |
telomeric repeat binding factor 1 |
increases expression |
EXP |
cypermethrin results in increased expression of TERF1 mRNA |
CTD |
PMID:21142847 |
|
NCBI chr 1:15,875,634...15,914,283
Ensembl chr 1:15,875,870...15,914,276
|
|
G |
Tet1 |
tet methylcytosine dioxygenase 1 |
multiple interactions |
ISO |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of TET1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of TET1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of TET1 mRNA |
CTD |
PMID:33051911 PMID:33396045 PMID:34896426 |
|
NCBI chr10:62,640,349...62,723,242
Ensembl chr10:62,640,349...62,744,775
|
|
G |
Tex14 |
testis expressed gene 14 intercellular bridge forming factor |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TEX14 protein |
CTD |
PMID:34896426 |
|
NCBI chr11:87,295,839...87,446,649
Ensembl chr11:87,295,891...87,446,649
|
|
G |
Tex24 |
testis expressed gene 24 |
increases expression |
EXP |
cypermethrin results in increased expression of TEX24 mRNA |
CTD |
PMID:29020013 |
|
NCBI chr 8:27,834,351...27,839,458
Ensembl chr 8:27,834,422...27,839,216
|
|
G |
Tff1 |
trefoil factor 1 |
increases expression |
ISO |
cypermethrin results in increased expression of TFF1 mRNA |
CTD |
PMID:12396874 PMID:20397420 |
|
NCBI chr17:31,380,369...31,384,034
Ensembl chr17:31,380,369...31,384,251
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
multiple interactions |
ISO |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of TGFB1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of TGFB1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TGFB1 protein; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of TGFB1 mRNA |
CTD |
PMID:33051911 PMID:33396045 PMID:34896426 |
|
NCBI chr 7:25,386,406...25,404,503
Ensembl chr 7:25,386,427...25,404,502
|
|
G |
Tgfb2 |
transforming growth factor, beta 2 |
multiple interactions |
ISO |
[fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of TGFB2 mRNA |
CTD |
PMID:36053783 |
|
NCBI chr 1:186,354,984...186,441,504
Ensembl chr 1:186,354,989...186,438,186
|
|
G |
Tgm1 |
transglutaminase 1, K polypeptide |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TGM1 protein |
CTD |
PMID:34896426 |
|
NCBI chr14:55,937,466...55,951,378
Ensembl chr14:55,937,466...55,951,383
|
|
G |
Tgoln1 |
trans-golgi network protein |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of TGOLN2 protein |
CTD |
PMID:34896426 |
|
NCBI chr 6:72,585,403...72,593,983
Ensembl chr 6:72,585,415...72,593,983
|
|
G |
Th |
tyrosine hydroxylase |
decreases expression |
ISO |
cypermethrin results in decreased expression of TH mRNA; cypermethrin results in decreased expression of TH protein |
CTD |
PMID:26115703 |
|
NCBI chr 7:142,446,516...142,453,732
Ensembl chr 7:142,446,489...142,484,865
|
|
G |
Thy1 |
thymus cell antigen 1, theta |
multiple interactions |
ISO |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of THY1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of THY1 mRNA |
CTD |
PMID:33051911 PMID:33396045 |
|
NCBI chr 9:43,954,681...43,959,876
Ensembl chr 9:43,954,681...43,959,876
|
|
G |
Tigd5 |
tigger transposable element derived 5 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TIGD5 protein |
CTD |
PMID:34896426 |
|
NCBI chr15:75,781,584...75,786,384
Ensembl chr15:75,781,584...75,786,384
|
|
G |
Timm10 |
translocase of inner mitochondrial membrane 10 |
increases expression |
EXP |
cypermethrin results in increased expression of TIMM10 mRNA |
CTD |
PMID:29020013 |
|
NCBI chr 2:84,657,365...84,660,557
Ensembl chr 2:84,657,341...84,660,557
|
|
G |
Timm8a1 |
translocase of inner mitochondrial membrane 8A1 |
increases expression |
EXP |
cypermethrin results in increased expression of TIMM8A1 mRNA |
CTD |
PMID:29020013 |
|
NCBI chr X:133,438,005...133,442,419
Ensembl chr X:133,438,005...133,442,614
|
|
G |
Tmed2 |
transmembrane p24 trafficking protein 2 |
decreases expression |
ISO |
cypermethrin results in decreased expression of TMED2 mRNA |
CTD |
PMID:22528246 |
|
NCBI chr 5:124,678,835...124,688,566
Ensembl chr 5:124,678,758...124,688,569
|
|
G |
Tmem74 |
transmembrane protein 74 |
increases expression |
EXP |
cypermethrin results in increased expression of TMEM74 mRNA |
CTD |
PMID:29020013 |
|
NCBI chr15:43,726,741...43,733,462
Ensembl chr15:43,728,042...43,733,432
|
|
G |
Tmod1 |
tropomodulin 1 |
increases expression |
EXP |
cypermethrin results in increased expression of TMOD1 mRNA |
CTD |
PMID:21142847 |
|
NCBI chr 4:46,038,940...46,116,032
Ensembl chr 4:46,038,935...46,116,032
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions affects expression increases expression |
ISO EXP |
Acetylcysteine inhibits the reaction [cypermethrin results in increased expression of TNF protein]; Quercetin inhibits the reaction [cypermethrin results in increased expression of TNF mRNA]; Sesame Oil affects the reaction [cypermethrin affects the expression of TNF] cypermethrin results in increased expression of TNF mRNA; cypermethrin results in increased expression of TNF protein cypermethrin inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA] |
CTD |
PMID:23900960 PMID:25816392 PMID:29471534 PMID:34714723 PMID:35876585 PMID:36063984 More...
|
|
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
|
|
G |
Tnp1 |
transition protein 1 |
multiple interactions |
ISO |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of TNP1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TNP1 mRNA |
CTD |
PMID:33051911 PMID:33396045 |
|
NCBI chr 1:73,054,233...73,055,058
Ensembl chr 1:73,054,233...73,055,068
|
|
G |
Tnp2 |
transition protein 2 |
multiple interactions |
ISO |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of TNP2 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of TNP2 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TNP2 mRNA |
CTD |
PMID:33051911 PMID:33396045 PMID:34896426 |
|
NCBI chr16:10,605,799...10,606,519
Ensembl chr16:10,605,800...10,606,524
|
|
G |
Tph1 |
tryptophan hydroxylase 1 |
decreases expression |
ISO |
cypermethrin results in decreased expression of TPH1 mRNA; cypermethrin results in decreased expression of TPH1 protein |
CTD |
PMID:26115703 |
|
NCBI chr 7:46,294,065...46,321,961
Ensembl chr 7:46,294,065...46,321,961
|
|
G |
Trdmt1 |
tRNA aspartic acid methyltransferase 1 |
multiple interactions |
ISO |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of DNMT2 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of TRDMT1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TRDMT1 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of DNMT2 mRNA |
CTD |
PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783 |
|
NCBI chr 2:13,509,690...13,549,475
Ensembl chr 2:13,513,825...13,549,479
|
|
G |
Trex1 |
three prime repair exonuclease 1 |
increases expression |
EXP |
cypermethrin results in increased expression of TREX1 mRNA |
CTD |
PMID:21142847 |
|
NCBI chr 9:108,887,000...108,888,791
Ensembl chr 9:108,887,001...108,888,802
|
|
G |
Trf |
transferrin |
increases expression |
EXP |
cypermethrin results in increased expression of TRF protein |
CTD |
PMID:30974244 |
|
NCBI chr 9:103,086,075...103,107,485
Ensembl chr 9:103,081,200...103,107,643
|
|
G |
Trim35 |
tripartite motif-containing 35 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TRIM35 protein |
CTD |
PMID:34896426 |
|
NCBI chr14:66,534,474...66,548,873
Ensembl chr14:66,534,480...66,548,873
|
|
G |
Trmt9b |
tRNA methyltransferase 9B |
increases expression |
EXP |
cypermethrin results in increased expression of TRMT9B mRNA |
CTD |
PMID:29020013 |
|
NCBI chr 8:36,924,643...36,981,738
Ensembl chr 8:36,924,702...36,983,724
|
|
G |
Trp53 |
transformation related protein 53 |
increases expression multiple interactions decreases expression increases mutagenesis |
ISO |
cypermethrin results in increased expression of TP53 mRNA; cypermethrin results in increased expression of TP53 protein Vitamin E inhibits the reaction [cypermethrin results in increased expression of TP53 mRNA] cypermethrin results in decreased expression of TP53 mRNA cypermethrin results in increased mutagenesis of TP53 exon Acetylcysteine inhibits the reaction [cypermethrin results in increased expression of TP53 mRNA] |
CTD |
PMID:22528246 PMID:24759048 PMID:27704156 PMID:28584332 PMID:29945211 PMID:32028016 PMID:36063984 More...
|
|
NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699
|
|
G |
Trpa1 |
transient receptor potential cation channel, subfamily A, member 1 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TRPA1 protein |
CTD |
PMID:34896426 |
|
NCBI chr 1:14,942,868...14,989,086
Ensembl chr 1:14,942,872...14,989,086
|
|
G |
Trpc1 |
transient receptor potential cation channel, subfamily C, member 1 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TRPC1 protein |
CTD |
PMID:34896426 |
|
NCBI chr 9:95,587,125...95,632,438
Ensembl chr 9:95,587,135...95,632,428
|
|
G |
Trpc2 |
transient receptor potential cation channel, subfamily C, member 2 |
increases expression |
EXP |
cypermethrin results in increased expression of TRPC2 mRNA |
CTD |
PMID:21142847 |
|
NCBI chr 7:101,732,323...101,746,071
Ensembl chr 7:101,732,323...101,745,603
|
|
G |
Trpc3 |
transient receptor potential cation channel, subfamily C, member 3 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TRPC3 protein |
CTD |
PMID:34896426 |
|
NCBI chr 3:36,674,626...36,744,276
Ensembl chr 3:36,674,631...36,744,316
|
|
G |
Trpc4 |
transient receptor potential cation channel, subfamily C, member 4 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TRPC4 protein |
CTD |
PMID:34896426 |
|
NCBI chr 3:54,063,441...54,225,892
Ensembl chr 3:54,063,456...54,225,892
|
|
G |
Trpm2 |
transient receptor potential cation channel, subfamily M, member 2 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of TRPM2 mRNA |
CTD |
PMID:33396045 PMID:34896426 |
|
NCBI chr10:77,743,556...77,805,746
Ensembl chr10:77,743,556...77,806,397
|
|
G |
Tshb |
thyroid stimulating hormone, beta subunit |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of TSHB protein |
CTD |
PMID:34896426 |
|
NCBI chr 3:102,684,621...102,718,175
Ensembl chr 3:102,682,781...102,690,034
|
|
G |
Tspo |
translocator protein |
multiple interactions |
ISO |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of TSPO mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of TSPO mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of TSPO mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of TSPO mRNA |
CTD |
PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783 |
|
NCBI chr15:83,447,774...83,458,404
Ensembl chr15:83,447,793...83,458,404
|
|
G |
Tubb3 |
tubulin, beta 3 class III |
increases expression |
ISO |
cypermethrin results in increased expression of TUBB3 mRNA |
CTD |
PMID:32028016 |
|
NCBI chr 8:124,138,292...124,148,754
Ensembl chr 8:124,138,163...124,148,754
|
|
G |
Twist2 |
twist basic helix-loop-helix transcription factor 2 |
increases expression |
EXP |
cypermethrin results in increased expression of TWIST2 mRNA |
CTD |
PMID:35031408 |
|
NCBI chr 1:91,729,183...91,775,756
Ensembl chr 1:91,729,183...91,775,750
|
|
G |
Txnip |
thioredoxin interacting protein |
increases expression decreases expression |
EXP |
cypermethrin results in increased expression of TXNIP mRNA cypermethrin results in decreased expression of TXNIP mRNA |
CTD |
PMID:21142847 PMID:29020013 |
|
NCBI chr 3:96,465,273...96,469,173
Ensembl chr 3:96,465,273...96,469,199
|
|
G |
Txnl4b |
thioredoxin-like 4B |
increases expression |
ISO |
cypermethrin results in increased expression of TXNL4B mRNA |
CTD |
PMID:27704156 |
|
NCBI chr 8:110,292,524...110,300,683
Ensembl chr 8:110,292,524...110,300,683
|
|
G |
Txnrd2 |
thioredoxin reductase 2 |
increases expression |
EXP |
cypermethrin results in increased expression of TXNRD2 mRNA |
CTD |
PMID:21142847 |
|
NCBI chr16:18,245,167...18,297,823
Ensembl chr16:18,245,134...18,297,823
|
|
G |
Txnrd3 |
thioredoxin reductase 3 |
increases expression |
EXP |
cypermethrin results in increased expression of TXNRD3 mRNA |
CTD |
PMID:21142847 |
|
NCBI chr 6:89,620,970...89,652,511
Ensembl chr 6:89,620,970...89,652,511
|
|
G |
Ubb |
ubiquitin B |
decreases expression |
ISO |
cypermethrin results in decreased expression of UBB mRNA |
CTD |
PMID:22528246 |
|
NCBI chr11:62,442,329...62,444,037
Ensembl chr11:62,441,997...62,444,039
|
|
G |
Ugt1a6b |
UDP glucuronosyltransferase 1 family, polypeptide A6B |
increases expression affects expression |
EXP |
cypermethrin results in increased expression of UGT1A6 cypermethrin affects the expression of UGT1A6 mRNA |
CTD |
PMID:32214279 |
|
NCBI chr 1:88,030,979...88,146,720
Ensembl chr 1:88,030,974...88,146,725
|
|
G |
Ulk1 |
unc-51 like kinase 1 |
increases expression |
ISO |
cypermethrin results in increased expression of ULK1 mRNA |
CTD |
PMID:27704156 |
|
NCBI chr 5:110,932,355...110,957,991
Ensembl chr 5:110,932,354...110,957,963
|
|
G |
Unc13b |
unc-13 homolog B |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of UNC13B protein |
CTD |
PMID:34896426 |
|
NCBI chr 4:43,046,193...43,264,873
Ensembl chr 4:43,058,953...43,264,871
|
|
G |
Unc5d |
unc-5 netrin receptor D |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of UNC5D protein |
CTD |
PMID:34896426 |
|
NCBI chr 8:29,136,745...29,709,698
Ensembl chr 8:29,136,745...29,709,664
|
|
G |
Ung |
uracil DNA glycosylase |
increases expression |
EXP |
cypermethrin results in increased expression of UNG mRNA |
CTD |
PMID:21142847 |
|
NCBI chr 5:114,268,427...114,277,382
Ensembl chr 5:114,268,447...114,277,384
|
|
G |
Usp17ld |
ubiquitin specific peptidase 17-like D |
decreases expression |
EXP |
cypermethrin results in decreased expression of USP17LD mRNA |
CTD |
PMID:29020013 |
|
NCBI chr 7:102,899,293...102,901,712
Ensembl chr 7:102,898,944...102,901,712
|
|
G |
Usp4 |
ubiquitin specific peptidase 4 (proto-oncogene) |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of USP4 protein |
CTD |
PMID:34896426 |
|
NCBI chr 9:108,223,763...108,269,744
Ensembl chr 9:108,225,052...108,269,744
|
|
G |
Vav1 |
vav 1 oncogene |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of VAV1 protein |
CTD |
PMID:34896426 |
|
NCBI chr17:57,586,080...57,636,236
Ensembl chr17:57,586,100...57,635,031
|
|
G |
Vegfc |
vascular endothelial growth factor C |
decreases expression |
ISO |
cypermethrin results in decreased expression of VEGFC mRNA |
CTD |
PMID:22528246 |
|
NCBI chr 8:54,530,567...54,639,489
Ensembl chr 8:54,530,641...54,640,131
|
|
G |
Veph1 |
ventricular zone expressed PH domain-containing 1 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of VEPH1 protein |
CTD |
PMID:34896426 |
|
NCBI chr 3:65,960,979...66,204,370
Ensembl chr 3:65,960,979...66,204,258
|
|
G |
Vim |
vimentin |
increases expression decreases expression multiple interactions |
EXP ISO |
cypermethrin results in increased expression of VIM mRNA cypermethrin results in decreased expression of VIM mRNA [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of VIM mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of VIM mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of VIM mRNA; [cypermethrin co-treated with Diethylhexyl Phthalate] results in decreased expression of VIM mRNA |
CTD |
PMID:21142847 PMID:22528246 PMID:24641848 PMID:33051911 PMID:33396045 PMID:34896426 More...
|
|
NCBI chr 2:13,579,122...13,587,637
Ensembl chr 2:13,578,738...13,587,637
|
|
G |
Vldlr |
very low density lipoprotein receptor |
increases expression |
ISO |
cypermethrin results in increased expression of VLDLR mRNA |
CTD |
PMID:25424538 |
|
NCBI chr19:27,190,070...27,231,631
Ensembl chr19:27,193,884...27,231,631
|
|
G |
Vmn1r84 |
vomeronasal 1 receptor 84 |
increases expression |
EXP |
cypermethrin results in increased expression of VMN1R84 mRNA |
CTD |
PMID:29020013 |
|
NCBI chr 7:12,095,735...12,096,691
Ensembl chr 7:12,094,240...12,103,200
|
|
G |
Vmn2r7 |
vomeronasal 2, receptor 7 |
increases expression |
EXP |
cypermethrin results in increased expression of VMN2R7 mRNA |
CTD |
PMID:29020013 |
|
NCBI chr 3:64,598,081...64,627,023
Ensembl chr 3:64,592,465...64,752,186
|
|
G |
Vpreb1a |
V-set pre-B cell surrogate light chain 1A |
decreases expression |
ISO |
cypermethrin results in decreased expression of VPREB1 mRNA |
CTD |
PMID:25424538 |
|
NCBI chr16:16,686,265...16,687,119
Ensembl chr16:16,686,267...16,688,707
|
|
G |
Washc2 |
WASH complex subunit 2 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of WASHC2 protein |
CTD |
PMID:34896426 |
|
NCBI chr 6:116,184,988...116,239,632
Ensembl chr 6:116,184,999...116,239,647
|
|
G |
Wdr26 |
WD repeat domain 26 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of WDR26 protein |
CTD |
PMID:34896426 |
|
NCBI chr 1:181,000,791...181,046,211
Ensembl chr 1:181,000,793...181,039,566
|
|
G |
Wdr81 |
WD repeat domain 81 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of WDR81 protein |
CTD |
PMID:34896426 |
|
NCBI chr11:75,331,769...75,345,544
Ensembl chr11:75,331,770...75,345,543
|
|
G |
Wnt1 |
wingless-type MMTV integration site family, member 1 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of WNT1 mRNA |
CTD |
PMID:33396045 |
|
NCBI chr15:98,687,738...98,691,711
Ensembl chr15:98,687,738...98,691,718
|
|
G |
Wnt3a |
wingless-type MMTV integration site family, member 3A |
increases expression |
ISO |
cypermethrin results in increased expression of WNT3A mRNA |
CTD |
PMID:32028016 |
|
NCBI chr11:59,138,859...59,181,579
Ensembl chr11:59,138,859...59,181,578
|
|
G |
Wnt4 |
wingless-type MMTV integration site family, member 4 |
multiple interactions increases expression |
ISO EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in increased expression of WNT4 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of WNT4 mRNA cypermethrin results in increased expression of WNT4 mRNA |
CTD |
PMID:33051911 PMID:33396045 PMID:35031408 |
|
NCBI chr 4:137,004,946...137,026,812
Ensembl chr 4:137,004,800...137,027,037
|
|
G |
Wnt5a |
wingless-type MMTV integration site family, member 5A |
increases expression |
ISO |
cypermethrin results in increased expression of WNT5A mRNA |
CTD |
PMID:32028016 |
|
NCBI chr14:28,224,962...28,249,405
Ensembl chr14:28,226,707...28,249,405
|
|
G |
Wnt7a |
wingless-type MMTV integration site family, member 7A |
increases expression |
ISO |
cypermethrin results in increased expression of WNT7A mRNA |
CTD |
PMID:32028016 |
|
NCBI chr 6:91,340,963...91,388,335
Ensembl chr 6:91,340,963...91,388,345
|
|
G |
Wrn |
Werner syndrome RecQ like helicase |
increases expression |
EXP |
cypermethrin results in increased expression of WRN mRNA |
CTD |
PMID:21142847 |
|
NCBI chr 8:33,724,400...33,875,591
Ensembl chr 8:33,724,412...33,875,555
|
|
G |
Wt1 |
WT1 transcription factor |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of WT1 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of WT1 mRNA |
CTD |
PMID:34896426 PMID:36053783 |
|
NCBI chr 2:104,956,874...105,003,959
Ensembl chr 2:104,956,874...105,003,961
|
|
G |
Wwp2 |
WW domain containing E3 ubiquitin protein ligase 2 |
increases expression multiple interactions |
ISO |
cypermethrin results in increased expression of WWP2 mRNA DNMT3A protein inhibits the reaction [cypermethrin results in increased expression of WWP2 mRNA] |
CTD |
PMID:34794910 |
|
NCBI chr 8:108,162,966...108,285,922
Ensembl chr 8:108,162,997...108,285,227
|
|
G |
Xaf1 |
XIAP associated factor 1 |
increases expression |
EXP |
cypermethrin results in increased expression of XAF1 mRNA |
CTD |
PMID:35031408 |
|
NCBI chr11:72,192,229...72,204,560
Ensembl chr11:72,192,455...72,204,559
|
|
G |
Xiap |
X-linked inhibitor of apoptosis |
increases expression |
ISO |
cypermethrin results in increased expression of XIAP mRNA |
CTD |
PMID:27704156 |
|
NCBI chr X:41,148,483...41,198,541
Ensembl chr X:41,148,556...41,198,533
|
|
G |
Xpnpep3 |
X-prolyl aminopeptidase 3, mitochondrial |
increases expression |
EXP |
cypermethrin results in increased expression of XPNPEP3 mRNA |
CTD |
PMID:29020013 |
|
NCBI chr15:81,284,282...81,341,683
Ensembl chr15:81,284,339...81,341,683
|
|
G |
Ybx1 |
Y box protein 1 |
increases expression |
ISO |
cypermethrin results in increased expression of YBX1 mRNA |
CTD |
PMID:22528246 |
|
NCBI chr 4:119,134,524...119,153,462
Ensembl chr 4:119,135,178...119,151,801
|
|
G |
Ybx2 |
Y box protein 2 |
multiple interactions |
ISO |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of YBX2 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of YBX2 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of YBX2 mRNA |
CTD |
PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783 |
|
NCBI chr11:69,826,652...69,832,430
Ensembl chr11:69,826,622...69,832,431
|
|
G |
Yy1 |
YY1 transcription factor |
multiple interactions decreases expression |
ISO EXP |
[diallyl trisulfide co-treated with cypermethrin] results in decreased expression of YY1 protein; [pyrazolanthrone co-treated with cypermethrin] results in decreased expression of YY1 protein cypermethrin results in decreased expression of YY1 mRNA; cypermethrin results in decreased expression of YY1 protein |
CTD |
PMID:34794910 |
|
NCBI chr12:108,758,841...108,786,074
Ensembl chr12:108,758,899...108,786,074
|
|
G |
Zbtb16 |
zinc finger and BTB domain containing 16 |
multiple interactions increases expression |
ISO |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of ZBTB16 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of ZBTB16 mRNA cypermethrin results in increased expression of ZBTB16 mRNA |
CTD |
PMID:33051911 PMID:33396045 PMID:35605701 |
|
NCBI chr 9:48,563,097...48,747,525
Ensembl chr 9:48,565,597...48,747,522
|
|
G |
Zfp148 |
zinc finger protein 148 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ZNF148 protein |
CTD |
PMID:34896426 |
|
NCBI chr16:33,201,145...33,324,273
Ensembl chr16:33,201,206...33,324,733
|
|
G |
Zfp300 |
zinc finger protein 300 |
increases expression |
EXP |
cypermethrin results in increased expression of ZFP300 mRNA |
CTD |
PMID:29020013 |
|
NCBI chr X:20,944,447...20,955,934
Ensembl chr X:20,945,413...20,955,766
|
|
G |
Zfp335 |
zinc finger protein 335 |
multiple interactions |
ISO |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ZNF335 protein |
CTD |
PMID:34896426 |
|
NCBI chr 2:164,733,802...164,756,034
Ensembl chr 2:164,733,802...164,753,677
|
|
G |
Zfp36l2 |
zinc finger protein 36, C3H type-like 2 |
increases expression |
EXP |
cypermethrin results in increased expression of ZFP36L2 mRNA |
CTD |
PMID:29020013 |
|
NCBI chr17:84,491,352...84,495,375
Ensembl chr17:84,491,359...84,495,375
|
|
G |
Zfp617 |
zinc finger protein 617 |
increases expression |
EXP |
cypermethrin results in increased expression of ZFP617 mRNA |
CTD |
PMID:29020013 |
|
NCBI chr 8:72,676,669...72,688,474
Ensembl chr 8:72,662,479...72,688,473
|
|
G |
Zfp709 |
zinc finger protein 709 |
increases expression |
EXP |
cypermethrin results in increased expression of ZFP709 mRNA |
CTD |
PMID:29020013 |
|
NCBI chr 8:72,635,912...72,646,409
Ensembl chr 8:72,635,863...72,649,571
|
|